Introduction  ||| S:24 E:45 ||| NN
The  ||| S:45 E:49 ||| DT
liver  ||| S:49 E:55 ||| NN
exclusively  ||| S:55 E:67 ||| RB
synthesizes  ||| S:67 E:79 ||| JJ
bile  ||| S:79 E:84 ||| JJ
acids  ||| S:84 E:90 ||| NNS
from  ||| S:90 E:103 ||| IN
cholesterol  ||| S:103 E:115 ||| NN
via  ||| S:115 E:119 ||| IN
two  ||| S:119 E:123 ||| CD
biosynthetic  ||| S:123 E:136 ||| CD
pathways ||| S:136 E:144 ||| NNS
.  ||| S:144 E:146 ||| .
The  ||| S:146 E:150 ||| DT
"classical ||| S:150 E:160 ||| NN
"  ||| S:160 E:170 ||| ''
pathway  ||| S:170 E:178 ||| NN
begins  ||| S:178 E:185 ||| VBZ
with  ||| S:185 E:190 ||| IN
the  ||| S:190 E:194 ||| DT
7Î±-hydroxylation  ||| S:194 E:211 ||| NN
of  ||| S:211 E:214 ||| IN
cholesterol  ||| S:214 E:226 ||| NN
and  ||| S:226 E:238 ||| CC
operates  ||| S:238 E:247 ||| VBZ
entirely  ||| S:247 E:256 ||| RB
in  ||| S:256 E:259 ||| IN
the  ||| S:259 E:263 ||| DT
liver  ||| S:263 E:269 ||| NN
[  ||| S:269 E:271 ||| -LRB-
1  ||| S:271 E:273 ||| LS
]  ||| S:273 E:275 ||| -RRB-
.  ||| S:275 E:277 ||| .
The  ||| S:277 E:281 ||| DT
"alternative ||| S:281 E:293 ||| NN
"  ||| S:293 E:303 ||| ''
pathway  ||| S:303 E:311 ||| NN
begins  ||| S:311 E:318 ||| VBZ
with  ||| S:318 E:323 ||| IN
the  ||| S:323 E:327 ||| DT
hydroxylation  ||| S:327 E:341 ||| NN
of  ||| S:341 E:344 ||| IN
the  ||| S:344 E:348 ||| DT
cholesterol  ||| S:348 E:368 ||| NN
side  ||| S:368 E:373 ||| NN
chain ||| S:373 E:378 ||| NN
.  ||| S:378 E:380 ||| .
Although  ||| S:380 E:389 ||| IN
this  ||| S:389 E:394 ||| DT
reaction  ||| S:394 E:403 ||| NN
occurs  ||| S:403 E:410 ||| VBZ
in  ||| S:410 E:413 ||| IN
a  ||| S:413 E:415 ||| DT
wide  ||| S:415 E:420 ||| JJ
variety  ||| S:420 E:436 ||| NN
of  ||| S:436 E:439 ||| IN
cells ||| S:439 E:444 ||| NNS
,  ||| S:444 E:446 ||| ,
the  ||| S:446 E:450 ||| DT
completion  ||| S:450 E:461 ||| NN
of  ||| S:461 E:464 ||| IN
bile  ||| S:464 E:469 ||| JJ
acid  ||| S:469 E:474 ||| NN
synthesis  ||| S:474 E:484 ||| NN
takes  ||| S:484 E:490 ||| VBZ
place  ||| S:490 E:504 ||| NN
in  ||| S:504 E:507 ||| IN
liver  ||| S:507 E:513 ||| JJ
cells ||| S:513 E:518 ||| NNS
.  ||| S:518 E:520 ||| .
The  ||| S:520 E:524 ||| DT
classical  ||| S:524 E:534 ||| JJ
pathway  ||| S:534 E:542 ||| NN
is  ||| S:542 E:545 ||| VBZ
responsible  ||| S:545 E:557 ||| JJ
for  ||| S:557 E:569 ||| IN
the  ||| S:569 E:573 ||| DT
bulk  ||| S:573 E:578 ||| NN
of  ||| S:578 E:581 ||| IN
the  ||| S:581 E:585 ||| DT
bile  ||| S:585 E:590 ||| JJ
acids  ||| S:590 E:596 ||| JJ
synthesized  ||| S:596 E:608 ||| NN
by  ||| S:608 E:611 ||| IN
the  ||| S:611 E:615 ||| DT
liver  ||| S:615 E:621 ||| NN
[  ||| S:621 E:623 ||| -LRB-
2  ||| S:623 E:625 ||| CD
3  ||| S:625 E:627 ||| CD
]  ||| S:627 E:637 ||| -RRB-
.  ||| S:637 E:647 ||| .
The  ||| S:647 E:651 ||| DT
major  ||| S:651 E:657 ||| JJ
bile  ||| S:657 E:662 ||| JJ
acid  ||| S:662 E:667 ||| NN
species  ||| S:667 E:675 ||| NNS
produced  ||| S:675 E:684 ||| VBN
by  ||| S:684 E:687 ||| IN
the  ||| S:687 E:691 ||| DT
liver  ||| S:691 E:697 ||| NNS
are  ||| S:697 E:709 ||| VBP
cholic  ||| S:709 E:716 ||| VBN
and  ||| S:716 E:720 ||| CC
chenodeoxycholic  ||| S:720 E:737 ||| JJ
acids ||| S:737 E:742 ||| NNS
.  ||| S:742 E:744 ||| .
These  ||| S:744 E:750 ||| DT
bile  ||| S:750 E:755 ||| JJ
acids  ||| S:755 E:761 ||| NNS
are  ||| S:761 E:773 ||| VBP
conjugated  ||| S:773 E:784 ||| VBN
to  ||| S:784 E:787 ||| TO
either  ||| S:787 E:794 ||| DT
taurine  ||| S:794 E:802 ||| NN
or  ||| S:802 E:805 ||| CC
glycine  ||| S:805 E:813 ||| NN
before  ||| S:813 E:820 ||| IN
secretion  ||| S:820 E:838 ||| NN
into  ||| S:838 E:843 ||| IN
bile  ||| S:843 E:848 ||| NNS
[  ||| S:848 E:850 ||| -LRB-
4  ||| S:850 E:852 ||| LS
]  ||| S:852 E:854 ||| -RRB-
,  ||| S:854 E:856 ||| ,
which  ||| S:856 E:862 ||| WDT
is  ||| S:862 E:865 ||| VBZ
subsequently  ||| S:865 E:878 ||| RB
released  ||| S:878 E:887 ||| VBN
into  ||| S:887 E:892 ||| IN
the  ||| S:892 E:904 ||| DT
small  ||| S:904 E:910 ||| JJ
intestine ||| S:910 E:919 ||| NN
.  ||| S:919 E:921 ||| .
Bile  ||| S:921 E:926 ||| JJ
acids  ||| S:926 E:932 ||| NNS
are  ||| S:932 E:936 ||| VBP
reclaimed  ||| S:936 E:946 ||| VBN
from  ||| S:946 E:951 ||| IN
the  ||| S:951 E:955 ||| DT
lumen  ||| S:955 E:961 ||| NN
of  ||| S:961 E:972 ||| IN
the  ||| S:972 E:976 ||| DT
intestine  ||| S:976 E:986 ||| NN
and  ||| S:986 E:990 ||| CC
returned  ||| S:990 E:999 ||| VBN
to  ||| S:999 E:1002 ||| TO
the  ||| S:1002 E:1006 ||| DT
liver  ||| S:1006 E:1012 ||| NN
via  ||| S:1012 E:1016 ||| IN
portal  ||| S:1016 E:1023 ||| JJ
blood  ||| S:1023 E:1037 ||| NN
for  ||| S:1037 E:1041 ||| IN
reuse  ||| S:1041 E:1047 ||| NNS
[  ||| S:1047 E:1049 ||| -LRB-
1  ||| S:1049 E:1051 ||| LS
]  ||| S:1051 E:1053 ||| -RRB-
.  ||| S:1053 E:1055 ||| .
The  ||| S:1055 E:1059 ||| DT
recovery  ||| S:1059 E:1068 ||| NN
of  ||| S:1068 E:1071 ||| IN
bile  ||| S:1071 E:1076 ||| JJ
acids  ||| S:1076 E:1082 ||| NNS
from  ||| S:1082 E:1087 ||| IN
the  ||| S:1087 E:1099 ||| DT
intestine  ||| S:1099 E:1109 ||| NN
is  ||| S:1109 E:1112 ||| VBZ
an  ||| S:1112 E:1115 ||| DT
efficient  ||| S:1115 E:1125 ||| JJ
process  ||| S:1125 E:1133 ||| NN
that  ||| S:1133 E:1138 ||| WDT
involves  ||| S:1138 E:1147 ||| VBZ
both  ||| S:1147 E:1160 ||| DT
passive  ||| S:1160 E:1168 ||| JJ
transport  ||| S:1168 E:1178 ||| NN
along  ||| S:1178 E:1184 ||| IN
the  ||| S:1184 E:1188 ||| DT
entire  ||| S:1188 E:1195 ||| JJ
axis  ||| S:1195 E:1200 ||| NN
of  ||| S:1200 E:1203 ||| IN
the  ||| S:1203 E:1207 ||| DT
intestine ||| S:1207 E:1216 ||| NN
,  ||| S:1216 E:1226 ||| ,
and  ||| S:1226 E:1230 ||| CC
active  ||| S:1230 E:1237 ||| JJ
transport  ||| S:1237 E:1247 ||| NN
in  ||| S:1247 E:1250 ||| IN
the  ||| S:1250 E:1254 ||| DT
terminal  ||| S:1254 E:1263 ||| NN
ileum  ||| S:1263 E:1269 ||| NNS
[  ||| S:1269 E:1271 ||| -LRB-
5  ||| S:1271 E:1273 ||| LS
]  ||| S:1273 E:1275 ||| -RRB-
.  ||| S:1275 E:1277 ||| .
The  ||| S:1277 E:1289 ||| DT
apical  ||| S:1289 E:1296 ||| FW
sodium ||| S:1296 E:1302 ||| FW
/ ||| S:1302 E:1303 ||| FW
bile  ||| S:1303 E:1308 ||| FW
acid  ||| S:1308 E:1313 ||| FW
co-transporter  ||| S:1313 E:1328 ||| FW
( ||| S:1328 E:1329 ||| -LRB-
asbt ||| S:1329 E:1333 ||| LS
)  ||| S:1333 E:1335 ||| -RRB-
mediates  ||| S:1335 E:1344 ||| VBZ
the  ||| S:1344 E:1356 ||| DT
active  ||| S:1356 E:1363 ||| JJ
uptake  ||| S:1363 E:1370 ||| NN
of  ||| S:1370 E:1373 ||| IN
conjugated  ||| S:1373 E:1384 ||| JJ
bile  ||| S:1384 E:1389 ||| JJ
acids  ||| S:1389 E:1395 ||| NNS
in  ||| S:1395 E:1398 ||| IN
the  ||| S:1398 E:1402 ||| DT
ileum  ||| S:1402 E:1408 ||| NN
[  ||| S:1408 E:1410 ||| -LRB-
5  ||| S:1410 E:1412 ||| CD
6  ||| S:1412 E:1414 ||| CD
]  ||| S:1414 E:1424 ||| -RRB-
.  ||| S:1424 E:1426 ||| .
In  ||| S:1426 E:1429 ||| IN
hepatocytes ||| S:1429 E:1440 ||| NN
,  ||| S:1440 E:1442 ||| ,
both  ||| S:1442 E:1447 ||| DT
sodium-dependent  ||| S:1447 E:1464 ||| JJ
and  ||| S:1464 E:1476 ||| CC
sodium-independent  ||| S:1476 E:1495 ||| JJ
transport  ||| S:1495 E:1505 ||| NN
systems  ||| S:1505 E:1513 ||| NNS
on  ||| S:1513 E:1516 ||| IN
the  ||| S:1516 E:1520 ||| DT
sinusoidal  ||| S:1520 E:1539 ||| FW
membranes  ||| S:1539 E:1549 ||| FW
extract  ||| S:1549 E:1557 ||| FW
bile  ||| S:1557 E:1562 ||| FW
acids  ||| S:1562 E:1568 ||| FW
from  ||| S:1568 E:1573 ||| IN
portal  ||| S:1573 E:1580 ||| JJ
blood ||| S:1580 E:1585 ||| NN
.  ||| S:1585 E:1587 ||| .
Of  ||| S:1587 E:1590 ||| IN
these ||| S:1590 E:1595 ||| DT
,  ||| S:1595 E:1605 ||| ,
the  ||| S:1605 E:1609 ||| DT
sodium ||| S:1609 E:1615 ||| FW
/ ||| S:1615 E:1616 ||| FW
bile  ||| S:1616 E:1621 ||| FW
acid  ||| S:1621 E:1626 ||| FW
co-transporting  ||| S:1626 E:1642 ||| FW
polypeptide  ||| S:1642 E:1654 ||| FW
( ||| S:1654 E:1655 ||| -LRB-
ntcp ||| S:1655 E:1659 ||| LS
)  ||| S:1659 E:1661 ||| -RRB-
is  ||| S:1661 E:1672 ||| VBZ
considered  ||| S:1672 E:1683 ||| VBN
to  ||| S:1683 E:1686 ||| TO
be  ||| S:1686 E:1689 ||| VB
quantitatively  ||| S:1689 E:1704 ||| VBN
the  ||| S:1704 E:1708 ||| DT
most  ||| S:1708 E:1713 ||| RBS
important  ||| S:1713 E:1731 ||| JJ
transporter  ||| S:1731 E:1743 ||| NN
of  ||| S:1743 E:1746 ||| IN
conjugated  ||| S:1746 E:1757 ||| JJ
bile  ||| S:1757 E:1762 ||| JJ
acids  ||| S:1762 E:1768 ||| NNS
in  ||| S:1768 E:1771 ||| IN
these  ||| S:1771 E:1777 ||| DT
cells  ||| S:1777 E:1783 ||| NNS
[  ||| S:1783 E:1785 ||| -LRB-
7  ||| S:1785 E:1787 ||| CD
8  ||| S:1787 E:1789 ||| CD
]  ||| S:1789 E:1799 ||| -RRB-
.  ||| S:1799 E:1801 ||| .
The  ||| S:1801 E:1805 ||| DT
transport  ||| S:1805 E:1815 ||| NN
of  ||| S:1815 E:1818 ||| IN
bile  ||| S:1818 E:1823 ||| JJ
acids  ||| S:1823 E:1829 ||| NNS
from  ||| S:1829 E:1834 ||| IN
the  ||| S:1834 E:1838 ||| DT
basolateral  ||| S:1838 E:1850 ||| NN
to  ||| S:1850 E:1853 ||| TO
the  ||| S:1853 E:1865 ||| DT
canalicular  ||| S:1865 E:1877 ||| JJ
membrane  ||| S:1877 E:1886 ||| NN
of  ||| S:1886 E:1889 ||| IN
liver  ||| S:1889 E:1895 ||| JJ
cells  ||| S:1895 E:1901 ||| NNS
is  ||| S:1901 E:1904 ||| VBZ
a  ||| S:1904 E:1906 ||| DT
poorly  ||| S:1906 E:1913 ||| RB
understood  ||| S:1913 E:1932 ||| VBN
process ||| S:1932 E:1939 ||| NN
.  ||| S:1939 E:1941 ||| .
Intracellular  ||| S:1941 E:1955 ||| JJ
bile  ||| S:1955 E:1960 ||| JJ
acid  ||| S:1960 E:1965 ||| JJ
binding  ||| S:1965 E:1973 ||| JJ
proteins  ||| S:1973 E:1982 ||| NNS
have  ||| S:1982 E:1987 ||| VBP
been  ||| S:1987 E:2000 ||| VBN
postulated  ||| S:2000 E:2011 ||| VBN
to  ||| S:2011 E:2014 ||| TO
participate  ||| S:2014 E:2026 ||| VB
in  ||| S:2026 E:2029 ||| IN
the  ||| S:2029 E:2033 ||| DT
transcellular  ||| S:2033 E:2047 ||| JJ
transport  ||| S:2047 E:2057 ||| NN
as  ||| S:2057 E:2068 ||| IN
well  ||| S:2068 E:2073 ||| RB
as  ||| S:2073 E:2076 ||| RB
to  ||| S:2076 E:2079 ||| TO
buffer  ||| S:2079 E:2086 ||| VB
against  ||| S:2086 E:2094 ||| IN
the  ||| S:2094 E:2098 ||| DT
cytotoxic  ||| S:2098 E:2108 ||| JJ
effects  ||| S:2108 E:2116 ||| NNS
of  ||| S:2116 E:2119 ||| IN
bile  ||| S:2119 E:2132 ||| JJ
acids ||| S:2132 E:2137 ||| NNS
.  ||| S:2137 E:2139 ||| .
ATP-dependent  ||| S:2139 E:2153 ||| JJ
transporters  ||| S:2153 E:2166 ||| NN
on  ||| S:2166 E:2169 ||| IN
the  ||| S:2169 E:2173 ||| DT
canalicular  ||| S:2173 E:2193 ||| JJ
membranes  ||| S:2193 E:2203 ||| NN
of  ||| S:2203 E:2206 ||| IN
hepatocytes  ||| S:2206 E:2218 ||| RB
mediate  ||| S:2218 E:2226 ||| VB
the  ||| S:2226 E:2230 ||| DT
secretion  ||| S:2230 E:2240 ||| NN
of  ||| S:2240 E:2243 ||| IN
bile  ||| S:2243 E:2256 ||| JJ
acids  ||| S:2256 E:2262 ||| NNS
into  ||| S:2262 E:2267 ||| IN
bile  ||| S:2267 E:2272 ||| NNS
[  ||| S:2272 E:2274 ||| -LRB-
9  ||| S:2274 E:2276 ||| CD
]  ||| S:2276 E:2278 ||| -RRB-
.  ||| S:2278 E:2288 ||| .
Recently ||| S:2288 E:2296 ||| RB
,  ||| S:2296 E:2298 ||| ,
it  ||| S:2298 E:2301 ||| PRP
was  ||| S:2301 E:2305 ||| VBD
discovered  ||| S:2305 E:2316 ||| VBN
that  ||| S:2316 E:2321 ||| IN
bile  ||| S:2321 E:2326 ||| JJ
acids  ||| S:2326 E:2332 ||| NNS
are  ||| S:2332 E:2336 ||| VBP
the  ||| S:2336 E:2348 ||| DT
natural  ||| S:2348 E:2356 ||| JJ
ligands  ||| S:2356 E:2364 ||| NN
for  ||| S:2364 E:2368 ||| IN
a  ||| S:2368 E:2370 ||| DT
nuclear  ||| S:2370 E:2378 ||| JJ
receptor  ||| S:2378 E:2387 ||| NN
termed  ||| S:2387 E:2394 ||| VBD
farnesoid  ||| S:2394 E:2404 ||| CD
x  ||| S:2404 E:2414 ||| SYM
receptor  ||| S:2414 E:2423 ||| FW
( ||| S:2423 E:2424 ||| -LRB-
FXR ||| S:2424 E:2427 ||| NNP
;  ||| S:2427 E:2429 ||| :
NR1H4 ||| S:2429 E:2434 ||| CD
)  ||| S:2434 E:2436 ||| -RRB-
[  ||| S:2436 E:2438 ||| -LRB-
10  ||| S:2438 E:2441 ||| CD
11  ||| S:2441 E:2444 ||| CD
12  ||| S:2444 E:2447 ||| CD
]  ||| S:2447 E:2449 ||| -RRB-
.  ||| S:2449 E:2451 ||| .
Therefore ||| S:2451 E:2460 ||| RB
,  ||| S:2460 E:2462 ||| ,
bile  ||| S:2462 E:2467 ||| JJ
acids  ||| S:2467 E:2481 ||| NNS
may  ||| S:2481 E:2485 ||| MD
be  ||| S:2485 E:2488 ||| VB
important  ||| S:2488 E:2498 ||| JJ
regulators  ||| S:2498 E:2509 ||| NNS
of  ||| S:2509 E:2512 ||| IN
gene  ||| S:2512 E:2517 ||| NN
expression  ||| S:2517 E:2528 ||| NN
in  ||| S:2528 E:2531 ||| IN
the  ||| S:2531 E:2535 ||| DT
liver  ||| S:2535 E:2549 ||| NN
and  ||| S:2549 E:2553 ||| CC
intestines ||| S:2553 E:2563 ||| NN
.  ||| S:2563 E:2565 ||| .
To  ||| S:2565 E:2568 ||| TO
date ||| S:2568 E:2572 ||| NN
,  ||| S:2572 E:2574 ||| ,
the  ||| S:2574 E:2578 ||| DT
genes  ||| S:2578 E:2584 ||| NNS
that  ||| S:2584 E:2589 ||| WDT
have  ||| S:2589 E:2594 ||| VBP
been  ||| S:2594 E:2599 ||| VBN
shown  ||| S:2599 E:2605 ||| VBN
to  ||| S:2605 E:2616 ||| TO
be  ||| S:2616 E:2619 ||| VB
responsive  ||| S:2619 E:2630 ||| JJ
to  ||| S:2630 E:2633 ||| TO
regulation  ||| S:2633 E:2644 ||| NN
by  ||| S:2644 E:2647 ||| IN
FXR  ||| S:2647 E:2651 ||| NNP
encode  ||| S:2651 E:2658 ||| NN
proteins  ||| S:2658 E:2667 ||| VBZ
involved  ||| S:2667 E:2684 ||| VBN
in  ||| S:2684 E:2687 ||| IN
the  ||| S:2687 E:2691 ||| DT
biosynthesis  ||| S:2691 E:2704 ||| NN
and  ||| S:2704 E:2708 ||| CC
transport  ||| S:2708 E:2718 ||| NN
of  ||| S:2718 E:2721 ||| IN
bile  ||| S:2721 E:2726 ||| JJ
acids  ||| S:2726 E:2732 ||| NNS
[  ||| S:2732 E:2734 ||| -LRB-
13  ||| S:2734 E:2737 ||| CD
]  ||| S:2737 E:2739 ||| -RRB-
.  ||| S:2739 E:2749 ||| .
Bile  ||| S:2749 E:2754 ||| JJ
acids  ||| S:2754 E:2760 ||| NNS
have  ||| S:2760 E:2765 ||| VBP
been  ||| S:2765 E:2770 ||| VBN
shown  ||| S:2770 E:2776 ||| VBN
to  ||| S:2776 E:2779 ||| TO
modulate  ||| S:2779 E:2788 ||| VB
a  ||| S:2788 E:2790 ||| DT
variety  ||| S:2790 E:2798 ||| NN
of  ||| S:2798 E:2801 ||| IN
other  ||| S:2801 E:2815 ||| JJ
cellular  ||| S:2815 E:2824 ||| JJ
functions ||| S:2824 E:2833 ||| NNS
,  ||| S:2833 E:2835 ||| ,
such  ||| S:2835 E:2840 ||| JJ
as  ||| S:2840 E:2843 ||| IN
secretion  ||| S:2843 E:2853 ||| NN
of  ||| S:2853 E:2856 ||| IN
lipoproteins  ||| S:2856 E:2869 ||| NNS
from  ||| S:2869 E:2882 ||| IN
hepatocytes  ||| S:2882 E:2894 ||| NNS
[  ||| S:2894 E:2896 ||| -LRB-
14  ||| S:2896 E:2899 ||| CD
15  ||| S:2899 E:2902 ||| CD
]  ||| S:2902 E:2904 ||| -RRB-
and  ||| S:2904 E:2908 ||| CC
translocation  ||| S:2908 E:2922 ||| NN
of  ||| S:2922 E:2925 ||| IN
bile  ||| S:2925 E:2930 ||| JJ
acid  ||| S:2930 E:2943 ||| NN
transporters  ||| S:2943 E:2956 ||| NN
to  ||| S:2956 E:2959 ||| TO
the  ||| S:2959 E:2963 ||| DT
hepatocyte  ||| S:2963 E:2974 ||| FW
canalicular  ||| S:2974 E:2986 ||| FW
membrane  ||| S:2986 E:2995 ||| FW
[  ||| S:2995 E:2997 ||| -LRB-
16  ||| S:2997 E:3000 ||| CD
]  ||| S:3000 E:3010 ||| -RRB-
.  ||| S:3010 E:3012 ||| .
In  ||| S:3012 E:3015 ||| IN
McNtcp  ||| S:3015 E:3022 ||| JJ
cells ||| S:3022 E:3027 ||| NNS
,  ||| S:3027 E:3029 ||| ,
which  ||| S:3029 E:3035 ||| WDT
are  ||| S:3035 E:3039 ||| VBP
liver-derived  ||| S:3039 E:3053 ||| JJ
cells  ||| S:3053 E:3059 ||| NNS
engineered  ||| S:3059 E:3078 ||| VBN
to  ||| S:3078 E:3081 ||| TO
transport  ||| S:3081 E:3091 ||| VB
bile  ||| S:3091 E:3096 ||| JJ
acids  ||| S:3096 E:3102 ||| NNS
actively  ||| S:3102 E:3111 ||| RB
[  ||| S:3111 E:3113 ||| -LRB-
17  ||| S:3113 E:3116 ||| CD
]  ||| S:3116 E:3118 ||| -RRB-
,  ||| S:3118 E:3128 ||| ,
taurine-conjugated  ||| S:3128 E:3147 ||| JJ
bile  ||| S:3147 E:3152 ||| NNS
acids  ||| S:3152 E:3158 ||| RB
induce  ||| S:3158 E:3165 ||| VB
the  ||| S:3165 E:3169 ||| DT
formation  ||| S:3169 E:3179 ||| NN
of  ||| S:3179 E:3190 ||| IN
intracellular  ||| S:3190 E:3204 ||| JJ
vesicles  ||| S:3204 E:3213 ||| NN
that  ||| S:3213 E:3218 ||| WDT
resembles  ||| S:3218 E:3228 ||| VBZ
structures  ||| S:3228 E:3239 ||| NNS
observed  ||| S:3239 E:3256 ||| VBD
in  ||| S:3256 E:3259 ||| IN
cholestatic  ||| S:3259 E:3271 ||| JJ
liver  ||| S:3271 E:3277 ||| NN
cells  ||| S:3277 E:3283 ||| NNS
without  ||| S:3283 E:3291 ||| IN
apparent  ||| S:3291 E:3300 ||| JJ
cellular  ||| S:3300 E:3317 ||| JJ
cytotoxicity  ||| S:3317 E:3330 ||| NNS
[  ||| S:3330 E:3332 ||| -LRB-
1  ||| S:3332 E:3334 ||| CD
18  ||| S:3334 E:3337 ||| CD
]  ||| S:3337 E:3339 ||| -RRB-
.  ||| S:3339 E:3341 ||| .
In  ||| S:3341 E:3344 ||| IN
contrast ||| S:3344 E:3352 ||| NN
,  ||| S:3352 E:3354 ||| ,
glycine-conjugated  ||| S:3354 E:3381 ||| JJ
bile  ||| S:3381 E:3386 ||| JJ
acids  ||| S:3386 E:3392 ||| NNS
promote  ||| S:3392 E:3400 ||| VBP
apoptosis  ||| S:3400 E:3410 ||| VBN
in  ||| S:3410 E:3413 ||| IN
these  ||| S:3413 E:3419 ||| DT
cells  ||| S:3419 E:3425 ||| NNS
[  ||| S:3425 E:3427 ||| -LRB-
19  ||| S:3427 E:3430 ||| CD
]  ||| S:3430 E:3432 ||| -RRB-
.  ||| S:3432 E:3434 ||| .
Thus ||| S:3434 E:3438 ||| RB
,  ||| S:3438 E:3448 ||| ,
different  ||| S:3448 E:3458 ||| JJ
classes  ||| S:3458 E:3466 ||| NNS
of  ||| S:3466 E:3469 ||| IN
conjugated  ||| S:3469 E:3480 ||| FW
bile  ||| S:3480 E:3485 ||| FW
acids  ||| S:3485 E:3491 ||| FW
stimulate  ||| S:3491 E:3509 ||| FW
distinctive  ||| S:3509 E:3521 ||| JJ
responses  ||| S:3521 E:3531 ||| NNS
in  ||| S:3531 E:3534 ||| IN
McNtcp  ||| S:3534 E:3541 ||| JJ
cells ||| S:3541 E:3546 ||| NNS
.  ||| S:3546 E:3548 ||| .
Whereas  ||| S:3548 E:3564 ||| IN
taurine-conjugated  ||| S:3564 E:3583 ||| JJ
bile  ||| S:3583 E:3588 ||| JJ
acids  ||| S:3588 E:3594 ||| NNS
are  ||| S:3594 E:3598 ||| VBP
well  ||| S:3598 E:3603 ||| RB
tolerated ||| S:3603 E:3612 ||| JJ
,  ||| S:3612 E:3622 ||| ,
glycine-conjugated  ||| S:3622 E:3641 ||| JJ
bile  ||| S:3641 E:3646 ||| JJ
acids  ||| S:3646 E:3652 ||| NNS
are  ||| S:3652 E:3656 ||| VBP
extremely  ||| S:3656 E:3666 ||| RB
cytotoxic ||| S:3666 E:3675 ||| VBN
.  ||| S:3675 E:3677 ||| .
Here  ||| S:3677 E:3690 ||| RB
we  ||| S:3690 E:3693 ||| PRP
examined  ||| S:3693 E:3702 ||| VBD
if  ||| S:3702 E:3705 ||| IN
this  ||| S:3705 E:3710 ||| DT
differential  ||| S:3710 E:3723 ||| JJ
response  ||| S:3723 E:3732 ||| NN
is  ||| S:3732 E:3735 ||| VBZ
limited  ||| S:3735 E:3743 ||| VBN
to  ||| S:3743 E:3754 ||| TO
cells  ||| S:3754 E:3760 ||| NNS
that  ||| S:3760 E:3765 ||| WDT
normally  ||| S:3765 E:3774 ||| RB
metabolize  ||| S:3774 E:3785 ||| JJ
bile  ||| S:3785 E:3790 ||| JJ
acids ||| S:3790 E:3795 ||| NNS
,  ||| S:3795 E:3797 ||| ,
and  ||| S:3797 E:3801 ||| CC
whether  ||| S:3801 E:3809 ||| IN
high  ||| S:3809 E:3822 ||| JJ
level  ||| S:3822 E:3828 ||| NN
expression  ||| S:3828 E:3839 ||| NN
of  ||| S:3839 E:3842 ||| IN
an  ||| S:3842 E:3845 ||| DT
intracellular  ||| S:3845 E:3859 ||| JJ
bile  ||| S:3859 E:3864 ||| JJ
acid  ||| S:3864 E:3869 ||| JJ
binding  ||| S:3869 E:3885 ||| JJ
protein  ||| S:3885 E:3893 ||| NN
can  ||| S:3893 E:3897 ||| MD
attenuate  ||| S:3897 E:3907 ||| VB
the  ||| S:3907 E:3911 ||| DT
cytotoxic  ||| S:3911 E:3921 ||| JJ
response  ||| S:3921 E:3930 ||| NN
of  ||| S:3930 E:3933 ||| IN
McNtcp.24  ||| S:3933 E:3951 ||| CD
cells  ||| S:3951 E:3957 ||| NNS
to  ||| S:3957 E:3960 ||| TO
glycine-conjugated  ||| S:3960 E:3979 ||| JJ
bile  ||| S:3979 E:3984 ||| JJ
acids ||| S:3984 E:3989 ||| NNS
.  ||| S:3989 E:4013 ||| .
Results  ||| S:4013 E:4040 ||| NNS
Differential  ||| S:4040 E:4053 ||| JJ
cytotoxicity  ||| S:4053 E:4066 ||| NN
of  ||| S:4066 E:4069 ||| IN
glycine-conjugated  ||| S:4069 E:4098 ||| JJ
bile  ||| S:4098 E:4103 ||| JJ
acids  ||| S:4103 E:4109 ||| NNS
in  ||| S:4109 E:4112 ||| IN
McNtcp.24  ||| S:4112 E:4122 ||| CD
cells  ||| S:4122 E:4138 ||| NNS
We  ||| S:4138 E:4141 ||| PRP
previously  ||| S:4141 E:4152 ||| RB
showed  ||| S:4152 E:4159 ||| VBD
that  ||| S:4159 E:4164 ||| DT
taurine-conjugated  ||| S:4164 E:4183 ||| JJ
bile  ||| S:4183 E:4198 ||| JJ
acids ||| S:4198 E:4203 ||| NNS
,  ||| S:4203 E:4205 ||| ,
such  ||| S:4205 E:4210 ||| JJ
as  ||| S:4210 E:4213 ||| IN
taurocholic  ||| S:4213 E:4225 ||| NNS
( ||| S:4225 E:4226 ||| -LRB-
TCA ||| S:4226 E:4229 ||| NNP
)  ||| S:4229 E:4231 ||| -RRB-
and  ||| S:4231 E:4245 ||| CC
taurochenodeoxycholic  ||| S:4245 E:4267 ||| NNS
( ||| S:4267 E:4268 ||| -LRB-
TCDCA ||| S:4268 E:4273 ||| NNP
)  ||| S:4273 E:4275 ||| -RRB-
acids ||| S:4275 E:4280 ||| NNS
,  ||| S:4280 E:4282 ||| ,
were  ||| S:4282 E:4287 ||| VBD
well  ||| S:4287 E:4292 ||| RB
tolerated  ||| S:4292 E:4312 ||| VBN
by  ||| S:4312 E:4315 ||| IN
McNtcp.24  ||| S:4315 E:4325 ||| CD
cells  ||| S:4325 E:4331 ||| NNS
[  ||| S:4331 E:4333 ||| -LRB-
18  ||| S:4333 E:4336 ||| CD
]  ||| S:4336 E:4338 ||| -RRB-
.  ||| S:4338 E:4340 ||| .
In  ||| S:4340 E:4343 ||| IN
contrast ||| S:4343 E:4351 ||| NN
,  ||| S:4351 E:4363 ||| ,
glycine-conjugated  ||| S:4363 E:4382 ||| JJ
bile  ||| S:4382 E:4387 ||| JJ
acids ||| S:4387 E:4392 ||| NNS
,  ||| S:4392 E:4394 ||| ,
such  ||| S:4394 E:4399 ||| JJ
as  ||| S:4399 E:4402 ||| IN
glycocholic  ||| S:4402 E:4414 ||| NNS
( ||| S:4414 E:4415 ||| -LRB-
GCA ||| S:4415 E:4418 ||| NNP
)  ||| S:4418 E:4430 ||| -RRB-
and  ||| S:4430 E:4434 ||| CC
glycochenodeoxycholic  ||| S:4434 E:4456 ||| NNS
( ||| S:4456 E:4457 ||| -LRB-
GCDCA ||| S:4457 E:4462 ||| NNP
)  ||| S:4462 E:4464 ||| -RRB-
acids ||| S:4464 E:4469 ||| NNS
,  ||| S:4469 E:4471 ||| ,
were  ||| S:4471 E:4476 ||| VBD
cytotoxic  ||| S:4476 E:4496 ||| VBN
to  ||| S:4496 E:4499 ||| TO
McNtcp.24  ||| S:4499 E:4509 ||| CD
cells  ||| S:4509 E:4515 ||| NNS
[  ||| S:4515 E:4517 ||| -LRB-
1  ||| S:4517 E:4519 ||| LS
]  ||| S:4519 E:4521 ||| -RRB-
concordant  ||| S:4521 E:4532 ||| NN
with  ||| S:4532 E:4537 ||| IN
what  ||| S:4537 E:4542 ||| WP
has  ||| S:4542 E:4546 ||| VBZ
been  ||| S:4546 E:4561 ||| VBN
documented  ||| S:4561 E:4572 ||| VBN
in  ||| S:4572 E:4575 ||| IN
hepatocytes  ||| S:4575 E:4587 ||| NNS
[  ||| S:4587 E:4589 ||| -LRB-
19  ||| S:4589 E:4592 ||| CD
]  ||| S:4592 E:4594 ||| -RRB-
.  ||| S:4594 E:4596 ||| .
Consistent  ||| S:4596 E:4607 ||| JJ
with  ||| S:4607 E:4612 ||| IN
the  ||| S:4612 E:4626 ||| DT
induction  ||| S:4626 E:4636 ||| NN
of  ||| S:4636 E:4639 ||| IN
apoptotic  ||| S:4639 E:4649 ||| JJ
cell  ||| S:4649 E:4654 ||| NN
death ||| S:4654 E:4659 ||| NN
;  ||| S:4659 E:4661 ||| :
GCDCA ||| S:4661 E:4666 ||| NNP
,  ||| S:4666 E:4668 ||| ,
but  ||| S:4668 E:4672 ||| CC
not  ||| S:4672 E:4676 ||| RB
TCA ||| S:4676 E:4679 ||| NNP
,  ||| S:4679 E:4691 ||| ,
preferentially  ||| S:4691 E:4706 ||| VBD
induced  ||| S:4706 E:4714 ||| VBN
the  ||| S:4714 E:4718 ||| DT
activation  ||| S:4718 E:4729 ||| NN
of  ||| S:4729 E:4732 ||| IN
the  ||| S:4732 E:4736 ||| DT
initiator  ||| S:4736 E:4756 ||| JJ
caspase  ||| S:4756 E:4764 ||| NN
8  ||| S:4764 E:4766 ||| CD
in  ||| S:4766 E:4769 ||| IN
McNtcp.24  ||| S:4769 E:4779 ||| CD
cells  ||| S:4779 E:4785 ||| NNS
( ||| S:4785 E:4786 ||| -LRB-
Figure  ||| S:4786 E:4793 ||| NNP
1A ||| S:4793 E:4795 ||| NNP
) ||| S:4795 E:4796 ||| -RRB-
.  ||| S:4796 E:4798 ||| .
Indeed ||| S:4798 E:4804 ||| RB
,  ||| S:4804 E:4816 ||| ,
glycine-conjugated  ||| S:4816 E:4835 ||| JJ
bile  ||| S:4835 E:4840 ||| JJ
acids  ||| S:4840 E:4846 ||| NNS
as  ||| S:4846 E:4849 ||| IN
a  ||| S:4849 E:4851 ||| DT
class  ||| S:4851 E:4857 ||| NN
of  ||| S:4857 E:4860 ||| IN
molecules  ||| S:4860 E:4880 ||| NNS
induced  ||| S:4880 E:4888 ||| VBP
genomic  ||| S:4888 E:4896 ||| JJ
DNA  ||| S:4896 E:4900 ||| NN
fragmentation  ||| S:4900 E:4914 ||| NN
in  ||| S:4914 E:4917 ||| IN
this  ||| S:4917 E:4922 ||| DT
cell  ||| S:4922 E:4927 ||| NN
line  ||| S:4927 E:4932 ||| NN
at  ||| S:4932 E:4945 ||| IN
low  ||| S:4945 E:4949 ||| JJ
concentrations  ||| S:4949 E:4964 ||| NNS
( ||| S:4964 E:4965 ||| -LRB-
50  ||| S:4965 E:4968 ||| CD
Î¼M ||| S:4968 E:4970 ||| NN
) ||| S:4970 E:4971 ||| -RRB-
,  ||| S:4971 E:4973 ||| ,
while  ||| S:4973 E:4979 ||| IN
their  ||| S:4979 E:4985 ||| PRP$
taurine  ||| S:4985 E:5003 ||| JJ
counterparts  ||| S:5003 E:5016 ||| NNS
did  ||| S:5016 E:5020 ||| VBD
not  ||| S:5020 E:5024 ||| RB
( ||| S:5024 E:5025 ||| -LRB-
Figure  ||| S:5025 E:5032 ||| NNP
1B ||| S:5032 E:5034 ||| NNP
) ||| S:5034 E:5035 ||| -RRB-
.  ||| S:5035 E:5037 ||| .
The  ||| S:5037 E:5041 ||| DT
cytotoxicity  ||| S:5041 E:5054 ||| NN
of  ||| S:5054 E:5067 ||| IN
glycine-conjugated  ||| S:5067 E:5086 ||| JJ
bile  ||| S:5086 E:5091 ||| NNS
acids  ||| S:5091 E:5097 ||| VBP
cannot  ||| S:5097 E:5104 ||| RB
be  ||| S:5104 E:5107 ||| VB
attributed  ||| S:5107 E:5118 ||| VBN
simply  ||| S:5118 E:5135 ||| RB
to  ||| S:5135 E:5138 ||| TO
the  ||| S:5138 E:5142 ||| DT
preferential  ||| S:5142 E:5155 ||| JJ
cellular  ||| S:5155 E:5164 ||| JJ
accumulation  ||| S:5164 E:5177 ||| NN
of  ||| S:5177 E:5180 ||| IN
these  ||| S:5180 E:5186 ||| DT
bile  ||| S:5186 E:5201 ||| JJ
acids  ||| S:5201 E:5207 ||| NNS
because  ||| S:5207 E:5215 ||| IN
McNtcp.24  ||| S:5215 E:5225 ||| CD
cells  ||| S:5225 E:5231 ||| NNS
can  ||| S:5231 E:5235 ||| MD
accumulate  ||| S:5235 E:5246 ||| VB
GCA  ||| S:5246 E:5250 ||| NNP
and  ||| S:5250 E:5254 ||| CC
TCA  ||| S:5254 E:5268 ||| NNP
to  ||| S:5268 E:5271 ||| TO
similar  ||| S:5271 E:5279 ||| JJ
levels  ||| S:5279 E:5286 ||| NNS
( ||| S:5286 E:5287 ||| -LRB-
Torchia  ||| S:5287 E:5295 ||| NNP
and  ||| S:5295 E:5299 ||| CC
Agellon ||| S:5299 E:5306 ||| NNP
,  ||| S:5306 E:5308 ||| ,
unpublished  ||| S:5308 E:5330 ||| JJ
observations ||| S:5330 E:5342 ||| NNS
) ||| S:5342 E:5343 ||| -RRB-
.  ||| S:5343 E:5355 ||| .
There  ||| S:5355 E:5361 ||| EX
is  ||| S:5361 E:5364 ||| VBZ
considerable  ||| S:5364 E:5377 ||| JJ
evidence  ||| S:5377 E:5386 ||| NN
to  ||| S:5386 E:5389 ||| TO
suggest  ||| S:5389 E:5397 ||| VB
that  ||| S:5397 E:5402 ||| DT
bile  ||| S:5402 E:5417 ||| JJ
acids  ||| S:5417 E:5423 ||| NNS
activate  ||| S:5423 E:5432 ||| VBP
a  ||| S:5432 E:5434 ||| DT
variety  ||| S:5434 E:5442 ||| NN
of  ||| S:5442 E:5445 ||| IN
cellular  ||| S:5445 E:5454 ||| JJ
signaling  ||| S:5454 E:5464 ||| JJ
pathways  ||| S:5464 E:5483 ||| NN
in  ||| S:5483 E:5486 ||| IN
liver  ||| S:5486 E:5492 ||| JJ
cells  ||| S:5492 E:5498 ||| NNS
[  ||| S:5498 E:5500 ||| -LRB-
20  ||| S:5500 E:5503 ||| CD
]  ||| S:5503 E:5505 ||| -RRB-
.  ||| S:5505 E:5507 ||| .
TCDCA  ||| S:5507 E:5513 ||| NNP
is  ||| S:5513 E:5516 ||| VBZ
capable  ||| S:5516 E:5524 ||| JJ
of  ||| S:5524 E:5527 ||| IN
activating  ||| S:5527 E:5548 ||| CD
PI3K  ||| S:5548 E:5553 ||| CD
activity  ||| S:5553 E:5562 ||| NN
in  ||| S:5562 E:5565 ||| IN
McNtcp.24  ||| S:5565 E:5575 ||| CD
cells  ||| S:5575 E:5581 ||| NNS
and ||| S:5581 E:5584 ||| CC
,  ||| S:5584 E:5586 ||| ,
direct  ||| S:5586 E:5593 ||| JJ
elevation  ||| S:5593 E:5603 ||| NN
of  ||| S:5603 E:5616 ||| IN
PI3K  ||| S:5616 E:5621 ||| CD
activity  ||| S:5621 E:5630 ||| NN
by  ||| S:5630 E:5633 ||| IN
transient  ||| S:5633 E:5643 ||| JJ
expression  ||| S:5643 E:5654 ||| NN
of  ||| S:5654 E:5657 ||| IN
a  ||| S:5657 E:5659 ||| DT
plasmid  ||| S:5659 E:5677 ||| JJ
encoding  ||| S:5677 E:5686 ||| JJ
PI3K  ||| S:5686 E:5691 ||| NN
can  ||| S:5691 E:5695 ||| MD
protect  ||| S:5695 E:5703 ||| VB
McNtcp.24  ||| S:5703 E:5713 ||| CD
cells  ||| S:5713 E:5719 ||| NNS
from  ||| S:5719 E:5734 ||| IN
GCDCA-induced  ||| S:5734 E:5748 ||| JJ
apoptosis  ||| S:5748 E:5758 ||| NNS
[  ||| S:5758 E:5760 ||| -LRB-
21  ||| S:5760 E:5763 ||| CD
]  ||| S:5763 E:5765 ||| -RRB-
.  ||| S:5765 E:5767 ||| .
TCA ||| S:5767 E:5770 ||| NNP
,  ||| S:5770 E:5772 ||| ,
like  ||| S:5772 E:5777 ||| IN
TCDCA ||| S:5777 E:5782 ||| NNP
,  ||| S:5782 E:5784 ||| ,
also  ||| S:5784 E:5799 ||| RB
caused  ||| S:5799 E:5806 ||| VBD
the  ||| S:5806 E:5810 ||| DT
elevation  ||| S:5810 E:5820 ||| NN
of  ||| S:5820 E:5823 ||| IN
PI3K  ||| S:5823 E:5828 ||| CD
activity  ||| S:5828 E:5837 ||| NN
in  ||| S:5837 E:5840 ||| IN
McNtcp.24  ||| S:5840 E:5850 ||| CD
cells  ||| S:5850 E:5866 ||| NNS
( ||| S:5866 E:5867 ||| -LRB-
Figure  ||| S:5867 E:5874 ||| NNP
2A ||| S:5874 E:5876 ||| NNP
) ||| S:5876 E:5877 ||| -RRB-
,  ||| S:5877 E:5879 ||| ,
suggesting  ||| S:5879 E:5890 ||| VBG
that  ||| S:5890 E:5895 ||| DT
activation  ||| S:5895 E:5906 ||| NN
of  ||| S:5906 E:5909 ||| IN
PI3K  ||| S:5909 E:5914 ||| NNP
may  ||| S:5914 E:5918 ||| MD
be  ||| S:5918 E:5921 ||| VB
a  ||| S:5921 E:5933 ||| DT
general  ||| S:5933 E:5941 ||| JJ
response  ||| S:5941 E:5950 ||| NN
to  ||| S:5950 E:5953 ||| TO
taurine-conjugated  ||| S:5953 E:5972 ||| JJ
bile  ||| S:5972 E:5977 ||| JJ
acids ||| S:5977 E:5982 ||| NNS
.  ||| S:5982 E:5994 ||| .
Treatment  ||| S:5994 E:6004 ||| NN
of  ||| S:6004 E:6007 ||| IN
McNtpc.24  ||| S:6007 E:6017 ||| CD
cells  ||| S:6017 E:6023 ||| NNS
with  ||| S:6023 E:6028 ||| IN
LY294002 ||| S:6028 E:6036 ||| NNP
,  ||| S:6036 E:6038 ||| ,
a  ||| S:6038 E:6040 ||| DT
PI3K  ||| S:6040 E:6055 ||| JJ
inhibitor ||| S:6055 E:6064 ||| NN
,  ||| S:6064 E:6066 ||| ,
prior  ||| S:6066 E:6072 ||| RB
to  ||| S:6072 E:6075 ||| TO
the  ||| S:6075 E:6079 ||| DT
addition  ||| S:6079 E:6088 ||| NN
of  ||| S:6088 E:6091 ||| IN
TCA  ||| S:6091 E:6095 ||| NNP
or  ||| S:6095 E:6098 ||| CC
TCDCA  ||| S:6098 E:6104 ||| NNP
resulted  ||| S:6104 E:6123 ||| VBD
in  ||| S:6123 E:6126 ||| IN
the  ||| S:6126 E:6130 ||| DT
loss  ||| S:6130 E:6135 ||| NN
of  ||| S:6135 E:6138 ||| IN
tolerance  ||| S:6138 E:6148 ||| NN
to  ||| S:6148 E:6151 ||| TO
these  ||| S:6151 E:6157 ||| DT
bile  ||| S:6157 E:6162 ||| JJ
acids  ||| S:6162 E:6168 ||| NNS
as  ||| S:6168 E:6181 ||| RB
demonstrated  ||| S:6181 E:6194 ||| VBN
by  ||| S:6194 E:6197 ||| IN
the  ||| S:6197 E:6201 ||| DT
activation  ||| S:6201 E:6212 ||| NN
of  ||| S:6212 E:6215 ||| IN
caspase  ||| S:6215 E:6223 ||| CD
8  ||| S:6223 E:6225 ||| CD
( ||| S:6225 E:6226 ||| -LRB-
Figure  ||| S:6226 E:6233 ||| NNP
2B ||| S:6233 E:6235 ||| NNP
) ||| S:6235 E:6236 ||| -RRB-
.  ||| S:6236 E:6248 ||| .
On  ||| S:6248 E:6251 ||| IN
the  ||| S:6251 E:6255 ||| DT
other  ||| S:6255 E:6261 ||| JJ
hand ||| S:6261 E:6265 ||| NN
,  ||| S:6265 E:6267 ||| ,
preincubation  ||| S:6267 E:6281 ||| VBG
of  ||| S:6281 E:6284 ||| IN
McNtcp.24  ||| S:6284 E:6294 ||| CD
cells  ||| S:6294 E:6300 ||| NNS
with  ||| S:6300 E:6315 ||| IN
either  ||| S:6315 E:6322 ||| DT
TCA  ||| S:6322 E:6326 ||| NNP
or  ||| S:6326 E:6329 ||| CC
TCDCA  ||| S:6329 E:6335 ||| NNP
attenuated  ||| S:6335 E:6346 ||| VBD
the  ||| S:6346 E:6350 ||| DT
GCDCA-mediated  ||| S:6350 E:6375 ||| JJ
activation  ||| S:6375 E:6386 ||| NN
of  ||| S:6386 E:6389 ||| IN
caspase  ||| S:6389 E:6397 ||| CD
8  ||| S:6397 E:6399 ||| CD
( ||| S:6399 E:6400 ||| -LRB-
Figure  ||| S:6400 E:6407 ||| NNP
2C ||| S:6407 E:6409 ||| NNP
) ||| S:6409 E:6410 ||| -RRB-
,  ||| S:6410 E:6412 ||| ,
suggesting  ||| S:6412 E:6423 ||| VBG
that  ||| S:6423 E:6428 ||| IN
the  ||| S:6428 E:6442 ||| DT
activation  ||| S:6442 E:6453 ||| NN
of  ||| S:6453 E:6456 ||| IN
a  ||| S:6456 E:6458 ||| DT
PI3K-dependent  ||| S:6458 E:6473 ||| JJ
survival  ||| S:6473 E:6482 ||| NN
pathway  ||| S:6482 E:6490 ||| NN
is  ||| S:6490 E:6503 ||| VBZ
dominant  ||| S:6503 E:6512 ||| JJ
over  ||| S:6512 E:6517 ||| IN
the  ||| S:6517 E:6521 ||| DT
death  ||| S:6521 E:6527 ||| NN
pathway ||| S:6527 E:6534 ||| NN
.  ||| S:6534 E:6536 ||| .
These  ||| S:6536 E:6542 ||| DT
results  ||| S:6542 E:6550 ||| NNS
also  ||| S:6550 E:6565 ||| RB
indicate  ||| S:6565 E:6574 ||| VB
that  ||| S:6574 E:6579 ||| IN
the  ||| S:6579 E:6583 ||| DT
differential  ||| S:6583 E:6596 ||| JJ
sensitivity  ||| S:6596 E:6608 ||| NN
of  ||| S:6608 E:6611 ||| IN
the  ||| S:6611 E:6625 ||| DT
liver-derived  ||| S:6625 E:6639 ||| JJ
McNtcp.24  ||| S:6639 E:6649 ||| CD
cells  ||| S:6649 E:6655 ||| NNS
to  ||| S:6655 E:6658 ||| TO
conjugated  ||| S:6658 E:6669 ||| VB
bile  ||| S:6669 E:6674 ||| JJ
acids  ||| S:6674 E:6680 ||| NN
is  ||| S:6680 E:6693 ||| VBZ
due  ||| S:6693 E:6697 ||| JJ
to  ||| S:6697 E:6700 ||| TO
the  ||| S:6700 E:6704 ||| DT
existence  ||| S:6704 E:6714 ||| NN
of  ||| S:6714 E:6717 ||| IN
a  ||| S:6717 E:6719 ||| DT
specific  ||| S:6719 E:6728 ||| JJ
mechanism  ||| S:6728 E:6738 ||| NN
that  ||| S:6738 E:6743 ||| WDT
is  ||| S:6743 E:6756 ||| VBZ
capable  ||| S:6756 E:6764 ||| JJ
of  ||| S:6764 E:6767 ||| IN
recognizing  ||| S:6767 E:6779 ||| VBG
different  ||| S:6779 E:6789 ||| JJ
classes  ||| S:6789 E:6797 ||| NNS
of  ||| S:6797 E:6800 ||| IN
conjugated  ||| S:6800 E:6821 ||| JJ
bile  ||| S:6821 E:6826 ||| JJ
acids ||| S:6826 E:6831 ||| NNS
.  ||| S:6831 E:6833 ||| .
In  ||| S:6833 E:6836 ||| IN
these  ||| S:6836 E:6842 ||| DT
cells ||| S:6842 E:6847 ||| NNS
,  ||| S:6847 E:6849 ||| ,
taurine-conjugated  ||| S:6849 E:6868 ||| JJ
bile  ||| S:6868 E:6873 ||| NNS
acids  ||| S:6873 E:6889 ||| VBP
specifically  ||| S:6889 E:6902 ||| RB
increase  ||| S:6902 E:6911 ||| VB
PI3K  ||| S:6911 E:6916 ||| CD
activity  ||| S:6916 E:6925 ||| NN
which ||| S:6925 E:6930 ||| WDT
,  ||| S:6930 E:6932 ||| ,
in  ||| S:6932 E:6935 ||| IN
turn ||| S:6935 E:6939 ||| NN
,  ||| S:6939 E:6941 ||| ,
leads  ||| S:6941 E:6957 ||| VBZ
to  ||| S:6957 E:6960 ||| TO
the  ||| S:6960 E:6964 ||| DT
activation  ||| S:6964 E:6975 ||| NN
of  ||| S:6975 E:6978 ||| IN
a  ||| S:6978 E:6980 ||| DT
survival  ||| S:6980 E:6989 ||| NN
pathway  ||| S:6989 E:6997 ||| NNS
[  ||| S:6997 E:6999 ||| -LRB-
22  ||| S:6999 E:7002 ||| CD
23  ||| S:7002 E:7005 ||| CD
]  ||| S:7005 E:7007 ||| -RRB-
.  ||| S:7007 E:7037 ||| .
Expression  ||| S:7037 E:7048 ||| NN
of  ||| S:7048 E:7051 ||| IN
bile  ||| S:7051 E:7056 ||| JJ
acid  ||| S:7056 E:7061 ||| NN
uptake  ||| S:7061 E:7068 ||| NN
activity  ||| S:7068 E:7077 ||| NN
in  ||| S:7077 E:7080 ||| IN
CHO  ||| S:7080 E:7094 ||| NNP
cells  ||| S:7094 E:7110 ||| NNS
To  ||| S:7110 E:7113 ||| TO
determine  ||| S:7113 E:7123 ||| VB
if  ||| S:7123 E:7126 ||| IN
non-liver  ||| S:7126 E:7136 ||| JJ
derived  ||| S:7136 E:7144 ||| JJ
cells  ||| S:7144 E:7150 ||| NNS
also  ||| S:7150 E:7155 ||| RB
posses  ||| S:7155 E:7172 ||| JJ
differential  ||| S:7172 E:7185 ||| NN
sensitivity  ||| S:7185 E:7197 ||| NN
to  ||| S:7197 E:7200 ||| TO
bile  ||| S:7200 E:7205 ||| VB
acid-induced  ||| S:7205 E:7228 ||| JJ
cytotoxicity ||| S:7228 E:7240 ||| NN
,  ||| S:7240 E:7242 ||| ,
we  ||| S:7242 E:7245 ||| PRP
engineered  ||| S:7245 E:7256 ||| VBD
CHO  ||| S:7256 E:7260 ||| NNP
cells  ||| S:7260 E:7266 ||| NNS
to  ||| S:7266 E:7269 ||| TO
take  ||| S:7269 E:7274 ||| VB
up  ||| S:7274 E:7277 ||| RP
bile  ||| S:7277 E:7292 ||| JJ
acids  ||| S:7292 E:7298 ||| NNS
actively  ||| S:7298 E:7307 ||| RB
by  ||| S:7307 E:7310 ||| IN
expressing  ||| S:7310 E:7321 ||| VBG
asbt ||| S:7321 E:7325 ||| NNS
.  ||| S:7325 E:7327 ||| .
Colonies  ||| S:7327 E:7336 ||| NNS
surviving  ||| S:7336 E:7346 ||| VBG
the  ||| S:7346 E:7360 ||| DT
selection  ||| S:7360 E:7370 ||| NN
process  ||| S:7370 E:7378 ||| NN
were  ||| S:7378 E:7383 ||| VBD
assayed  ||| S:7383 E:7391 ||| VBN
for  ||| S:7391 E:7395 ||| IN
asbt  ||| S:7395 E:7400 ||| JJ
activity  ||| S:7400 E:7409 ||| NN
and  ||| S:7409 E:7423 ||| CC
several  ||| S:7423 E:7431 ||| JJ
clones  ||| S:7431 E:7438 ||| NNS
showing  ||| S:7438 E:7446 ||| VBG
a  ||| S:7446 E:7448 ||| DT
range  ||| S:7448 E:7454 ||| NN
of  ||| S:7454 E:7457 ||| IN
bile  ||| S:7457 E:7462 ||| JJ
acid  ||| S:7462 E:7467 ||| NN
uptake  ||| S:7467 E:7484 ||| NN
activities  ||| S:7484 E:7495 ||| NNS
were  ||| S:7495 E:7500 ||| VBD
selected  ||| S:7500 E:7509 ||| VBN
for  ||| S:7509 E:7513 ||| IN
further  ||| S:7513 E:7521 ||| JJ
analysis ||| S:7521 E:7529 ||| NN
.  ||| S:7529 E:7531 ||| .
Analysis  ||| S:7531 E:7550 ||| NN
of  ||| S:7550 E:7553 ||| IN
total  ||| S:7553 E:7559 ||| JJ
RNA  ||| S:7559 E:7563 ||| NNP
from  ||| S:7563 E:7568 ||| IN
the  ||| S:7568 E:7572 ||| DT
selected  ||| S:7572 E:7581 ||| JJ
clones  ||| S:7581 E:7588 ||| NNS
( ||| S:7588 E:7589 ||| -LRB-
CHO.asbt ||| S:7589 E:7597 ||| NNP
)  ||| S:7597 E:7599 ||| -RRB-
readily  ||| S:7599 E:7617 ||| RB
showed  ||| S:7617 E:7624 ||| VBD
the  ||| S:7624 E:7628 ||| DT
presence  ||| S:7628 E:7637 ||| NN
of  ||| S:7637 E:7640 ||| IN
the  ||| S:7640 E:7644 ||| DT
recombinant  ||| S:7644 E:7656 ||| JJ
asbt  ||| S:7656 E:7661 ||| JJ
mRNA  ||| S:7661 E:7666 ||| NN
( ||| S:7666 E:7667 ||| -LRB-
Figure  ||| S:7667 E:7684 ||| NNP
3A ||| S:7684 E:7686 ||| NNP
) ||| S:7686 E:7687 ||| -RRB-
.  ||| S:7687 E:7689 ||| .
Correspondingly ||| S:7689 E:7704 ||| NNP
,  ||| S:7704 E:7706 ||| ,
in  ||| S:7706 E:7709 ||| IN
CHO.asbt  ||| S:7709 E:7718 ||| CD
lysates ||| S:7718 E:7725 ||| NN
,  ||| S:7725 E:7727 ||| ,
an  ||| S:7727 E:7740 ||| DT
immunoreactive  ||| S:7740 E:7755 ||| JJ
band  ||| S:7755 E:7760 ||| NN
of  ||| S:7760 E:7763 ||| IN
comparable  ||| S:7763 E:7774 ||| JJ
size  ||| S:7774 E:7779 ||| NN
( ||| S:7779 E:7780 ||| -LRB-
~45  ||| S:7780 E:7784 ||| NNP
kDa ||| S:7784 E:7787 ||| NNP
)  ||| S:7787 E:7789 ||| -RRB-
to  ||| S:7789 E:7792 ||| TO
rat  ||| S:7792 E:7806 ||| VB
asbt  ||| S:7806 E:7811 ||| JJ
protein  ||| S:7811 E:7819 ||| NN
can  ||| S:7819 E:7823 ||| MD
be  ||| S:7823 E:7826 ||| VB
easily  ||| S:7826 E:7833 ||| RB
detected  ||| S:7833 E:7842 ||| VBN
using  ||| S:7842 E:7848 ||| VBG
an  ||| S:7848 E:7851 ||| DT
anti-asbt  ||| S:7851 E:7871 ||| JJ
antibody  ||| S:7871 E:7880 ||| NN
( ||| S:7880 E:7881 ||| -LRB-
Figure  ||| S:7881 E:7888 ||| NNP
3B ||| S:7888 E:7890 ||| NNP
) ||| S:7890 E:7891 ||| -RRB-
.  ||| S:7891 E:7893 ||| .
The  ||| S:7893 E:7897 ||| DT
uptake  ||| S:7897 E:7904 ||| NN
of  ||| S:7904 E:7907 ||| IN
bile  ||| S:7907 E:7912 ||| JJ
acids  ||| S:7912 E:7918 ||| NNS
by  ||| S:7918 E:7921 ||| IN
the  ||| S:7921 E:7935 ||| DT
CHO.asbt  ||| S:7935 E:7944 ||| CD
cells  ||| S:7944 E:7950 ||| NNS
was  ||| S:7950 E:7954 ||| VBD
saturable  ||| S:7954 E:7964 ||| VBN
with  ||| S:7964 E:7969 ||| IN
an  ||| S:7969 E:7972 ||| DT
apparent  ||| S:7972 E:7981 ||| JJ
K  ||| S:7981 E:7994 ||| NNP
m  ||| S:7994 E:7996 ||| VBZ
ranging  ||| S:7996 E:8004 ||| VBG
between  ||| S:8004 E:8012 ||| IN
22  ||| S:8012 E:8015 ||| CD
to  ||| S:8015 E:8018 ||| TO
25  ||| S:8018 E:8021 ||| CD
Î¼M  ||| S:8021 E:8024 ||| NNS
( ||| S:8024 E:8025 ||| -LRB-
Figure  ||| S:8025 E:8042 ||| NNP
3C ||| S:8042 E:8044 ||| NNP
) ||| S:8044 E:8045 ||| -RRB-
.  ||| S:8045 E:8047 ||| .
The  ||| S:8047 E:8051 ||| DT
V  ||| S:8051 E:8064 ||| NNP
max  ||| S:8064 E:8068 ||| NN
values  ||| S:8068 E:8075 ||| VBZ
ranged  ||| S:8075 E:8082 ||| VBN
from  ||| S:8082 E:8087 ||| IN
0.323  ||| S:8087 E:8093 ||| CD
to  ||| S:8093 E:8096 ||| TO
2.769  ||| S:8096 E:8112 ||| FW
nmol ||| S:8112 E:8116 ||| FW
/ ||| S:8116 E:8117 ||| FW
mg  ||| S:8117 E:8120 ||| FW
protein ||| S:8120 E:8127 ||| FW
/ ||| S:8127 E:8128 ||| FW
min  ||| S:8128 E:8132 ||| FW
and  ||| S:8132 E:8136 ||| CC
correlated  ||| S:8136 E:8147 ||| NN
with  ||| S:8147 E:8152 ||| IN
the  ||| S:8152 E:8156 ||| DT
abundance  ||| S:8156 E:8166 ||| NN
of  ||| S:8166 E:8179 ||| IN
the  ||| S:8179 E:8183 ||| DT
recombinant  ||| S:8183 E:8195 ||| JJ
asbt  ||| S:8195 E:8200 ||| JJ
mRNA  ||| S:8200 E:8205 ||| JJ
encoded  ||| S:8205 E:8213 ||| NN
by  ||| S:8213 E:8216 ||| IN
the  ||| S:8216 E:8220 ||| DT
transgene ||| S:8220 E:8229 ||| NN
.  ||| S:8229 E:8231 ||| .
The  ||| S:8231 E:8245 ||| DT
uptake  ||| S:8245 E:8252 ||| NN
of  ||| S:8252 E:8255 ||| IN
25  ||| S:8255 E:8258 ||| CD
Î¼M  ||| S:8258 E:8261 ||| JJ
TCA  ||| S:8261 E:8265 ||| NN
by  ||| S:8265 E:8268 ||| IN
CHO.asbt.8  ||| S:8268 E:8279 ||| NNP
and  ||| S:8279 E:8283 ||| CC
CHO.asbt.35  ||| S:8283 E:8295 ||| CD
cells  ||| S:8295 E:8311 ||| NNS
reached  ||| S:8311 E:8319 ||| VBD
steady  ||| S:8319 E:8326 ||| JJ
state  ||| S:8326 E:8332 ||| NN
within  ||| S:8332 E:8339 ||| IN
10  ||| S:8339 E:8342 ||| CD
min  ||| S:8342 E:8346 ||| NNS
( ||| S:8346 E:8347 ||| -LRB-
Figure  ||| S:8347 E:8354 ||| NNP
3D ||| S:8354 E:8356 ||| NNP
) ||| S:8356 E:8357 ||| -RRB-
,  ||| S:8357 E:8359 ||| ,
implying  ||| S:8359 E:8378 ||| VBG
the  ||| S:8378 E:8382 ||| DT
presence  ||| S:8382 E:8391 ||| NN
of  ||| S:8391 E:8394 ||| IN
a  ||| S:8394 E:8396 ||| DT
pathway  ||| S:8396 E:8404 ||| NN
for  ||| S:8404 E:8408 ||| IN
bile  ||| S:8408 E:8413 ||| JJ
acid  ||| S:8413 E:8418 ||| NN
efflux  ||| S:8418 E:8425 ||| NN
in  ||| S:8425 E:8428 ||| IN
CHO  ||| S:8428 E:8442 ||| NNP
cells ||| S:8442 E:8447 ||| NNS
.  ||| S:8447 E:8449 ||| .
Furthermore ||| S:8449 E:8460 ||| RB
,  ||| S:8460 E:8462 ||| ,
it  ||| S:8462 E:8465 ||| PRP
was  ||| S:8465 E:8469 ||| VBD
possible  ||| S:8469 E:8478 ||| JJ
to  ||| S:8478 E:8481 ||| TO
chase  ||| S:8481 E:8487 ||| VB
the  ||| S:8487 E:8501 ||| DT
incorporated  ||| S:8501 E:8514 ||| JJ
radiolabeled  ||| S:8514 E:8527 ||| JJ
TCA  ||| S:8527 E:8531 ||| NN
from  ||| S:8531 E:8536 ||| IN
CHO.asbt.49  ||| S:8536 E:8548 ||| NNP
and  ||| S:8548 E:8562 ||| CC
CHO.asbt.35  ||| S:8562 E:8574 ||| CD
cells  ||| S:8574 E:8580 ||| NNS
( ||| S:8580 E:8581 ||| -LRB-
Figure  ||| S:8581 E:8588 ||| NNP
3E ||| S:8588 E:8590 ||| NNP
) ||| S:8590 E:8591 ||| -RRB-
.  ||| S:8591 E:8593 ||| .
These  ||| S:8593 E:8599 ||| DT
results  ||| S:8599 E:8607 ||| NNS
demonstrate  ||| S:8607 E:8629 ||| VBP
that  ||| S:8629 E:8634 ||| IN
CHO.asbt  ||| S:8634 E:8643 ||| CD
cells  ||| S:8643 E:8649 ||| NNS
express  ||| S:8649 E:8657 ||| VBP
a  ||| S:8657 E:8659 ||| DT
fully  ||| S:8659 E:8665 ||| RB
functional  ||| S:8665 E:8676 ||| JJ
asbt  ||| S:8676 E:8691 ||| JJ
protein ||| S:8691 E:8698 ||| NN
.  ||| S:8698 E:8728 ||| .
Cytotoxic  ||| S:8728 E:8738 ||| JJ
potential  ||| S:8738 E:8748 ||| NN
of  ||| S:8748 E:8751 ||| IN
bile  ||| S:8751 E:8756 ||| JJ
acids  ||| S:8756 E:8762 ||| NNS
in  ||| S:8762 E:8765 ||| IN
CHO.asbt.35  ||| S:8765 E:8787 ||| CD
cells  ||| S:8787 E:8803 ||| NNS
The  ||| S:8803 E:8807 ||| DT
increase  ||| S:8807 E:8816 ||| NN
of  ||| S:8816 E:8819 ||| IN
LDH  ||| S:8819 E:8823 ||| NNP
activity  ||| S:8823 E:8832 ||| NN
in  ||| S:8832 E:8835 ||| IN
the  ||| S:8835 E:8839 ||| DT
culture  ||| S:8839 E:8847 ||| NN
medium  ||| S:8847 E:8854 ||| NN
of  ||| S:8854 E:8867 ||| IN
CHO.asbt.35  ||| S:8867 E:8879 ||| NNP
and  ||| S:8879 E:8883 ||| CC
McNtcp.24  ||| S:8883 E:8893 ||| CD
cells  ||| S:8893 E:8899 ||| NNS
after  ||| S:8899 E:8905 ||| IN
treatment  ||| S:8905 E:8915 ||| NN
with  ||| S:8915 E:8930 ||| IN
glycine-  ||| S:8930 E:8939 ||| JJ
and  ||| S:8939 E:8943 ||| CC
taurine-conjugated  ||| S:8943 E:8962 ||| JJ
bile  ||| S:8962 E:8967 ||| JJ
acids  ||| S:8967 E:8973 ||| NNS
were  ||| S:8973 E:8978 ||| VBD
compared  ||| S:8978 E:8997 ||| VBN
to  ||| S:8997 E:9000 ||| TO
assess  ||| S:9000 E:9007 ||| VB
the  ||| S:9007 E:9011 ||| DT
cytotoxic  ||| S:9011 E:9021 ||| JJ
potential  ||| S:9021 E:9031 ||| NN
of  ||| S:9031 E:9034 ||| IN
bile  ||| S:9034 E:9039 ||| JJ
acids  ||| S:9039 E:9045 ||| NNS
on  ||| S:9045 E:9048 ||| IN
these  ||| S:9048 E:9064 ||| DT
cells ||| S:9064 E:9069 ||| NNS
.  ||| S:9069 E:9071 ||| .
The  ||| S:9071 E:9075 ||| DT
CHO.asbt.35  ||| S:9075 E:9087 ||| JJ
cell  ||| S:9087 E:9092 ||| NN
line  ||| S:9092 E:9097 ||| NN
was  ||| S:9097 E:9101 ||| VBD
chosen  ||| S:9101 E:9108 ||| VBN
for  ||| S:9108 E:9112 ||| IN
this  ||| S:9112 E:9127 ||| DT
study  ||| S:9127 E:9133 ||| NN
because  ||| S:9133 E:9141 ||| IN
this  ||| S:9141 E:9146 ||| DT
cell  ||| S:9146 E:9151 ||| NN
line  ||| S:9151 E:9156 ||| NN
has  ||| S:9156 E:9160 ||| VBZ
bile  ||| S:9160 E:9165 ||| JJ
acid  ||| S:9165 E:9170 ||| NN
uptake  ||| S:9170 E:9187 ||| NN
activity  ||| S:9187 E:9196 ||| NN
that  ||| S:9196 E:9201 ||| WDT
was  ||| S:9201 E:9205 ||| VBD
comparable  ||| S:9205 E:9216 ||| JJ
to  ||| S:9216 E:9219 ||| TO
McNtcp.24  ||| S:9219 E:9229 ||| CD
cells  ||| S:9229 E:9235 ||| NNS
[  ||| S:9235 E:9237 ||| -LRB-
17  ||| S:9237 E:9240 ||| CD
]  ||| S:9240 E:9242 ||| -RRB-
.  ||| S:9242 E:9254 ||| .
LDH  ||| S:9254 E:9258 ||| NNP
activity  ||| S:9258 E:9267 ||| NN
in  ||| S:9267 E:9270 ||| IN
the  ||| S:9270 E:9274 ||| DT
culture  ||| S:9274 E:9282 ||| NN
medium  ||| S:9282 E:9289 ||| NN
of  ||| S:9289 E:9292 ||| IN
McNtcp.24  ||| S:9292 E:9302 ||| CD
cells  ||| S:9302 E:9318 ||| NNS
increased  ||| S:9318 E:9328 ||| VBN
by  ||| S:9328 E:9331 ||| IN
20  ||| S:9331 E:9334 ||| CD
to  ||| S:9334 E:9337 ||| TO
31 ||| S:9337 E:9339 ||| CD
%  ||| S:9339 E:9341 ||| NN
within  ||| S:9341 E:9348 ||| IN
2  ||| S:9348 E:9350 ||| CD
h  ||| S:9350 E:9352 ||| NN
of  ||| S:9352 E:9355 ||| IN
incubating  ||| S:9355 E:9366 ||| VBG
the  ||| S:9366 E:9370 ||| DT
cells  ||| S:9370 E:9386 ||| NNS
in  ||| S:9386 E:9389 ||| IN
medium  ||| S:9389 E:9396 ||| NN
containing  ||| S:9396 E:9407 ||| VBG
100  ||| S:9407 E:9411 ||| CD
Î¼M  ||| S:9411 E:9414 ||| NN
of  ||| S:9414 E:9417 ||| IN
glycine  ||| S:9417 E:9425 ||| JJ
conjugates  ||| S:9425 E:9436 ||| NN
of  ||| S:9436 E:9449 ||| IN
cholic  ||| S:9449 E:9456 ||| JJ
acid ||| S:9456 E:9460 ||| NN
,  ||| S:9460 E:9462 ||| ,
chenodeoxycholic  ||| S:9462 E:9479 ||| JJ
acid ||| S:9479 E:9483 ||| NN
,  ||| S:9483 E:9485 ||| ,
and  ||| S:9485 E:9489 ||| CC
deoxycholic  ||| S:9489 E:9501 ||| JJ
acid  ||| S:9501 E:9516 ||| NN
( ||| S:9516 E:9517 ||| -LRB-
GCA ||| S:9517 E:9520 ||| NNP
,  ||| S:9520 E:9522 ||| ,
GCDCA ||| S:9522 E:9527 ||| NNP
,  ||| S:9527 E:9529 ||| ,
GDCA ||| S:9529 E:9533 ||| NNP
,  ||| S:9533 E:9535 ||| ,
respectively ||| S:9535 E:9547 ||| RB
)  ||| S:9547 E:9549 ||| -RRB-
( ||| S:9549 E:9550 ||| -LRB-
Figure  ||| S:9550 E:9557 ||| NNP
4A ||| S:9557 E:9559 ||| NNP
) ||| S:9559 E:9560 ||| -RRB-
.  ||| S:9560 E:9562 ||| .
GCDCA  ||| S:9562 E:9568 ||| NNP
was  ||| S:9568 E:9582 ||| VBD
the  ||| S:9582 E:9586 ||| DT
most  ||| S:9586 E:9591 ||| RBS
potent  ||| S:9591 E:9598 ||| JJ
in  ||| S:9598 E:9601 ||| IN
inducing  ||| S:9601 E:9610 ||| VBG
the  ||| S:9610 E:9614 ||| DT
release  ||| S:9614 E:9622 ||| NN
of  ||| S:9622 E:9625 ||| IN
LDH  ||| S:9625 E:9629 ||| NNP
among  ||| S:9629 E:9635 ||| IN
the  ||| S:9635 E:9649 ||| DT
bile  ||| S:9649 E:9654 ||| JJ
acids  ||| S:9654 E:9660 ||| NNS
tested  ||| S:9660 E:9667 ||| VBN
whereas  ||| S:9667 E:9675 ||| IN
TCA  ||| S:9675 E:9679 ||| NNP
had  ||| S:9679 E:9683 ||| VBD
little  ||| S:9683 E:9690 ||| JJ
effect  ||| S:9690 E:9697 ||| NN
as  ||| S:9697 E:9710 ||| IN
compared  ||| S:9710 E:9719 ||| VBN
to  ||| S:9719 E:9722 ||| TO
the  ||| S:9722 E:9726 ||| DT
no  ||| S:9726 E:9729 ||| DT
addition  ||| S:9729 E:9738 ||| NN
controls ||| S:9738 E:9746 ||| NNS
.  ||| S:9746 E:9748 ||| .
In  ||| S:9748 E:9751 ||| IN
contrast ||| S:9751 E:9759 ||| NN
,  ||| S:9759 E:9771 ||| ,
incubation  ||| S:9771 E:9782 ||| VBG
of  ||| S:9782 E:9785 ||| IN
CHO.asbt.35  ||| S:9785 E:9797 ||| CD
cells  ||| S:9797 E:9803 ||| NNS
in  ||| S:9803 E:9806 ||| IN
medium  ||| S:9806 E:9813 ||| NN
containing  ||| S:9813 E:9824 ||| VBG
100  ||| S:9824 E:9838 ||| CD
Î¼M  ||| S:9838 E:9841 ||| NN
of  ||| S:9841 E:9844 ||| IN
taurine-  ||| S:9844 E:9853 ||| JJ
or  ||| S:9853 E:9856 ||| CC
glycine-conjugated  ||| S:9856 E:9875 ||| JJ
bile  ||| S:9875 E:9880 ||| NNS
acids  ||| S:9880 E:9886 ||| VBP
resulted  ||| S:9886 E:9905 ||| VBN
in  ||| S:9905 E:9908 ||| IN
a  ||| S:9908 E:9910 ||| DT
time  ||| S:9910 E:9915 ||| NN
dependent  ||| S:9915 E:9925 ||| JJ
increase  ||| S:9925 E:9934 ||| NN
of  ||| S:9934 E:9937 ||| IN
LDH  ||| S:9937 E:9941 ||| NNP
activity  ||| S:9941 E:9950 ||| NN
the  ||| S:9950 E:9954 ||| DT
culture  ||| S:9954 E:9972 ||| NN
medium  ||| S:9972 E:9979 ||| NN
( ||| S:9979 E:9980 ||| -LRB-
Figure  ||| S:9980 E:9987 ||| NNP
4B ||| S:9987 E:9989 ||| NNP
) ||| S:9989 E:9990 ||| -RRB-
.  ||| S:9990 E:9992 ||| .
GCA  ||| S:9992 E:9996 ||| NNP
and  ||| S:9996 E:10000 ||| CC
GCDCA  ||| S:10000 E:10006 ||| NNP
were  ||| S:10006 E:10011 ||| VBD
equally  ||| S:10011 E:10019 ||| RB
potent  ||| S:10019 E:10026 ||| JJ
in  ||| S:10026 E:10039 ||| IN
increasing  ||| S:10039 E:10050 ||| VBG
LDH  ||| S:10050 E:10054 ||| NNP
activity ||| S:10054 E:10062 ||| NN
,  ||| S:10062 E:10064 ||| ,
raising  ||| S:10064 E:10072 ||| VBG
the  ||| S:10072 E:10076 ||| DT
level  ||| S:10076 E:10082 ||| NN
in  ||| S:10082 E:10085 ||| IN
the  ||| S:10085 E:10089 ||| DT
medium  ||| S:10089 E:10106 ||| NN
of  ||| S:10106 E:10109 ||| IN
treated  ||| S:10109 E:10117 ||| JJ
cells  ||| S:10117 E:10123 ||| NNS
by  ||| S:10123 E:10126 ||| IN
40 ||| S:10126 E:10128 ||| CD
%  ||| S:10128 E:10130 ||| NN
within  ||| S:10130 E:10137 ||| IN
6  ||| S:10137 E:10139 ||| CD
h ||| S:10139 E:10140 ||| NNS
.  ||| S:10140 E:10142 ||| .
Taurine-conjugated  ||| S:10142 E:10171 ||| JJ
bile  ||| S:10171 E:10176 ||| NNS
acids  ||| S:10176 E:10182 ||| VBP
also  ||| S:10182 E:10187 ||| RB
raised  ||| S:10187 E:10194 ||| VBD
the  ||| S:10194 E:10198 ||| DT
LDH  ||| S:10198 E:10202 ||| NNP
activity  ||| S:10202 E:10211 ||| NN
in  ||| S:10211 E:10214 ||| IN
the  ||| S:10214 E:10218 ||| DT
medium  ||| S:10218 E:10225 ||| NN
of  ||| S:10225 E:10238 ||| IN
treated  ||| S:10238 E:10246 ||| JJ
cells  ||| S:10246 E:10252 ||| NNS
to  ||| S:10252 E:10255 ||| TO
levels  ||| S:10255 E:10262 ||| NNS
approaching  ||| S:10262 E:10274 ||| VBG
GDCA-treated  ||| S:10274 E:10287 ||| JJ
cells  ||| S:10287 E:10303 ||| NNS
( ||| S:10303 E:10304 ||| -LRB-
Figure  ||| S:10304 E:10311 ||| NNP
4B ||| S:10311 E:10313 ||| NNP
) ||| S:10313 E:10314 ||| -RRB-
.  ||| S:10314 E:10316 ||| .
Treatment  ||| S:10316 E:10326 ||| NN
of  ||| S:10326 E:10329 ||| IN
McArdle  ||| S:10329 E:10337 ||| NNP
RH-7777  ||| S:10337 E:10345 ||| NNP
and  ||| S:10345 E:10349 ||| CC
CHO  ||| S:10349 E:10353 ||| NNP
cells  ||| S:10353 E:10369 ||| NNS
with  ||| S:10369 E:10374 ||| IN
taurine-  ||| S:10374 E:10383 ||| JJ
or  ||| S:10383 E:10386 ||| CC
glycine-conjugated  ||| S:10386 E:10405 ||| JJ
bile  ||| S:10405 E:10410 ||| JJ
acids  ||| S:10410 E:10416 ||| NNS
had  ||| S:10416 E:10420 ||| VBD
little  ||| S:10420 E:10437 ||| JJ
effect  ||| S:10437 E:10444 ||| NN
on  ||| S:10444 E:10447 ||| IN
the  ||| S:10447 E:10451 ||| DT
release  ||| S:10451 E:10459 ||| NN
of  ||| S:10459 E:10462 ||| IN
LDH  ||| S:10462 E:10466 ||| NNP
( ||| S:10466 E:10467 ||| -LRB-
Figure  ||| S:10467 E:10474 ||| NNP
4Cand  ||| S:10474 E:10480 ||| NNP
4D ||| S:10480 E:10482 ||| NNP
) ||| S:10482 E:10483 ||| -RRB-
,  ||| S:10483 E:10495 ||| ,
indicating  ||| S:10495 E:10506 ||| VBG
that  ||| S:10506 E:10511 ||| IN
bile  ||| S:10511 E:10516 ||| JJ
acid  ||| S:10516 E:10521 ||| NN
uptake  ||| S:10521 E:10528 ||| NN
activity  ||| S:10528 E:10537 ||| NN
is  ||| S:10537 E:10540 ||| VBZ
necessary  ||| S:10540 E:10550 ||| JJ
to  ||| S:10550 E:10563 ||| TO
manifest  ||| S:10563 E:10572 ||| VB
their  ||| S:10572 E:10578 ||| PRP$
cytotoxic  ||| S:10578 E:10588 ||| JJ
potential  ||| S:10588 E:10598 ||| NN
in  ||| S:10598 E:10601 ||| IN
both  ||| S:10601 E:10606 ||| DT
cell  ||| S:10606 E:10611 ||| NN
lines ||| S:10611 E:10616 ||| NNS
.  ||| S:10616 E:10618 ||| .
In  ||| S:10618 E:10631 ||| IN
addition ||| S:10631 E:10639 ||| NN
,  ||| S:10639 E:10641 ||| ,
the  ||| S:10641 E:10645 ||| DT
cytotoxicity  ||| S:10645 E:10658 ||| NN
was  ||| S:10658 E:10662 ||| VBD
specific  ||| S:10662 E:10671 ||| JJ
to  ||| S:10671 E:10674 ||| TO
conjugated  ||| S:10674 E:10695 ||| VB
bile  ||| S:10695 E:10700 ||| JJ
acids  ||| S:10700 E:10706 ||| NNS
since  ||| S:10706 E:10712 ||| IN
the  ||| S:10712 E:10716 ||| DT
addition  ||| S:10716 E:10725 ||| NN
of  ||| S:10725 E:10728 ||| IN
non-conjugated  ||| S:10728 E:10743 ||| JJ
bile  ||| S:10743 E:10758 ||| JJ
acids  ||| S:10758 E:10764 ||| NNS
to  ||| S:10764 E:10767 ||| TO
the  ||| S:10767 E:10771 ||| DT
culture  ||| S:10771 E:10779 ||| NN
medium  ||| S:10779 E:10786 ||| NN
of  ||| S:10786 E:10789 ||| IN
bile  ||| S:10789 E:10794 ||| JJ
acid-transporting  ||| S:10794 E:10822 ||| JJ
cells  ||| S:10822 E:10828 ||| NNS
had  ||| S:10828 E:10832 ||| VBD
a  ||| S:10832 E:10834 ||| DT
negligible  ||| S:10834 E:10845 ||| JJ
effect  ||| S:10845 E:10852 ||| NN
on  ||| S:10852 E:10855 ||| IN
the  ||| S:10855 E:10859 ||| DT
release  ||| S:10859 E:10867 ||| NN
of  ||| S:10867 E:10870 ||| IN
LDH  ||| S:10870 E:10874 ||| NNP
into  ||| S:10874 E:10889 ||| IN
the  ||| S:10889 E:10893 ||| DT
culture  ||| S:10893 E:10901 ||| NN
medium ||| S:10901 E:10907 ||| NN
.  ||| S:10907 E:10937 ||| .
Mechanism  ||| S:10937 E:10947 ||| NN
of  ||| S:10947 E:10950 ||| IN
cell  ||| S:10950 E:10955 ||| NN
death  ||| S:10955 E:10971 ||| NN
Members  ||| S:10971 E:10979 ||| NNS
of  ||| S:10979 E:10982 ||| IN
the  ||| S:10982 E:10986 ||| DT
caspase  ||| S:10986 E:10994 ||| JJ
family  ||| S:10994 E:11001 ||| NN
of  ||| S:11001 E:11004 ||| IN
cysteine  ||| S:11004 E:11013 ||| JJ
proteases  ||| S:11013 E:11033 ||| NNS
have  ||| S:11033 E:11038 ||| VBP
been  ||| S:11038 E:11043 ||| VBN
implicated  ||| S:11043 E:11054 ||| VBN
in  ||| S:11054 E:11057 ||| IN
the  ||| S:11057 E:11061 ||| DT
initiation  ||| S:11061 E:11072 ||| NN
and  ||| S:11072 E:11076 ||| CC
execution  ||| S:11076 E:11096 ||| NN
phase  ||| S:11096 E:11102 ||| NN
of  ||| S:11102 E:11105 ||| IN
apoptosis  ||| S:11105 E:11115 ||| NNS
[  ||| S:11115 E:11117 ||| -LRB-
24  ||| S:11117 E:11120 ||| CD
]  ||| S:11120 E:11122 ||| -RRB-
.  ||| S:11122 E:11124 ||| .
In  ||| S:11124 E:11127 ||| IN
addition ||| S:11127 E:11135 ||| NN
,  ||| S:11135 E:11137 ||| ,
several  ||| S:11137 E:11145 ||| JJ
studies  ||| S:11145 E:11163 ||| NNS
have  ||| S:11163 E:11168 ||| VBP
shown  ||| S:11168 E:11174 ||| VBN
the  ||| S:11174 E:11178 ||| DT
activation  ||| S:11178 E:11189 ||| NN
of  ||| S:11189 E:11192 ||| IN
the  ||| S:11192 E:11196 ||| DT
caspase  ||| S:11196 E:11204 ||| JJ
cascade  ||| S:11204 E:11212 ||| NN
by  ||| S:11212 E:11215 ||| IN
toxic  ||| S:11215 E:11231 ||| JJ
bile  ||| S:11231 E:11236 ||| JJ
acids  ||| S:11236 E:11242 ||| NNS
in  ||| S:11242 E:11245 ||| IN
hepatocytes  ||| S:11245 E:11257 ||| NNS
[  ||| S:11257 E:11259 ||| -LRB-
25  ||| S:11259 E:11262 ||| CD
26  ||| S:11262 E:11265 ||| CD
]  ||| S:11265 E:11267 ||| -RRB-
.  ||| S:11267 E:11269 ||| .
We  ||| S:11269 E:11272 ||| PRP
thus  ||| S:11272 E:11277 ||| RB
measured  ||| S:11277 E:11296 ||| VBN
caspase  ||| S:11296 E:11304 ||| JJ
activity  ||| S:11304 E:11313 ||| NN
after  ||| S:11313 E:11319 ||| IN
bile  ||| S:11319 E:11324 ||| JJ
acid  ||| S:11324 E:11329 ||| NN
treatment  ||| S:11329 E:11339 ||| NN
in  ||| S:11339 E:11342 ||| IN
CHO.asbt.35  ||| S:11342 E:11364 ||| CD
cells ||| S:11364 E:11369 ||| NNS
.  ||| S:11369 E:11371 ||| .
Activation  ||| S:11371 E:11382 ||| NNP
of  ||| S:11382 E:11385 ||| IN
caspase  ||| S:11385 E:11393 ||| CD
8  ||| S:11393 E:11395 ||| CD
was  ||| S:11395 E:11399 ||| VBD
detected  ||| S:11399 E:11408 ||| VBN
in  ||| S:11408 E:11421 ||| IN
CHO.asbt.35  ||| S:11421 E:11433 ||| CD
cells  ||| S:11433 E:11439 ||| NNS
after  ||| S:11439 E:11445 ||| IN
treatment  ||| S:11445 E:11455 ||| NN
with  ||| S:11455 E:11460 ||| IN
either  ||| S:11460 E:11467 ||| DT
taurine-  ||| S:11467 E:11476 ||| JJ
or  ||| S:11476 E:11489 ||| CC
glycine-  ||| S:11489 E:11498 ||| JJ
conjugated  ||| S:11498 E:11509 ||| FW
bile  ||| S:11509 E:11514 ||| FW
acids  ||| S:11514 E:11520 ||| FW
( ||| S:11520 E:11521 ||| -LRB-
Figure  ||| S:11521 E:11528 ||| NNP
5A ||| S:11528 E:11530 ||| NNP
) ||| S:11530 E:11531 ||| -RRB-
,  ||| S:11531 E:11533 ||| ,
but  ||| S:11533 E:11537 ||| CC
absent  ||| S:11537 E:11544 ||| JJ
in  ||| S:11544 E:11557 ||| IN
bile  ||| S:11557 E:11562 ||| JJ
acid-treated  ||| S:11562 E:11575 ||| JJ
CHO  ||| S:11575 E:11579 ||| NN
cells  ||| S:11579 E:11585 ||| NNS
( ||| S:11585 E:11586 ||| -LRB-
Figures  ||| S:11586 E:11594 ||| NNP
5A ||| S:11594 E:11596 ||| NNP
) ||| S:11596 E:11597 ||| -RRB-
.  ||| S:11597 E:11599 ||| .
Analysis  ||| S:11599 E:11608 ||| NN
of  ||| S:11608 E:11621 ||| IN
genomic  ||| S:11621 E:11629 ||| JJ
DNA  ||| S:11629 E:11633 ||| NN
isolated  ||| S:11633 E:11642 ||| VBN
from  ||| S:11642 E:11647 ||| IN
treated  ||| S:11647 E:11655 ||| JJ
cells  ||| S:11655 E:11661 ||| NNS
showed  ||| S:11661 E:11668 ||| VBD
that  ||| S:11668 E:11673 ||| IN
TCA  ||| S:11673 E:11687 ||| NNP
and  ||| S:11687 E:11691 ||| CC
GCDCA  ||| S:11691 E:11697 ||| NNP
induced  ||| S:11697 E:11705 ||| JJ
DNA  ||| S:11705 E:11709 ||| NN
laddering  ||| S:11709 E:11719 ||| NN
in  ||| S:11719 E:11722 ||| IN
CHO.asbt.35  ||| S:11722 E:11734 ||| CD
cells  ||| S:11734 E:11750 ||| NNS
( ||| S:11750 E:11751 ||| -LRB-
Figure  ||| S:11751 E:11758 ||| NNP
5B ||| S:11758 E:11760 ||| NNP
) ||| S:11760 E:11761 ||| -RRB-
,  ||| S:11761 E:11763 ||| ,
indicating  ||| S:11763 E:11774 ||| VBG
that  ||| S:11774 E:11779 ||| IN
both  ||| S:11779 E:11784 ||| DT
classes  ||| S:11784 E:11792 ||| NNS
of  ||| S:11792 E:11795 ||| IN
conjugated  ||| S:11795 E:11816 ||| FW
bile  ||| S:11816 E:11821 ||| FW
acids  ||| S:11821 E:11827 ||| FW
induce  ||| S:11827 E:11834 ||| FW
apoptosis  ||| S:11834 E:11844 ||| FW
in  ||| S:11844 E:11847 ||| IN
this  ||| S:11847 E:11852 ||| DT
non-hepatic  ||| S:11852 E:11864 ||| JJ
derived  ||| S:11864 E:11882 ||| JJ
cell  ||| S:11882 E:11887 ||| NN
line ||| S:11887 E:11891 ||| NN
.  ||| S:11891 E:11893 ||| .
To  ||| S:11893 E:11896 ||| TO
further  ||| S:11896 E:11904 ||| RB
characterize  ||| S:11904 E:11917 ||| VB
the  ||| S:11917 E:11921 ||| DT
initiation  ||| S:11921 E:11932 ||| NN
of  ||| S:11932 E:11935 ||| IN
the  ||| S:11935 E:11949 ||| DT
caspase  ||| S:11949 E:11957 ||| JJ
cascade ||| S:11957 E:11964 ||| NN
,  ||| S:11964 E:11966 ||| ,
we  ||| S:11966 E:11969 ||| PRP
determined  ||| S:11969 E:11980 ||| VBD
the  ||| S:11980 E:11984 ||| DT
time  ||| S:11984 E:11989 ||| NN
course  ||| S:11989 E:11996 ||| NN
of  ||| S:11996 E:11999 ||| IN
caspase  ||| S:11999 E:12017 ||| JJ
activation  ||| S:12017 E:12028 ||| NN
by  ||| S:12028 E:12031 ||| IN
bile  ||| S:12031 E:12036 ||| JJ
acids  ||| S:12036 E:12042 ||| NNS
in  ||| S:12042 E:12045 ||| IN
CHO.asbt.35  ||| S:12045 E:12057 ||| NNP
and  ||| S:12057 E:12061 ||| CC
McNtcp.24  ||| S:12061 E:12081 ||| CD
cells ||| S:12081 E:12086 ||| NNS
.  ||| S:12086 E:12088 ||| .
Activation  ||| S:12088 E:12099 ||| NNP
of  ||| S:12099 E:12102 ||| IN
caspase  ||| S:12102 E:12110 ||| CD
8  ||| S:12110 E:12112 ||| CD
in  ||| S:12112 E:12115 ||| IN
both  ||| S:12115 E:12120 ||| DT
cell  ||| S:12120 E:12125 ||| NN
lines  ||| S:12125 E:12131 ||| NNS
was  ||| S:12131 E:12145 ||| VBD
first  ||| S:12145 E:12151 ||| RB
detected  ||| S:12151 E:12160 ||| VBN
by  ||| S:12160 E:12163 ||| IN
30  ||| S:12163 E:12166 ||| CD
min  ||| S:12166 E:12170 ||| NNS
following  ||| S:12170 E:12180 ||| VBG
GCDCA-treatment  ||| S:12180 E:12196 ||| JJ
and  ||| S:12196 E:12210 ||| CC
was  ||| S:12210 E:12214 ||| VBD
maximal  ||| S:12214 E:12222 ||| VBN
by  ||| S:12222 E:12225 ||| IN
60  ||| S:12225 E:12228 ||| CD
min  ||| S:12228 E:12232 ||| NNS
( ||| S:12232 E:12233 ||| -LRB-
Figure  ||| S:12233 E:12240 ||| NNP
6 ||| S:12240 E:12241 ||| CD
) ||| S:12241 E:12242 ||| -RRB-
.  ||| S:12242 E:12244 ||| .
In  ||| S:12244 E:12247 ||| IN
contrast ||| S:12247 E:12255 ||| NN
,  ||| S:12255 E:12267 ||| ,
TCA-mediated  ||| S:12267 E:12280 ||| JJ
activation  ||| S:12280 E:12291 ||| NN
of  ||| S:12291 E:12294 ||| IN
caspase  ||| S:12294 E:12302 ||| CD
8  ||| S:12302 E:12304 ||| CD
was  ||| S:12304 E:12308 ||| VBD
first  ||| S:12308 E:12314 ||| RB
detected  ||| S:12314 E:12333 ||| VBN
at  ||| S:12333 E:12336 ||| IN
60  ||| S:12336 E:12339 ||| CD
min  ||| S:12339 E:12343 ||| NNS
and  ||| S:12343 E:12347 ||| CC
reached  ||| S:12347 E:12355 ||| VBD
the  ||| S:12355 E:12359 ||| DT
levels  ||| S:12359 E:12366 ||| NNS
induced  ||| S:12366 E:12374 ||| VBN
by  ||| S:12374 E:12377 ||| IN
GCDCA  ||| S:12377 E:12383 ||| NNP
by  ||| S:12383 E:12386 ||| IN
120  ||| S:12386 E:12400 ||| CD
min ||| S:12400 E:12403 ||| NNS
.  ||| S:12403 E:12415 ||| .
Because  ||| S:12415 E:12423 ||| IN
the  ||| S:12423 E:12427 ||| DT
bile  ||| S:12427 E:12432 ||| JJ
acid  ||| S:12432 E:12437 ||| NN
transporters  ||| S:12437 E:12450 ||| VBZ
used  ||| S:12450 E:12455 ||| VBN
to  ||| S:12455 E:12458 ||| TO
establish  ||| S:12458 E:12478 ||| VB
bile  ||| S:12478 E:12483 ||| JJ
acid  ||| S:12483 E:12488 ||| NN
uptake  ||| S:12488 E:12495 ||| NN
activity  ||| S:12495 E:12504 ||| NN
in  ||| S:12504 E:12507 ||| IN
McNtcp.24  ||| S:12507 E:12517 ||| NNP
and  ||| S:12517 E:12521 ||| CC
CHO.asbt.35  ||| S:12521 E:12543 ||| CD
cells  ||| S:12543 E:12549 ||| NNS
were  ||| S:12549 E:12554 ||| VBD
not  ||| S:12554 E:12558 ||| RB
the  ||| S:12558 E:12562 ||| DT
same ||| S:12562 E:12566 ||| JJ
,  ||| S:12566 E:12568 ||| ,
it  ||| S:12568 E:12571 ||| PRP
was  ||| S:12571 E:12575 ||| VBD
possible  ||| S:12575 E:12584 ||| JJ
that  ||| S:12584 E:12589 ||| IN
the  ||| S:12589 E:12603 ||| DT
sensitivity  ||| S:12603 E:12615 ||| NN
of  ||| S:12615 E:12618 ||| IN
CHO.asbt.35  ||| S:12618 E:12630 ||| CD
cells  ||| S:12630 E:12636 ||| NNS
to  ||| S:12636 E:12639 ||| TO
taurine-conjugated  ||| S:12639 E:12668 ||| JJ
bile  ||| S:12668 E:12673 ||| JJ
acids  ||| S:12673 E:12679 ||| NNS
was  ||| S:12679 E:12683 ||| VBD
a  ||| S:12683 E:12685 ||| DT
consequence  ||| S:12685 E:12697 ||| NN
of  ||| S:12697 E:12700 ||| IN
asbt  ||| S:12700 E:12705 ||| JJ
expression ||| S:12705 E:12715 ||| NN
.  ||| S:12715 E:12717 ||| .
To  ||| S:12717 E:12730 ||| TO
address  ||| S:12730 E:12738 ||| VB
this  ||| S:12738 E:12743 ||| DT
possibility ||| S:12743 E:12754 ||| NN
,  ||| S:12754 E:12756 ||| ,
asbt  ||| S:12756 E:12761 ||| NN
was  ||| S:12761 E:12765 ||| VBD
expressed  ||| S:12765 E:12775 ||| VBN
in  ||| S:12775 E:12778 ||| IN
McArdle  ||| S:12778 E:12796 ||| JJ
RH-7777  ||| S:12796 E:12804 ||| CD
cells  ||| S:12804 E:12810 ||| NNS
and  ||| S:12810 E:12814 ||| CC
then  ||| S:12814 E:12819 ||| RB
tested  ||| S:12819 E:12826 ||| VBN
for  ||| S:12826 E:12830 ||| IN
response  ||| S:12830 E:12839 ||| NN
to  ||| S:12839 E:12842 ||| TO
glycine-  ||| S:12842 E:12861 ||| JJ
and  ||| S:12861 E:12865 ||| CC
taurine-conjugated  ||| S:12865 E:12884 ||| JJ
bile  ||| S:12884 E:12889 ||| JJ
acids ||| S:12889 E:12894 ||| NNS
.  ||| S:12894 E:12896 ||| .
As  ||| S:12896 E:12899 ||| RB
shown  ||| S:12899 E:12905 ||| VBN
in  ||| S:12905 E:12908 ||| IN
Figure  ||| S:12908 E:12915 ||| NN
7A ||| S:12915 E:12917 ||| NN
,  ||| S:12917 E:12929 ||| ,
asbt  ||| S:12929 E:12934 ||| FW
conferred  ||| S:12934 E:12944 ||| FW
active  ||| S:12944 E:12951 ||| FW
bile  ||| S:12951 E:12956 ||| FW
acid  ||| S:12956 E:12961 ||| FW
uptake  ||| S:12961 E:12968 ||| FW
activity  ||| S:12968 E:12977 ||| NN
in  ||| S:12977 E:12990 ||| IN
transfected  ||| S:12990 E:13002 ||| JJ
cells ||| S:13002 E:13007 ||| NNS
.  ||| S:13007 E:13009 ||| .
However ||| S:13009 E:13016 ||| RB
,  ||| S:13016 E:13018 ||| ,
activation  ||| S:13018 E:13029 ||| VBG
of  ||| S:13029 E:13032 ||| IN
caspase  ||| S:13032 E:13040 ||| CD
8  ||| S:13040 E:13042 ||| CD
was  ||| S:13042 E:13056 ||| VBD
evident  ||| S:13056 E:13064 ||| JJ
only  ||| S:13064 E:13069 ||| JJ
in  ||| S:13069 E:13072 ||| IN
the  ||| S:13072 E:13076 ||| DT
cells  ||| S:13076 E:13082 ||| NNS
that  ||| S:13082 E:13087 ||| WDT
were  ||| S:13087 E:13092 ||| VBD
treated  ||| S:13092 E:13100 ||| VBN
with  ||| S:13100 E:13105 ||| IN
GCDCA  ||| S:13105 E:13121 ||| NNP
( ||| S:13121 E:13122 ||| -LRB-
Figure  ||| S:13122 E:13129 ||| NNP
7B ||| S:13129 E:13131 ||| NNP
) ||| S:13131 E:13132 ||| -RRB-
.  ||| S:13132 E:13134 ||| .
These  ||| S:13134 E:13140 ||| DT
results  ||| S:13140 E:13148 ||| NNS
demonstrate  ||| S:13148 E:13160 ||| VBP
that  ||| S:13160 E:13165 ||| IN
the  ||| S:13165 E:13179 ||| DT
sensitivity  ||| S:13179 E:13191 ||| NN
of  ||| S:13191 E:13194 ||| IN
this  ||| S:13194 E:13199 ||| DT
cell  ||| S:13199 E:13204 ||| NN
line  ||| S:13204 E:13209 ||| NN
to  ||| S:13209 E:13212 ||| TO
taurine-  ||| S:13212 E:13221 ||| JJ
and  ||| S:13221 E:13235 ||| CC
glycine-conjugated  ||| S:13235 E:13254 ||| JJ
bile  ||| S:13254 E:13259 ||| JJ
acids  ||| S:13259 E:13265 ||| NN
is  ||| S:13265 E:13268 ||| VBZ
not  ||| S:13268 E:13272 ||| RB
dependent  ||| S:13272 E:13282 ||| JJ
on  ||| S:13282 E:13285 ||| IN
a  ||| S:13285 E:13297 ||| DT
specific  ||| S:13297 E:13306 ||| JJ
kind  ||| S:13306 E:13311 ||| NN
of  ||| S:13311 E:13314 ||| IN
bile  ||| S:13314 E:13319 ||| JJ
acid  ||| S:13319 E:13324 ||| NN
transporter ||| S:13324 E:13335 ||| NN
.  ||| S:13335 E:13347 ||| .
Activation  ||| S:13347 E:13358 ||| NNP
of  ||| S:13358 E:13361 ||| IN
a  ||| S:13361 E:13363 ||| DT
PI3K-dependent  ||| S:13363 E:13378 ||| JJ
pathway  ||| S:13378 E:13386 ||| NN
by  ||| S:13386 E:13399 ||| IN
taurine-conjugated  ||| S:13399 E:13418 ||| JJ
bile  ||| S:13418 E:13423 ||| JJ
acids  ||| S:13423 E:13429 ||| NN
appears  ||| S:13429 E:13437 ||| VBZ
to  ||| S:13437 E:13440 ||| TO
decide  ||| S:13440 E:13447 ||| VB
the  ||| S:13447 E:13451 ||| DT
fate  ||| S:13451 E:13466 ||| NN
of  ||| S:13466 E:13469 ||| IN
McNtcp.24  ||| S:13469 E:13479 ||| CD
cells  ||| S:13479 E:13485 ||| NNS
( ||| S:13485 E:13486 ||| -LRB-
Figure  ||| S:13486 E:13493 ||| NNP
2and  ||| S:13493 E:13498 ||| NNP
ref.  ||| S:13498 E:13503 ||| NNP
[  ||| S:13503 E:13505 ||| -LRB-
21  ||| S:13505 E:13508 ||| CD
]  ||| S:13508 E:13510 ||| CD
) ||| S:13510 E:13511 ||| -RRB-
.  ||| S:13511 E:13513 ||| .
Therefore ||| S:13513 E:13522 ||| RB
,  ||| S:13522 E:13534 ||| ,
we  ||| S:13534 E:13537 ||| PRP
determined  ||| S:13537 E:13548 ||| VBD
if  ||| S:13548 E:13551 ||| IN
PI3K  ||| S:13551 E:13556 ||| CD
activity  ||| S:13556 E:13565 ||| NN
was  ||| S:13565 E:13569 ||| VBD
altered  ||| S:13569 E:13577 ||| VBN
in  ||| S:13577 E:13580 ||| IN
bile  ||| S:13580 E:13595 ||| JJ
acid-treated  ||| S:13595 E:13608 ||| JJ
CHO.asbt.35  ||| S:13608 E:13620 ||| CD
cells ||| S:13620 E:13625 ||| NNS
.  ||| S:13625 E:13627 ||| .
As  ||| S:13627 E:13630 ||| RB
shown  ||| S:13630 E:13636 ||| VBN
in  ||| S:13636 E:13639 ||| IN
Figure  ||| S:13639 E:13646 ||| NNP
8 ||| S:13646 E:13647 ||| CD
,  ||| S:13647 E:13659 ||| ,
PI3K  ||| S:13659 E:13664 ||| CD
activity  ||| S:13664 E:13673 ||| NN
in  ||| S:13673 E:13676 ||| IN
response  ||| S:13676 E:13685 ||| NN
to  ||| S:13685 E:13688 ||| TO
TCA  ||| S:13688 E:13692 ||| NNP
or  ||| S:13692 E:13695 ||| CC
GCDCA  ||| S:13695 E:13701 ||| NNP
was  ||| S:13701 E:13705 ||| VBD
not  ||| S:13705 E:13709 ||| RB
evident  ||| S:13709 E:13727 ||| JJ
in  ||| S:13727 E:13730 ||| IN
CHO.asbt.35  ||| S:13730 E:13742 ||| CD
cells ||| S:13742 E:13747 ||| NNS
,  ||| S:13747 E:13749 ||| ,
suggesting  ||| S:13749 E:13760 ||| VBG
that  ||| S:13760 E:13765 ||| IN
the  ||| S:13765 E:13769 ||| DT
inability  ||| S:13769 E:13779 ||| NN
to  ||| S:13779 E:13792 ||| TO
activate  ||| S:13792 E:13801 ||| VB
survival  ||| S:13801 E:13810 ||| NN
pathways  ||| S:13810 E:13819 ||| NN
by  ||| S:13819 E:13822 ||| IN
taurine-conjugated  ||| S:13822 E:13841 ||| JJ
bile  ||| S:13841 E:13856 ||| JJ
acids  ||| S:13856 E:13862 ||| NNS
commit  ||| S:13862 E:13869 ||| VBP
these  ||| S:13869 E:13875 ||| DT
cells  ||| S:13875 E:13881 ||| NNS
to  ||| S:13881 E:13884 ||| TO
apoptosis ||| S:13884 E:13893 ||| VB
.  ||| S:13893 E:13895 ||| .
These  ||| S:13895 E:13901 ||| DT
findings  ||| S:13901 E:13920 ||| NNS
also  ||| S:13920 E:13925 ||| RB
indicate  ||| S:13925 E:13934 ||| VB
that  ||| S:13934 E:13939 ||| DT
liver  ||| S:13939 E:13945 ||| NN
derived  ||| S:13945 E:13953 ||| VBN
cells  ||| S:13953 E:13959 ||| NNS
posses  ||| S:13959 E:13966 ||| VBP
a  ||| S:13966 E:13968 ||| DT
mechanism  ||| S:13968 E:13988 ||| NN
that  ||| S:13988 E:13993 ||| WDT
responds  ||| S:13993 E:14002 ||| VBZ
to  ||| S:14002 E:14005 ||| TO
taurine-conjugated  ||| S:14005 E:14024 ||| JJ
bile  ||| S:14024 E:14029 ||| NNS
acids  ||| S:14029 E:14035 ||| VBP
leading  ||| S:14035 E:14043 ||| VBG
to  ||| S:14043 E:14056 ||| TO
the  ||| S:14056 E:14060 ||| DT
activation  ||| S:14060 E:14071 ||| NN
of  ||| S:14071 E:14074 ||| IN
PI3K ||| S:14074 E:14078 ||| CD
.  ||| S:14078 E:14108 ||| .
Cytotoxic  ||| S:14108 E:14118 ||| JJ
potential  ||| S:14118 E:14128 ||| NN
of  ||| S:14128 E:14131 ||| IN
bile  ||| S:14131 E:14136 ||| JJ
acids  ||| S:14136 E:14142 ||| NNS
in  ||| S:14142 E:14155 ||| IN
HBAB-expressing  ||| S:14155 E:14171 ||| JJ
McNtcp.24  ||| S:14171 E:14181 ||| CD
cells  ||| S:14181 E:14197 ||| NNS
It  ||| S:14197 E:14200 ||| PRP
has  ||| S:14200 E:14204 ||| VBZ
been  ||| S:14204 E:14209 ||| VBN
suggested  ||| S:14209 E:14219 ||| VBN
that  ||| S:14219 E:14224 ||| IN
sequestration  ||| S:14224 E:14238 ||| NN
of  ||| S:14238 E:14241 ||| IN
bile  ||| S:14241 E:14246 ||| JJ
acids  ||| S:14246 E:14262 ||| NNS
by  ||| S:14262 E:14265 ||| IN
intracellular  ||| S:14265 E:14279 ||| JJ
bile  ||| S:14279 E:14284 ||| JJ
acid  ||| S:14284 E:14289 ||| JJ
binding  ||| S:14289 E:14297 ||| JJ
proteins  ||| S:14297 E:14306 ||| NNS
may  ||| S:14306 E:14310 ||| MD
also  ||| S:14310 E:14325 ||| RB
protect  ||| S:14325 E:14333 ||| VB
cells  ||| S:14333 E:14339 ||| NNS
from  ||| S:14339 E:14344 ||| IN
bile  ||| S:14344 E:14349 ||| JJ
acid  ||| S:14349 E:14354 ||| NN
cytotoxicity ||| S:14354 E:14366 ||| NN
.  ||| S:14366 E:14368 ||| .
Thus ||| S:14368 E:14372 ||| RB
,  ||| S:14372 E:14374 ||| ,
the  ||| S:14374 E:14388 ||| DT
human  ||| S:14388 E:14394 ||| JJ
bile  ||| S:14394 E:14399 ||| JJ
acid  ||| S:14399 E:14404 ||| NN
binder  ||| S:14404 E:14411 ||| NNS
( ||| S:14411 E:14412 ||| -LRB-
HBAB ||| S:14412 E:14416 ||| NNP
)  ||| S:14416 E:14418 ||| -RRB-
was  ||| S:14418 E:14422 ||| VBD
expressed  ||| S:14422 E:14432 ||| VBN
in  ||| S:14432 E:14435 ||| IN
McNtcp.24  ||| S:14435 E:14455 ||| CD
cells  ||| S:14455 E:14461 ||| NNS
to  ||| S:14461 E:14464 ||| TO
determine  ||| S:14464 E:14474 ||| VB
if  ||| S:14474 E:14477 ||| IN
this  ||| S:14477 E:14482 ||| DT
class  ||| S:14482 E:14488 ||| NN
of  ||| S:14488 E:14491 ||| IN
proteins  ||| S:14491 E:14500 ||| NNS
can  ||| S:14500 E:14504 ||| MD
protect  ||| S:14504 E:14522 ||| VB
against  ||| S:14522 E:14530 ||| IN
GCDCA  ||| S:14530 E:14536 ||| NNP
cytotoxicity ||| S:14536 E:14548 ||| NN
.  ||| S:14548 E:14550 ||| .
Figure  ||| S:14550 E:14557 ||| NN
9Ashows  ||| S:14557 E:14565 ||| VBZ
the  ||| S:14565 E:14569 ||| DT
presence  ||| S:14569 E:14588 ||| NN
of  ||| S:14588 E:14591 ||| IN
the  ||| S:14591 E:14595 ||| DT
recombinant  ||| S:14595 E:14607 ||| JJ
mRNA  ||| S:14607 E:14612 ||| JJ
encoding  ||| S:14612 E:14621 ||| NNS
the  ||| S:14621 E:14625 ||| DT
recombinant  ||| S:14625 E:14637 ||| JJ
HBAB  ||| S:14637 E:14642 ||| NN
in  ||| S:14642 E:14655 ||| IN
clones  ||| S:14655 E:14662 ||| NNS
that  ||| S:14662 E:14667 ||| WDT
have  ||| S:14667 E:14672 ||| VBP
incorporated  ||| S:14672 E:14685 ||| VBN
the  ||| S:14685 E:14689 ||| DT
HBAB  ||| S:14689 E:14694 ||| NNP
expression  ||| S:14694 E:14705 ||| NN
vector  ||| S:14705 E:14722 ||| NN
into  ||| S:14722 E:14727 ||| IN
their  ||| S:14727 E:14733 ||| PRP$
genomes ||| S:14733 E:14740 ||| NN
.  ||| S:14740 E:14742 ||| .
In  ||| S:14742 E:14745 ||| IN
addition ||| S:14745 E:14753 ||| NN
,  ||| S:14753 E:14755 ||| ,
the  ||| S:14755 E:14759 ||| DT
HBAB  ||| S:14759 E:14764 ||| NNP
protein  ||| S:14764 E:14782 ||| NN
abundance  ||| S:14782 E:14792 ||| NN
in  ||| S:14792 E:14795 ||| IN
the  ||| S:14795 E:14799 ||| DT
total  ||| S:14799 E:14805 ||| JJ
lysates  ||| S:14805 E:14813 ||| JJ
correlated  ||| S:14813 E:14824 ||| NN
with  ||| S:14824 E:14829 ||| IN
the  ||| S:14829 E:14843 ||| DT
abundance  ||| S:14843 E:14853 ||| NN
of  ||| S:14853 E:14856 ||| IN
the  ||| S:14856 E:14860 ||| DT
HBAB  ||| S:14860 E:14865 ||| NNP
mRNA  ||| S:14865 E:14870 ||| NNP
( ||| S:14870 E:14871 ||| -LRB-
Figure  ||| S:14871 E:14878 ||| NNP
9A ||| S:14878 E:14880 ||| NNP
) ||| S:14880 E:14881 ||| -RRB-
.  ||| S:14881 E:14883 ||| .
Analysis  ||| S:14883 E:14892 ||| NN
of  ||| S:14892 E:14905 ||| IN
radiolabeled  ||| S:14905 E:14918 ||| FW
TCA  ||| S:14918 E:14922 ||| FW
uptake  ||| S:14922 E:14929 ||| FW
( ||| S:14929 E:14930 ||| -LRB-
Figure  ||| S:14930 E:14937 ||| NNP
9B ||| S:14937 E:14939 ||| NNP
)  ||| S:14939 E:14941 ||| -RRB-
showed  ||| S:14941 E:14948 ||| VBD
that  ||| S:14948 E:14963 ||| DT
expression  ||| S:14963 E:14974 ||| NN
of  ||| S:14974 E:14977 ||| IN
HBAB  ||| S:14977 E:14982 ||| NNP
had  ||| S:14982 E:14986 ||| VBD
minimal  ||| S:14986 E:14994 ||| JJ
impact  ||| S:14994 E:15001 ||| NN
on  ||| S:15001 E:15004 ||| IN
bile  ||| S:15004 E:15009 ||| JJ
acid  ||| S:15009 E:15014 ||| NN
uptake  ||| S:15014 E:15031 ||| NN
despite  ||| S:15031 E:15039 ||| IN
the  ||| S:15039 E:15043 ||| DT
fact  ||| S:15043 E:15048 ||| NN
that  ||| S:15048 E:15053 ||| IN
the  ||| S:15053 E:15057 ||| DT
range  ||| S:15057 E:15063 ||| NN
of  ||| S:15063 E:15066 ||| IN
HBAB  ||| S:15066 E:15071 ||| NNP
protein  ||| S:15071 E:15079 ||| NN
abundance  ||| S:15079 E:15099 ||| NNS
was  ||| S:15099 E:15103 ||| VBD
up  ||| S:15103 E:15106 ||| RP
to  ||| S:15106 E:15109 ||| TO
5-fold  ||| S:15109 E:15116 ||| CD
greater  ||| S:15116 E:15124 ||| JJR
than  ||| S:15124 E:15129 ||| IN
that  ||| S:15129 E:15134 ||| DT
in  ||| S:15134 E:15137 ||| IN
the  ||| S:15137 E:15141 ||| DT
lowest  ||| S:15141 E:15148 ||| JJS
HBAB  ||| S:15148 E:15163 ||| JJ
expressing  ||| S:15163 E:15174 ||| JJ
cell ||| S:15174 E:15178 ||| NN
.  ||| S:15178 E:15180 ||| .
Moreover ||| S:15180 E:15188 ||| RB
,  ||| S:15188 E:15190 ||| ,
the  ||| S:15190 E:15194 ||| DT
rates  ||| S:15194 E:15200 ||| NNS
of  ||| S:15200 E:15203 ||| IN
decline  ||| S:15203 E:15211 ||| NN
in  ||| S:15211 E:15214 ||| IN
the  ||| S:15214 E:15228 ||| DT
amount  ||| S:15228 E:15235 ||| NN
of  ||| S:15235 E:15238 ||| IN
radiolabeled  ||| S:15238 E:15251 ||| JJ
TCA  ||| S:15251 E:15255 ||| NNS
associated  ||| S:15255 E:15266 ||| VBN
with  ||| S:15266 E:15271 ||| IN
the  ||| S:15271 E:15275 ||| DT
cells  ||| S:15275 E:15291 ||| NNS
after  ||| S:15291 E:15297 ||| IN
withdrawal  ||| S:15297 E:15308 ||| NN
of  ||| S:15308 E:15311 ||| IN
the  ||| S:15311 E:15315 ||| DT
radiolabeled  ||| S:15315 E:15328 ||| JJ
bile  ||| S:15328 E:15333 ||| JJ
acids  ||| S:15333 E:15339 ||| NNS
from  ||| S:15339 E:15344 ||| IN
the  ||| S:15344 E:15358 ||| DT
culture  ||| S:15358 E:15366 ||| NN
medium  ||| S:15366 E:15373 ||| NN
was  ||| S:15373 E:15377 ||| VBD
comparable  ||| S:15377 E:15388 ||| JJ
among  ||| S:15388 E:15394 ||| IN
the  ||| S:15394 E:15398 ||| DT
different  ||| S:15398 E:15408 ||| JJ
clones  ||| S:15408 E:15425 ||| NNS
( ||| S:15425 E:15426 ||| -LRB-
Figure  ||| S:15426 E:15433 ||| NNP
9C ||| S:15433 E:15435 ||| NNP
) ||| S:15435 E:15436 ||| -RRB-
,  ||| S:15436 E:15438 ||| ,
indicating  ||| S:15438 E:15449 ||| VBG
that  ||| S:15449 E:15454 ||| IN
the  ||| S:15454 E:15458 ||| DT
rate  ||| S:15458 E:15463 ||| NN
of  ||| S:15463 E:15466 ||| IN
bile  ||| S:15466 E:15471 ||| JJ
acid  ||| S:15471 E:15476 ||| NN
efflux  ||| S:15476 E:15493 ||| NN
from  ||| S:15493 E:15498 ||| IN
these  ||| S:15498 E:15504 ||| DT
cells  ||| S:15504 E:15510 ||| NNS
was  ||| S:15510 E:15514 ||| VBD
also  ||| S:15514 E:15519 ||| RB
not  ||| S:15519 E:15523 ||| RB
affected  ||| S:15523 E:15532 ||| VBN
by  ||| S:15532 E:15535 ||| IN
the  ||| S:15535 E:15539 ||| DT
presence  ||| S:15539 E:15548 ||| NN
of  ||| S:15548 E:15561 ||| IN
HBAB ||| S:15561 E:15565 ||| NNP
.  ||| S:15565 E:15577 ||| .
Incubation  ||| S:15577 E:15588 ||| NNP
of  ||| S:15588 E:15591 ||| IN
the  ||| S:15591 E:15595 ||| DT
BN  ||| S:15595 E:15598 ||| NNP
clones  ||| S:15598 E:15605 ||| NNS
with  ||| S:15605 E:15610 ||| IN
GCDCA  ||| S:15610 E:15616 ||| NNP
increased  ||| S:15616 E:15626 ||| VBD
the  ||| S:15626 E:15640 ||| DT
LDH  ||| S:15640 E:15644 ||| NNP
activity  ||| S:15644 E:15653 ||| NN
in  ||| S:15653 E:15656 ||| IN
the  ||| S:15656 E:15660 ||| DT
culture  ||| S:15660 E:15668 ||| NN
medium  ||| S:15668 E:15675 ||| NN
to  ||| S:15675 E:15678 ||| TO
a  ||| S:15678 E:15680 ||| DT
level  ||| S:15680 E:15686 ||| NN
similar  ||| S:15686 E:15694 ||| JJ
to  ||| S:15694 E:15707 ||| TO
that  ||| S:15707 E:15712 ||| DT
in  ||| S:15712 E:15715 ||| IN
the  ||| S:15715 E:15719 ||| DT
medium  ||| S:15719 E:15726 ||| NN
of  ||| S:15726 E:15729 ||| IN
GCDCA-treated  ||| S:15729 E:15743 ||| JJ
McNtcp.24  ||| S:15743 E:15753 ||| CD
cells  ||| S:15753 E:15769 ||| NNS
( ||| S:15769 E:15770 ||| -LRB-
Figure  ||| S:15770 E:15777 ||| NNP
10A ||| S:15777 E:15780 ||| NNP
) ||| S:15780 E:15781 ||| -RRB-
.  ||| S:15781 E:15783 ||| .
In  ||| S:15783 E:15786 ||| IN
addition ||| S:15786 E:15794 ||| NN
,  ||| S:15794 E:15796 ||| ,
caspase  ||| S:15796 E:15804 ||| CD
8  ||| S:15804 E:15806 ||| CD
activity  ||| S:15806 E:15815 ||| NN
in  ||| S:15815 E:15818 ||| IN
bile  ||| S:15818 E:15833 ||| JJ
acid-treated  ||| S:15833 E:15846 ||| JJ
BN.25 ||| S:15846 E:15851 ||| NN
,  ||| S:15851 E:15853 ||| ,
BN.46  ||| S:15853 E:15859 ||| NNP
and  ||| S:15859 E:15863 ||| CC
BN.49  ||| S:15863 E:15869 ||| NNP
was  ||| S:15869 E:15873 ||| VBD
comparable  ||| S:15873 E:15884 ||| JJ
to  ||| S:15884 E:15897 ||| TO
that  ||| S:15897 E:15902 ||| DT
in  ||| S:15902 E:15905 ||| IN
McNtcp.24 ||| S:15905 E:15914 ||| NNP
,  ||| S:15914 E:15916 ||| ,
which  ||| S:15916 E:15922 ||| WDT
were  ||| S:15922 E:15927 ||| VBD
elevated  ||| S:15927 E:15936 ||| VBN
compared  ||| S:15936 E:15945 ||| VBN
to  ||| S:15945 E:15948 ||| TO
that  ||| S:15948 E:15963 ||| DT
in  ||| S:15963 E:15966 ||| IN
McArdle  ||| S:15966 E:15974 ||| JJ
RH-7777  ||| S:15974 E:15982 ||| CD
cells  ||| S:15982 E:15988 ||| NNS
( ||| S:15988 E:15989 ||| -LRB-
Figure  ||| S:15989 E:15996 ||| NNP
10B ||| S:15996 E:15999 ||| NNP
) ||| S:15999 E:16000 ||| -RRB-
.  ||| S:16000 E:16002 ||| .
The  ||| S:16002 E:16006 ||| DT
time  ||| S:16006 E:16011 ||| NN
course  ||| S:16011 E:16018 ||| NN
of  ||| S:16018 E:16031 ||| IN
caspase  ||| S:16031 E:16039 ||| CD
8  ||| S:16039 E:16041 ||| CD
activation  ||| S:16041 E:16052 ||| NN
in  ||| S:16052 E:16055 ||| IN
BN  ||| S:16055 E:16058 ||| NNP
cells  ||| S:16058 E:16064 ||| NNS
after  ||| S:16064 E:16070 ||| IN
treatment  ||| S:16070 E:16080 ||| NN
with  ||| S:16080 E:16085 ||| IN
10  ||| S:16085 E:16098 ||| CD
Î¼M  ||| S:16098 E:16101 ||| JJ
bile  ||| S:16101 E:16106 ||| JJ
acids  ||| S:16106 E:16112 ||| NNS
was  ||| S:16112 E:16116 ||| VBD
similar  ||| S:16116 E:16124 ||| JJ
to  ||| S:16124 E:16127 ||| TO
that  ||| S:16127 E:16132 ||| WDT
observed  ||| S:16132 E:16141 ||| VBD
for  ||| S:16141 E:16145 ||| IN
McNtcp.24  ||| S:16145 E:16165 ||| CD
cells  ||| S:16165 E:16171 ||| NNS
( ||| S:16171 E:16172 ||| -LRB-
Figure  ||| S:16172 E:16179 ||| NNP
10C ||| S:16179 E:16182 ||| NNP
) ||| S:16182 E:16183 ||| -RRB-
.  ||| S:16183 E:16185 ||| .
Therefore ||| S:16185 E:16194 ||| RB
,  ||| S:16194 E:16196 ||| ,
the  ||| S:16196 E:16200 ||| DT
presence  ||| S:16200 E:16209 ||| NN
of  ||| S:16209 E:16212 ||| IN
an  ||| S:16212 E:16225 ||| DT
intracellular  ||| S:16225 E:16239 ||| JJ
bile  ||| S:16239 E:16244 ||| JJ
acid  ||| S:16244 E:16249 ||| JJ
binding  ||| S:16249 E:16257 ||| JJ
protein  ||| S:16257 E:16265 ||| NN
did  ||| S:16265 E:16269 ||| VBD
not  ||| S:16269 E:16273 ||| RB
protect  ||| S:16273 E:16291 ||| VB
these  ||| S:16291 E:16297 ||| DT
cells  ||| S:16297 E:16303 ||| NNS
from  ||| S:16303 E:16308 ||| IN
glycine-conjugated  ||| S:16308 E:16327 ||| JJ
bile  ||| S:16327 E:16332 ||| JJ
acid  ||| S:16332 E:16347 ||| NN
cytotoxicity ||| S:16347 E:16359 ||| NN
,  ||| S:16359 E:16361 ||| ,
even  ||| S:16361 E:16366 ||| RB
at  ||| S:16366 E:16369 ||| IN
low  ||| S:16369 E:16373 ||| JJ
bile  ||| S:16373 E:16378 ||| JJ
acid  ||| S:16378 E:16383 ||| NN
concentrations ||| S:16383 E:16397 ||| NNS
.  ||| S:16397 E:16399 ||| .
These  ||| S:16399 E:16415 ||| DT
results  ||| S:16415 E:16423 ||| NNS
indicate  ||| S:16423 E:16432 ||| VBP
that  ||| S:16432 E:16437 ||| IN
the  ||| S:16437 E:16441 ||| DT
activation  ||| S:16441 E:16452 ||| NN
of  ||| S:16452 E:16455 ||| IN
a  ||| S:16455 E:16457 ||| DT
signaling  ||| S:16457 E:16477 ||| JJ
cascade  ||| S:16477 E:16485 ||| NN
involving  ||| S:16485 E:16495 ||| VBG
PI3K  ||| S:16495 E:16500 ||| NNP
is  ||| S:16500 E:16503 ||| VBZ
the  ||| S:16503 E:16507 ||| DT
dominant  ||| S:16507 E:16516 ||| JJ
mechanism  ||| S:16516 E:16536 ||| NN
responsible  ||| S:16536 E:16548 ||| JJ
for  ||| S:16548 E:16552 ||| IN
protecting  ||| S:16552 E:16563 ||| VBG
McNtcp.24  ||| S:16563 E:16573 ||| CD
cells  ||| S:16573 E:16579 ||| NNS
from  ||| S:16579 E:16584 ||| IN
the  ||| S:16584 E:16598 ||| DT
cytotoxicity  ||| S:16598 E:16611 ||| NN
of  ||| S:16611 E:16614 ||| IN
glycine-conjugated  ||| S:16614 E:16633 ||| JJ
bile  ||| S:16633 E:16638 ||| JJ
acids ||| S:16638 E:16643 ||| NNS
.  ||| S:16643 E:16676 ||| .
Discussion  ||| S:16676 E:16695 ||| NN
In  ||| S:16695 E:16698 ||| IN
this  ||| S:16698 E:16703 ||| DT
study ||| S:16703 E:16708 ||| NN
,  ||| S:16708 E:16710 ||| ,
we  ||| S:16710 E:16713 ||| PRP
determined  ||| S:16713 E:16724 ||| VBD
if  ||| S:16724 E:16727 ||| IN
the  ||| S:16727 E:16731 ||| DT
differential  ||| S:16731 E:16752 ||| JJ
sensitivity  ||| S:16752 E:16764 ||| NN
elaborated  ||| S:16764 E:16775 ||| NN
by  ||| S:16775 E:16778 ||| IN
the  ||| S:16778 E:16782 ||| DT
liver-derived  ||| S:16782 E:16796 ||| JJ
McNtcp.24  ||| S:16796 E:16806 ||| CD
cell  ||| S:16806 E:16819 ||| NN
line  ||| S:16819 E:16824 ||| NN
to  ||| S:16824 E:16827 ||| TO
different  ||| S:16827 E:16837 ||| JJ
classes  ||| S:16837 E:16845 ||| NNS
of  ||| S:16845 E:16848 ||| IN
conjugated  ||| S:16848 E:16859 ||| JJ
bile  ||| S:16859 E:16864 ||| JJ
acids  ||| S:16864 E:16870 ||| NN
is  ||| S:16870 E:16881 ||| VBZ
limited  ||| S:16881 E:16889 ||| VBN
to  ||| S:16889 E:16892 ||| TO
cells  ||| S:16892 E:16898 ||| NNS
that  ||| S:16898 E:16903 ||| WDT
normally  ||| S:16903 E:16912 ||| RB
transport  ||| S:16912 E:16922 ||| VB
bile  ||| S:16922 E:16927 ||| JJ
acids ||| S:16927 E:16932 ||| NNS
.  ||| S:16932 E:16934 ||| .
We  ||| S:16934 E:16945 ||| PRP
previously  ||| S:16945 E:16956 ||| RB
demonstrated  ||| S:16956 E:16969 ||| VBN
that  ||| S:16969 E:16974 ||| IN
taurine-conjugated  ||| S:16974 E:16993 ||| JJ
bile  ||| S:16993 E:16998 ||| JJ
acids  ||| S:16998 E:17012 ||| NNS
are  ||| S:17012 E:17016 ||| VBP
not  ||| S:17016 E:17020 ||| RB
toxic  ||| S:17020 E:17026 ||| JJ
to  ||| S:17026 E:17029 ||| TO
McNtcp.24  ||| S:17029 E:17039 ||| CD
cells  ||| S:17039 E:17045 ||| NNS
[  ||| S:17045 E:17047 ||| -LRB-
18  ||| S:17047 E:17050 ||| CD
]  ||| S:17050 E:17052 ||| -RRB-
.  ||| S:17052 E:17054 ||| .
In  ||| S:17054 E:17057 ||| IN
contrast ||| S:17057 E:17065 ||| NN
,  ||| S:17065 E:17075 ||| ,
glycine-conjugated  ||| S:17075 E:17094 ||| FW
bile  ||| S:17094 E:17099 ||| FW
acids  ||| S:17099 E:17105 ||| FW
induce  ||| S:17105 E:17112 ||| FW
apoptosis  ||| S:17112 E:17122 ||| FW
in  ||| S:17122 E:17125 ||| IN
McNtcp.24  ||| S:17125 E:17143 ||| CD
cells  ||| S:17143 E:17149 ||| NNS
and  ||| S:17149 E:17153 ||| CC
primary  ||| S:17153 E:17161 ||| JJ
mouse  ||| S:17161 E:17167 ||| NN
hepatocytes ||| S:17167 E:17178 ||| NN
,  ||| S:17178 E:17180 ||| ,
through  ||| S:17180 E:17188 ||| IN
activation  ||| S:17188 E:17199 ||| NN
of  ||| S:17199 E:17210 ||| IN
the  ||| S:17210 E:17214 ||| DT
Fas  ||| S:17214 E:17218 ||| JJ
receptor  ||| S:17218 E:17227 ||| NN
in  ||| S:17227 E:17230 ||| IN
a  ||| S:17230 E:17232 ||| DT
FasL-independent  ||| S:17232 E:17249 ||| JJ
manner  ||| S:17249 E:17256 ||| NN
[  ||| S:17256 E:17258 ||| -LRB-
19  ||| S:17258 E:17261 ||| CD
25  ||| S:17261 E:17264 ||| CD
]  ||| S:17264 E:17266 ||| -RRB-
.  ||| S:17266 E:17276 ||| .
Moreover ||| S:17276 E:17284 ||| RB
,  ||| S:17284 E:17286 ||| ,
GCDCA  ||| S:17286 E:17292 ||| NNP
was  ||| S:17292 E:17296 ||| VBD
demonstrated  ||| S:17296 E:17309 ||| VBN
to  ||| S:17309 E:17312 ||| TO
activate  ||| S:17312 E:17321 ||| VB
both  ||| S:17321 E:17326 ||| DT
initiator  ||| S:17326 E:17344 ||| NN
and  ||| S:17344 E:17348 ||| CC
effector  ||| S:17348 E:17357 ||| JJ
caspases ||| S:17357 E:17365 ||| NN
,  ||| S:17365 E:17367 ||| ,
and  ||| S:17367 E:17371 ||| CC
that  ||| S:17371 E:17376 ||| IN
the  ||| S:17376 E:17380 ||| DT
apoptotic  ||| S:17380 E:17390 ||| JJ
response  ||| S:17390 E:17399 ||| NN
can  ||| S:17399 E:17411 ||| MD
be  ||| S:17411 E:17414 ||| VB
blocked  ||| S:17414 E:17422 ||| VBN
by  ||| S:17422 E:17425 ||| IN
Crm  ||| S:17425 E:17429 ||| NNP
A ||| S:17429 E:17430 ||| NNP
,  ||| S:17430 E:17432 ||| ,
a  ||| S:17432 E:17434 ||| DT
caspase  ||| S:17434 E:17442 ||| JJ
8  ||| S:17442 E:17444 ||| CD
inhibitor  ||| S:17444 E:17454 ||| NNS
[  ||| S:17454 E:17456 ||| -LRB-
25  ||| S:17456 E:17459 ||| CD
]  ||| S:17459 E:17461 ||| -RRB-
.  ||| S:17461 E:17463 ||| .
The  ||| S:17463 E:17475 ||| DT
mechanism  ||| S:17475 E:17485 ||| NN
by  ||| S:17485 E:17488 ||| IN
which  ||| S:17488 E:17494 ||| WDT
bile  ||| S:17494 E:17499 ||| VBP
acids  ||| S:17499 E:17505 ||| RB
stimulate  ||| S:17505 E:17515 ||| VB
the  ||| S:17515 E:17519 ||| DT
activation  ||| S:17519 E:17530 ||| NN
of  ||| S:17530 E:17541 ||| IN
Fas  ||| S:17541 E:17545 ||| NNP
receptor  ||| S:17545 E:17554 ||| NN
remains  ||| S:17554 E:17562 ||| VBZ
unclear ||| S:17562 E:17569 ||| JJ
.  ||| S:17569 E:17571 ||| .
In  ||| S:17571 E:17574 ||| IN
Fas  ||| S:17574 E:17578 ||| NNP
deficient  ||| S:17578 E:17588 ||| JJ
hepatocytes ||| S:17588 E:17599 ||| NN
,  ||| S:17599 E:17609 ||| ,
toxic  ||| S:17609 E:17615 ||| JJ
bile  ||| S:17615 E:17620 ||| JJ
acids  ||| S:17620 E:17626 ||| NNS
were  ||| S:17626 E:17631 ||| VBD
still  ||| S:17631 E:17637 ||| RB
able  ||| S:17637 E:17642 ||| JJ
to  ||| S:17642 E:17645 ||| TO
induce  ||| S:17645 E:17652 ||| VB
apoptosis ||| S:17652 E:17661 ||| NNS
,  ||| S:17661 E:17671 ||| ,
suggesting  ||| S:17671 E:17682 ||| VBG
that  ||| S:17682 E:17687 ||| IN
bile  ||| S:17687 E:17692 ||| JJ
acids  ||| S:17692 E:17698 ||| NNS
are  ||| S:17698 E:17702 ||| VBP
capable  ||| S:17702 E:17710 ||| JJ
of  ||| S:17710 E:17713 ||| IN
stimulating  ||| S:17713 E:17733 ||| VBG
multiple  ||| S:17733 E:17742 ||| JJ
pathways  ||| S:17742 E:17751 ||| NN
to  ||| S:17751 E:17754 ||| TO
initiate  ||| S:17754 E:17763 ||| VB
cell  ||| S:17763 E:17768 ||| NN
death  ||| S:17768 E:17774 ||| NN
[  ||| S:17774 E:17776 ||| -LRB-
26  ||| S:17776 E:17779 ||| CD
]  ||| S:17779 E:17781 ||| -RRB-
.  ||| S:17781 E:17791 ||| .
To  ||| S:17791 E:17794 ||| TO
gain  ||| S:17794 E:17799 ||| VB
further  ||| S:17799 E:17807 ||| JJ
insight  ||| S:17807 E:17815 ||| NN
into  ||| S:17815 E:17820 ||| IN
the  ||| S:17820 E:17824 ||| DT
specificity  ||| S:17824 E:17836 ||| NN
of  ||| S:17836 E:17839 ||| IN
bile  ||| S:17839 E:17852 ||| JJ
acid  ||| S:17852 E:17857 ||| NN
cytotoxicity ||| S:17857 E:17869 ||| NN
,  ||| S:17869 E:17871 ||| ,
we  ||| S:17871 E:17874 ||| PRP
conferred  ||| S:17874 E:17884 ||| VBD
active  ||| S:17884 E:17891 ||| JJ
bile  ||| S:17891 E:17896 ||| JJ
acid  ||| S:17896 E:17901 ||| NN
uptake  ||| S:17901 E:17916 ||| NN
capacity  ||| S:17916 E:17925 ||| NN
in  ||| S:17925 E:17928 ||| IN
CHO  ||| S:17928 E:17932 ||| NNP
cells ||| S:17932 E:17937 ||| NNS
,  ||| S:17937 E:17939 ||| ,
a  ||| S:17939 E:17941 ||| DT
cell  ||| S:17941 E:17946 ||| NN
type  ||| S:17946 E:17951 ||| NN
that  ||| S:17951 E:17956 ||| WDT
does  ||| S:17956 E:17961 ||| VBZ
not  ||| S:17961 E:17965 ||| RB
normally  ||| S:17965 E:17982 ||| RB
metabolize  ||| S:17982 E:17993 ||| JJ
bile  ||| S:17993 E:17998 ||| JJ
acids ||| S:17998 E:18003 ||| NNS
,  ||| S:18003 E:18005 ||| ,
by  ||| S:18005 E:18008 ||| IN
expressing  ||| S:18008 E:18019 ||| VBG
a  ||| S:18019 E:18021 ||| DT
bile  ||| S:18021 E:18026 ||| JJ
acid  ||| S:18026 E:18039 ||| NN
transporter ||| S:18039 E:18050 ||| NN
.  ||| S:18050 E:18052 ||| .
CHO.asbt  ||| S:18052 E:18061 ||| NNP
cells  ||| S:18061 E:18067 ||| NNS
produce  ||| S:18067 E:18075 ||| VBP
recombinant  ||| S:18075 E:18087 ||| JJ
asbt  ||| S:18087 E:18092 ||| NN
with  ||| S:18092 E:18097 ||| IN
a  ||| S:18097 E:18107 ||| DT
molecular  ||| S:18107 E:18117 ||| JJ
mass  ||| S:18117 E:18122 ||| NN
and  ||| S:18122 E:18126 ||| CC
kinetic  ||| S:18126 E:18134 ||| JJ
parameters  ||| S:18134 E:18145 ||| NNS
that  ||| S:18145 E:18150 ||| WDT
are  ||| S:18150 E:18154 ||| VBP
similar  ||| S:18154 E:18162 ||| JJ
to  ||| S:18162 E:18173 ||| TO
previously  ||| S:18173 E:18184 ||| RB
reported  ||| S:18184 E:18193 ||| VBN
values  ||| S:18193 E:18200 ||| NNS
[  ||| S:18200 E:18202 ||| -LRB-
6  ||| S:18202 E:18204 ||| CD
]  ||| S:18204 E:18206 ||| -RRB-
.  ||| S:18206 E:18208 ||| .
It  ||| S:18208 E:18211 ||| PRP
is  ||| S:18211 E:18214 ||| VBZ
not  ||| S:18214 E:18218 ||| RB
known  ||| S:18218 E:18224 ||| VBN
if  ||| S:18224 E:18227 ||| IN
CHO  ||| S:18227 E:18239 ||| NNP
cells  ||| S:18239 E:18245 ||| NNS
have  ||| S:18245 E:18250 ||| VBP
pathways  ||| S:18250 E:18259 ||| JJ
capable  ||| S:18259 E:18267 ||| JJ
of  ||| S:18267 E:18270 ||| IN
facilitating  ||| S:18270 E:18283 ||| VBG
the  ||| S:18283 E:18287 ||| DT
efflux  ||| S:18287 E:18294 ||| NN
of  ||| S:18294 E:18305 ||| IN
bile  ||| S:18305 E:18310 ||| JJ
acids  ||| S:18310 E:18316 ||| NNS
out  ||| S:18316 E:18320 ||| RP
of  ||| S:18320 E:18323 ||| IN
the  ||| S:18323 E:18327 ||| DT
cell ||| S:18327 E:18331 ||| NN
.  ||| S:18331 E:18333 ||| .
The  ||| S:18333 E:18337 ||| DT
apparent  ||| S:18337 E:18346 ||| JJ
efflux  ||| S:18346 E:18353 ||| NN
observed  ||| S:18353 E:18362 ||| VBD
in  ||| S:18362 E:18373 ||| IN
CHO.asbt.35  ||| S:18373 E:18385 ||| NNP
could  ||| S:18385 E:18391 ||| MD
be  ||| S:18391 E:18394 ||| VB
attributed  ||| S:18394 E:18405 ||| VBN
to  ||| S:18405 E:18408 ||| TO
the  ||| S:18408 E:18412 ||| DT
fact  ||| S:18412 E:18417 ||| NN
that  ||| S:18417 E:18422 ||| IN
asbt  ||| S:18422 E:18427 ||| NN
is  ||| S:18427 E:18438 ||| VBZ
capable  ||| S:18438 E:18446 ||| VBG
a  ||| S:18446 E:18448 ||| DT
bidirectional  ||| S:18448 E:18462 ||| JJ
transport  ||| S:18462 E:18472 ||| NN
of  ||| S:18472 E:18475 ||| IN
bile  ||| S:18475 E:18480 ||| JJ
acids  ||| S:18480 E:18486 ||| NNS
[  ||| S:18486 E:18488 ||| -LRB-
27  ||| S:18488 E:18491 ||| CD
]  ||| S:18491 E:18493 ||| -RRB-
.  ||| S:18493 E:18503 ||| .
However ||| S:18503 E:18510 ||| RB
,  ||| S:18510 E:18512 ||| ,
it  ||| S:18512 E:18515 ||| PRP
is  ||| S:18515 E:18518 ||| VBZ
conceivable  ||| S:18518 E:18530 ||| VBN
that  ||| S:18530 E:18535 ||| IN
an  ||| S:18535 E:18538 ||| DT
efflux  ||| S:18538 E:18545 ||| JJ
mechanism  ||| S:18545 E:18555 ||| NN
that  ||| S:18555 E:18568 ||| WDT
recognizes  ||| S:18568 E:18579 ||| VBZ
bile  ||| S:18579 E:18584 ||| JJ
acids  ||| S:18584 E:18590 ||| NN
exists  ||| S:18590 E:18597 ||| VBZ
in  ||| S:18597 E:18600 ||| IN
CHO  ||| S:18600 E:18604 ||| NNP
cells  ||| S:18604 E:18610 ||| NNS
and  ||| S:18610 E:18614 ||| CC
other  ||| S:18614 E:18628 ||| JJ
mammalian  ||| S:18628 E:18638 ||| JJ
cells ||| S:18638 E:18643 ||| NNS
.  ||| S:18643 E:18645 ||| .
Indeed ||| S:18645 E:18651 ||| RB
,  ||| S:18651 E:18653 ||| ,
yeast  ||| S:18653 E:18659 ||| NN
and  ||| S:18659 E:18663 ||| CC
plants  ||| S:18663 E:18670 ||| NNS
express  ||| S:18670 E:18678 ||| VBP
proteins  ||| S:18678 E:18695 ||| NNS
capable  ||| S:18695 E:18703 ||| JJ
of  ||| S:18703 E:18706 ||| IN
active  ||| S:18706 E:18713 ||| JJ
bile  ||| S:18713 E:18718 ||| JJ
acid  ||| S:18718 E:18723 ||| NN
transport  ||| S:18723 E:18733 ||| NN
[  ||| S:18733 E:18735 ||| -LRB-
28  ||| S:18735 E:18738 ||| CD
]  ||| S:18738 E:18740 ||| -RRB-
.  ||| S:18740 E:18742 ||| .
As  ||| S:18742 E:18745 ||| IN
these  ||| S:18745 E:18759 ||| DT
organisms  ||| S:18759 E:18769 ||| NNS
do  ||| S:18769 E:18772 ||| VBP
not  ||| S:18772 E:18776 ||| RB
normally  ||| S:18776 E:18785 ||| RB
synthesize  ||| S:18785 E:18796 ||| VB
bile  ||| S:18796 E:18801 ||| JJ
acids ||| S:18801 E:18806 ||| NNS
,  ||| S:18806 E:18808 ||| ,
their  ||| S:18808 E:18822 ||| PRP$
ability  ||| S:18822 E:18830 ||| NN
to  ||| S:18830 E:18833 ||| TO
transport  ||| S:18833 E:18843 ||| VB
bile  ||| S:18843 E:18848 ||| JJ
acids  ||| S:18848 E:18854 ||| NNS
may  ||| S:18854 E:18858 ||| MD
illustrate  ||| S:18858 E:18869 ||| VB
a  ||| S:18869 E:18879 ||| DT
generalized  ||| S:18879 E:18891 ||| JJ
mechanism  ||| S:18891 E:18901 ||| NN
for  ||| S:18901 E:18905 ||| IN
cellular  ||| S:18905 E:18914 ||| JJ
transport  ||| S:18914 E:18924 ||| NN
of  ||| S:18924 E:18927 ||| IN
hydrophobic  ||| S:18927 E:18947 ||| JJ
organic  ||| S:18947 E:18955 ||| JJ
anions ||| S:18955 E:18961 ||| NN
.  ||| S:18961 E:18971 ||| .
CHO.asbt.35  ||| S:18971 E:18983 ||| NNP
cells  ||| S:18983 E:18989 ||| NNS
were  ||| S:18989 E:18994 ||| VBD
used  ||| S:18994 E:18999 ||| VBN
as  ||| S:18999 E:19002 ||| IN
a  ||| S:19002 E:19004 ||| DT
model  ||| S:19004 E:19010 ||| NN
to  ||| S:19010 E:19013 ||| TO
assess  ||| S:19013 E:19020 ||| VB
the  ||| S:19020 E:19032 ||| DT
cytotoxic  ||| S:19032 E:19042 ||| JJ
potential  ||| S:19042 E:19052 ||| NN
of  ||| S:19052 E:19055 ||| IN
taurine-  ||| S:19055 E:19064 ||| JJ
and  ||| S:19064 E:19068 ||| CC
glycine-conjugated  ||| S:19068 E:19087 ||| JJ
bile  ||| S:19087 E:19100 ||| JJ
acids  ||| S:19100 E:19106 ||| NNS
in  ||| S:19106 E:19109 ||| IN
non-hepatic  ||| S:19109 E:19121 ||| JJ
derived  ||| S:19121 E:19129 ||| NN
and  ||| S:19129 E:19133 ||| CC
non-bile  ||| S:19133 E:19142 ||| JJ
acid  ||| S:19142 E:19147 ||| NN
metabolizing  ||| S:19147 E:19168 ||| NN
cells ||| S:19168 E:19173 ||| NNS
.  ||| S:19173 E:19175 ||| .
Unlike  ||| S:19175 E:19182 ||| IN
McNtcp.24  ||| S:19182 E:19192 ||| CD
cells ||| S:19192 E:19197 ||| NNS
,  ||| S:19197 E:19199 ||| ,
treatment  ||| S:19199 E:19209 ||| NN
of  ||| S:19209 E:19212 ||| IN
CHO.asbt  ||| S:19212 E:19221 ||| CD
clones  ||| S:19221 E:19236 ||| NNS
with  ||| S:19236 E:19241 ||| IN
taurine-conjugated  ||| S:19241 E:19260 ||| JJ
bile  ||| S:19260 E:19265 ||| NNS
acids  ||| S:19265 E:19271 ||| VBP
resulted  ||| S:19271 E:19280 ||| VBN
in  ||| S:19280 E:19283 ||| IN
cell  ||| S:19283 E:19288 ||| NN
death ||| S:19288 E:19293 ||| NN
.  ||| S:19293 E:19303 ||| .
TCA  ||| S:19303 E:19307 ||| NNP
was  ||| S:19307 E:19311 ||| VBD
the  ||| S:19311 E:19315 ||| DT
most  ||| S:19315 E:19320 ||| RBS
potent  ||| S:19320 E:19327 ||| JJ
of  ||| S:19327 E:19330 ||| IN
taurine-conjugated  ||| S:19330 E:19349 ||| JJ
bile  ||| S:19349 E:19354 ||| JJ
acid  ||| S:19354 E:19367 ||| NN
tested ||| S:19367 E:19373 ||| VBD
.  ||| S:19373 E:19375 ||| .
It  ||| S:19375 E:19378 ||| PRP
is  ||| S:19378 E:19381 ||| VBZ
unlikely  ||| S:19381 E:19390 ||| JJ
that  ||| S:19390 E:19395 ||| IN
the  ||| S:19395 E:19399 ||| DT
observed  ||| S:19399 E:19408 ||| JJ
cytotoxicity  ||| S:19408 E:19421 ||| NN
of  ||| S:19421 E:19432 ||| IN
the  ||| S:19432 E:19436 ||| DT
conjugated  ||| S:19436 E:19447 ||| JJ
bile  ||| S:19447 E:19452 ||| JJ
acids  ||| S:19452 E:19458 ||| NNS
could  ||| S:19458 E:19464 ||| MD
be  ||| S:19464 E:19467 ||| VB
attributed  ||| S:19467 E:19478 ||| VBN
to  ||| S:19478 E:19481 ||| TO
the  ||| S:19481 E:19493 ||| DT
generalized  ||| S:19493 E:19505 ||| JJ
intracellular  ||| S:19505 E:19519 ||| JJ
accumulation  ||| S:19519 E:19532 ||| NN
of  ||| S:19532 E:19535 ||| IN
bile  ||| S:19535 E:19540 ||| JJ
acids  ||| S:19540 E:19554 ||| NNS
because  ||| S:19554 E:19562 ||| IN
unconjugated  ||| S:19562 E:19575 ||| JJ
bile  ||| S:19575 E:19580 ||| JJ
acids  ||| S:19580 E:19586 ||| NNS
were  ||| S:19586 E:19591 ||| VBD
transported  ||| S:19591 E:19603 ||| VBN
by  ||| S:19603 E:19614 ||| IN
CHO.asbt  ||| S:19614 E:19623 ||| CD
cells  ||| S:19623 E:19629 ||| NNS
but  ||| S:19629 E:19633 ||| CC
did  ||| S:19633 E:19637 ||| VBD
not  ||| S:19637 E:19641 ||| RB
cause  ||| S:19641 E:19647 ||| VB
significant  ||| S:19647 E:19659 ||| JJ
release  ||| S:19659 E:19667 ||| NN
of  ||| S:19667 E:19670 ||| IN
LDH  ||| S:19670 E:19682 ||| NNP
into  ||| S:19682 E:19687 ||| IN
the  ||| S:19687 E:19691 ||| DT
culture  ||| S:19691 E:19699 ||| NN
medium  ||| S:19699 E:19706 ||| NN
( ||| S:19706 E:19707 ||| -LRB-
Torchia  ||| S:19707 E:19715 ||| NNP
and  ||| S:19715 E:19719 ||| CC
Agellon ||| S:19719 E:19726 ||| NNP
,  ||| S:19726 E:19728 ||| ,
unpublished  ||| S:19728 E:19748 ||| JJ
observations ||| S:19748 E:19760 ||| NNS
) ||| S:19760 E:19761 ||| -RRB-
.  ||| S:19761 E:19763 ||| .
In  ||| S:19763 E:19766 ||| IN
contrast ||| S:19766 E:19774 ||| NN
,  ||| S:19774 E:19776 ||| ,
glycine-conjugated  ||| S:19776 E:19795 ||| JJ
bile  ||| S:19795 E:19800 ||| JJ
acids  ||| S:19800 E:19814 ||| NNS
( ||| S:19814 E:19815 ||| -LRB-
GCDCA  ||| S:19815 E:19821 ||| NNP
in  ||| S:19821 E:19824 ||| IN
particular ||| S:19824 E:19834 ||| JJ
)  ||| S:19834 E:19836 ||| -RRB-
were  ||| S:19836 E:19841 ||| VBD
highly  ||| S:19841 E:19848 ||| RB
effective  ||| S:19848 E:19858 ||| JJ
at  ||| S:19858 E:19861 ||| IN
causing  ||| S:19861 E:19869 ||| VBG
the  ||| S:19869 E:19881 ||| DT
increase  ||| S:19881 E:19890 ||| NN
in  ||| S:19890 E:19893 ||| IN
LDH  ||| S:19893 E:19897 ||| NNP
activity  ||| S:19897 E:19906 ||| NN
in  ||| S:19906 E:19909 ||| IN
the  ||| S:19909 E:19913 ||| DT
culture  ||| S:19913 E:19921 ||| NN
medium  ||| S:19921 E:19928 ||| NN
of  ||| S:19928 E:19931 ||| IN
both  ||| S:19931 E:19944 ||| DT
McNtcp.24  ||| S:19944 E:19954 ||| NNP
and  ||| S:19954 E:19958 ||| CC
CHO.asbt.35  ||| S:19958 E:19970 ||| CD
cells ||| S:19970 E:19975 ||| NNS
.  ||| S:19975 E:19977 ||| .
Primary  ||| S:19977 E:19985 ||| JJ
hepatocytes  ||| S:19985 E:20005 ||| JJ
exhibit  ||| S:20005 E:20013 ||| NN
differential  ||| S:20013 E:20026 ||| NN
sensitivity  ||| S:20026 E:20038 ||| NN
to  ||| S:20038 E:20041 ||| TO
taurine-  ||| S:20041 E:20050 ||| JJ
and  ||| S:20050 E:20062 ||| CC
glycine-conjugated  ||| S:20062 E:20081 ||| JJ
bile  ||| S:20081 E:20086 ||| JJ
acids  ||| S:20086 E:20092 ||| NNS
in  ||| S:20092 E:20095 ||| IN
culture  ||| S:20095 E:20103 ||| NN
[  ||| S:20103 E:20105 ||| -LRB-
29  ||| S:20105 E:20108 ||| CD
]  ||| S:20108 E:20110 ||| -RRB-
.  ||| S:20110 E:20112 ||| .
The  ||| S:20112 E:20116 ||| DT
bile  ||| S:20116 E:20129 ||| JJ
acid-transporting  ||| S:20129 E:20147 ||| JJ
WIF-B  ||| S:20147 E:20153 ||| JJ
cells ||| S:20153 E:20158 ||| NNS
,  ||| S:20158 E:20160 ||| ,
which  ||| S:20160 E:20166 ||| WDT
are  ||| S:20166 E:20170 ||| VBP
rat  ||| S:20170 E:20174 ||| JJ
hepatoma-human  ||| S:20174 E:20197 ||| JJ
fibroblast  ||| S:20197 E:20208 ||| JJ
hybrids  ||| S:20208 E:20216 ||| NNS
[  ||| S:20216 E:20218 ||| -LRB-
30  ||| S:20218 E:20221 ||| CD
]  ||| S:20221 E:20223 ||| -RRB-
,  ||| S:20223 E:20225 ||| ,
remain  ||| S:20225 E:20232 ||| VBP
viable  ||| S:20232 E:20239 ||| VBN
even  ||| S:20239 E:20244 ||| RB
when  ||| S:20244 E:20249 ||| WRB
grown  ||| S:20249 E:20263 ||| VBN
in  ||| S:20263 E:20266 ||| IN
TCA-containing  ||| S:20266 E:20281 ||| JJ
culture  ||| S:20281 E:20289 ||| NN
medium  ||| S:20289 E:20296 ||| NN
for  ||| S:20296 E:20300 ||| IN
up  ||| S:20300 E:20303 ||| RB
to  ||| S:20303 E:20306 ||| TO
14  ||| S:20306 E:20309 ||| CD
days  ||| S:20309 E:20314 ||| NNS
[  ||| S:20314 E:20316 ||| -LRB-
31  ||| S:20316 E:20319 ||| CD
]  ||| S:20319 E:20321 ||| -RRB-
.  ||| S:20321 E:20331 ||| .
In  ||| S:20331 E:20334 ||| IN
contrast ||| S:20334 E:20342 ||| NN
,  ||| S:20342 E:20344 ||| ,
our  ||| S:20344 E:20348 ||| PRP$
study  ||| S:20348 E:20354 ||| NN
shows  ||| S:20354 E:20360 ||| NNS
that  ||| S:20360 E:20365 ||| IN
taurine-conjugated  ||| S:20365 E:20384 ||| JJ
bile  ||| S:20384 E:20397 ||| JJ
acids  ||| S:20397 E:20403 ||| NN
is  ||| S:20403 E:20406 ||| VBZ
toxic  ||| S:20406 E:20412 ||| JJ
to  ||| S:20412 E:20415 ||| TO
a  ||| S:20415 E:20417 ||| DT
cell  ||| S:20417 E:20422 ||| NN
type  ||| S:20422 E:20427 ||| NN
that  ||| S:20427 E:20432 ||| WDT
is  ||| S:20432 E:20435 ||| VBZ
not  ||| S:20435 E:20439 ||| RB
normally  ||| S:20439 E:20448 ||| RB
exposed  ||| S:20448 E:20464 ||| VBN
to  ||| S:20464 E:20467 ||| TO
bile  ||| S:20467 E:20472 ||| VB
acids ||| S:20472 E:20477 ||| NNS
.  ||| S:20477 E:20479 ||| .
Liver  ||| S:20479 E:20485 ||| JJ
cells ||| S:20485 E:20490 ||| NNS
,  ||| S:20490 E:20492 ||| ,
which  ||| S:20492 E:20498 ||| WDT
normally  ||| S:20498 E:20507 ||| RB
metabolize  ||| S:20507 E:20518 ||| JJ
bile  ||| S:20518 E:20531 ||| JJ
acids ||| S:20531 E:20536 ||| NNS
,  ||| S:20536 E:20538 ||| ,
apparently  ||| S:20538 E:20549 ||| RB
possess  ||| S:20549 E:20557 ||| VB
a  ||| S:20557 E:20559 ||| DT
mechanism  ||| S:20559 E:20569 ||| NN
that  ||| S:20569 E:20574 ||| WDT
can  ||| S:20574 E:20578 ||| MD
distinguish  ||| S:20578 E:20598 ||| VB
and  ||| S:20598 E:20602 ||| CC
differentially  ||| S:20602 E:20617 ||| RB
elaborate  ||| S:20617 E:20627 ||| VB
distinct  ||| S:20627 E:20636 ||| JJ
biological  ||| S:20636 E:20647 ||| JJ
activities  ||| S:20647 E:20666 ||| NNS
of  ||| S:20666 E:20669 ||| IN
taurine-  ||| S:20669 E:20678 ||| JJ
and  ||| S:20678 E:20682 ||| CC
glycine-conjugated  ||| S:20682 E:20701 ||| JJ
bile  ||| S:20701 E:20706 ||| JJ
acids ||| S:20706 E:20711 ||| NNS
.  ||| S:20711 E:20721 ||| .
Both  ||| S:20721 E:20726 ||| DT
taurine-  ||| S:20726 E:20735 ||| JJ
and  ||| S:20735 E:20739 ||| CC
glycine-conjugated  ||| S:20739 E:20758 ||| JJ
bile  ||| S:20758 E:20763 ||| NNS
acids  ||| S:20763 E:20769 ||| RB
induce  ||| S:20769 E:20784 ||| VB
apoptotic  ||| S:20784 E:20794 ||| JJ
cell  ||| S:20794 E:20799 ||| NN
death  ||| S:20799 E:20805 ||| NN
in  ||| S:20805 E:20808 ||| IN
CHO.asbt.35  ||| S:20808 E:20820 ||| CD
cells ||| S:20820 E:20825 ||| NNS
.  ||| S:20825 E:20827 ||| .
The  ||| S:20827 E:20831 ||| DT
involvement  ||| S:20831 E:20851 ||| NN
of  ||| S:20851 E:20854 ||| IN
the  ||| S:20854 E:20858 ||| DT
caspase  ||| S:20858 E:20866 ||| JJ
cascade  ||| S:20866 E:20874 ||| NN
in  ||| S:20874 E:20877 ||| IN
CHO.asbt.35  ||| S:20877 E:20889 ||| CD
cells  ||| S:20889 E:20895 ||| NNS
was  ||| S:20895 E:20899 ||| VBD
illustrated  ||| S:20899 E:20919 ||| VBN
by  ||| S:20919 E:20922 ||| IN
the  ||| S:20922 E:20926 ||| DT
fact  ||| S:20926 E:20931 ||| NN
that  ||| S:20931 E:20936 ||| IN
conjugated  ||| S:20936 E:20947 ||| JJ
bile  ||| S:20947 E:20952 ||| NNS
acids  ||| S:20952 E:20958 ||| VBP
activated  ||| S:20958 E:20968 ||| VBN
caspase  ||| S:20968 E:20976 ||| CD
8  ||| S:20976 E:20986 ||| CD
in  ||| S:20986 E:20989 ||| IN
a  ||| S:20989 E:20991 ||| DT
time  ||| S:20991 E:20996 ||| NN
dependent  ||| S:20996 E:21006 ||| JJ
manner ||| S:21006 E:21012 ||| NN
.  ||| S:21012 E:21014 ||| .
However ||| S:21014 E:21021 ||| RB
,  ||| S:21021 E:21023 ||| ,
the  ||| S:21023 E:21027 ||| DT
different  ||| S:21027 E:21037 ||| JJ
profile  ||| S:21037 E:21053 ||| NN
of  ||| S:21053 E:21056 ||| IN
caspase  ||| S:21056 E:21064 ||| CD
8  ||| S:21064 E:21066 ||| CD
activation  ||| S:21066 E:21077 ||| NN
suggests  ||| S:21077 E:21086 ||| VBZ
that  ||| S:21086 E:21091 ||| DT
taurine-  ||| S:21091 E:21100 ||| JJ
and  ||| S:21100 E:21112 ||| CC
glycine-conjugated  ||| S:21112 E:21131 ||| JJ
bile  ||| S:21131 E:21136 ||| JJ
acids  ||| S:21136 E:21142 ||| NNS
may  ||| S:21142 E:21146 ||| MD
trigger  ||| S:21146 E:21154 ||| VB
apoptosis  ||| S:21154 E:21164 ||| VBN
by  ||| S:21164 E:21175 ||| IN
different  ||| S:21175 E:21185 ||| JJ
pathways ||| S:21185 E:21193 ||| NN
.  ||| S:21193 E:21195 ||| .
At  ||| S:21195 E:21198 ||| IN
present ||| S:21198 E:21205 ||| JJ
,  ||| S:21205 E:21207 ||| ,
it  ||| S:21207 E:21210 ||| PRP
is  ||| S:21210 E:21213 ||| VBZ
not  ||| S:21213 E:21217 ||| RB
known  ||| S:21217 E:21223 ||| VBN
how  ||| S:21223 E:21235 ||| WRB
conjugated  ||| S:21235 E:21246 ||| JJ
bile  ||| S:21246 E:21251 ||| JJ
acids  ||| S:21251 E:21257 ||| NNS
activate  ||| S:21257 E:21266 ||| VBP
caspases  ||| S:21266 E:21275 ||| VBN
in  ||| S:21275 E:21278 ||| IN
CHO.asbt.35  ||| S:21278 E:21298 ||| CD
cells ||| S:21298 E:21303 ||| NNS
.  ||| S:21303 E:21305 ||| .
A  ||| S:21305 E:21307 ||| DT
protein  ||| S:21307 E:21315 ||| NN
that  ||| S:21315 E:21320 ||| WDT
is  ||| S:21320 E:21323 ||| VBZ
immunoreactive  ||| S:21323 E:21338 ||| VBN
to  ||| S:21338 E:21341 ||| TO
a  ||| S:21341 E:21343 ||| DT
Fas  ||| S:21343 E:21347 ||| JJ
receptor  ||| S:21347 E:21364 ||| NN
antiserum  ||| S:21364 E:21374 ||| NNS
and  ||| S:21374 E:21378 ||| CC
has  ||| S:21378 E:21382 ||| VBZ
a  ||| S:21382 E:21384 ||| DT
molecular  ||| S:21384 E:21394 ||| JJ
mass  ||| S:21394 E:21399 ||| NN
similar  ||| S:21399 E:21407 ||| JJ
to  ||| S:21407 E:21410 ||| TO
the  ||| S:21410 E:21414 ||| DT
rat  ||| S:21414 E:21418 ||| JJ
Fas  ||| S:21418 E:21430 ||| JJ
receptor  ||| S:21430 E:21439 ||| NN
is  ||| S:21439 E:21442 ||| VBZ
detectable  ||| S:21442 E:21453 ||| VBN
in  ||| S:21453 E:21456 ||| IN
CHO  ||| S:21456 E:21460 ||| NNP
cell  ||| S:21460 E:21465 ||| NN
extracts  ||| S:21465 E:21474 ||| NNS
( ||| S:21474 E:21475 ||| -LRB-
Torchia  ||| S:21475 E:21483 ||| NNP
and  ||| S:21483 E:21495 ||| CC
Agellon ||| S:21495 E:21502 ||| NNP
,  ||| S:21502 E:21504 ||| ,
unpublished  ||| S:21504 E:21516 ||| JJ
results ||| S:21516 E:21523 ||| NNS
) ||| S:21523 E:21524 ||| -RRB-
.  ||| S:21524 E:21526 ||| .
This  ||| S:21526 E:21531 ||| DT
leaves  ||| S:21531 E:21538 ||| VBZ
the  ||| S:21538 E:21542 ||| DT
possibility  ||| S:21542 E:21562 ||| NN
that  ||| S:21562 E:21567 ||| IN
conjugated  ||| S:21567 E:21578 ||| JJ
bile  ||| S:21578 E:21583 ||| JJ
acids  ||| S:21583 E:21589 ||| NNS
may  ||| S:21589 E:21593 ||| MD
activate  ||| S:21593 E:21602 ||| VB
the  ||| S:21602 E:21606 ||| DT
apoptotic  ||| S:21606 E:21624 ||| JJ
cascade  ||| S:21624 E:21632 ||| NN
through  ||| S:21632 E:21640 ||| IN
Fas  ||| S:21640 E:21644 ||| NNP
receptor  ||| S:21644 E:21653 ||| NN
in  ||| S:21653 E:21656 ||| IN
this  ||| S:21656 E:21661 ||| DT
cell  ||| S:21661 E:21666 ||| NN
line ||| S:21666 E:21670 ||| NN
,  ||| S:21670 E:21672 ||| ,
as  ||| S:21672 E:21683 ||| IN
glycine-conjugated  ||| S:21683 E:21702 ||| JJ
bile  ||| S:21702 E:21707 ||| JJ
acids  ||| S:21707 E:21713 ||| NNS
do  ||| S:21713 E:21716 ||| VBP
in  ||| S:21716 E:21719 ||| IN
hepatocytes  ||| S:21719 E:21731 ||| NNS
[  ||| S:21731 E:21733 ||| -LRB-
25  ||| S:21733 E:21736 ||| CD
]  ||| S:21736 E:21738 ||| -RRB-
.  ||| S:21738 E:21748 ||| .
However ||| S:21748 E:21755 ||| RB
,  ||| S:21755 E:21757 ||| ,
the  ||| S:21757 E:21761 ||| DT
activation  ||| S:21761 E:21772 ||| NN
of  ||| S:21772 E:21775 ||| IN
caspases  ||| S:21775 E:21784 ||| NN
does  ||| S:21784 E:21789 ||| VBZ
not  ||| S:21789 E:21793 ||| RB
require  ||| S:21793 E:21801 ||| VB
a  ||| S:21801 E:21811 ||| DT
specific  ||| S:21811 E:21820 ||| JJ
kind  ||| S:21820 E:21825 ||| NN
of  ||| S:21825 E:21828 ||| IN
bile  ||| S:21828 E:21833 ||| JJ
acid  ||| S:21833 E:21838 ||| NN
transporter  ||| S:21838 E:21850 ||| NN
since  ||| S:21850 E:21856 ||| IN
TCA  ||| S:21856 E:21860 ||| NNP
is  ||| S:21860 E:21863 ||| VBZ
not  ||| S:21863 E:21875 ||| RB
toxic  ||| S:21875 E:21881 ||| JJ
to  ||| S:21881 E:21884 ||| TO
McArdle  ||| S:21884 E:21892 ||| JJ
RH-7777  ||| S:21892 E:21900 ||| CD
cells  ||| S:21900 E:21906 ||| NNS
irrespective  ||| S:21906 E:21919 ||| RB
of  ||| S:21919 E:21922 ||| IN
whether  ||| S:21922 E:21938 ||| IN
these  ||| S:21938 E:21944 ||| DT
cells  ||| S:21944 E:21950 ||| NNS
internalize  ||| S:21950 E:21962 ||| VBP
bile  ||| S:21962 E:21967 ||| JJ
acids  ||| S:21967 E:21973 ||| NNS
via  ||| S:21973 E:21977 ||| IN
ntcp  ||| S:21977 E:21982 ||| NN
or  ||| S:21982 E:21985 ||| CC
asbt ||| S:21985 E:21989 ||| NN
.  ||| S:21989 E:21999 ||| .
The  ||| S:21999 E:22003 ||| DT
differential  ||| S:22003 E:22016 ||| JJ
response  ||| S:22016 E:22025 ||| NN
of  ||| S:22025 E:22028 ||| IN
McNtcp.24  ||| S:22028 E:22038 ||| CD
cells  ||| S:22038 E:22044 ||| NNS
to  ||| S:22044 E:22055 ||| TO
different  ||| S:22055 E:22065 ||| JJ
classes  ||| S:22065 E:22073 ||| NNS
of  ||| S:22073 E:22076 ||| IN
conjugated  ||| S:22076 E:22087 ||| JJ
bile  ||| S:22087 E:22092 ||| JJ
acids  ||| S:22092 E:22098 ||| NN
is  ||| S:22098 E:22101 ||| VBZ
apparently  ||| S:22101 E:22120 ||| RB
due  ||| S:22120 E:22124 ||| JJ
to  ||| S:22124 E:22127 ||| TO
the  ||| S:22127 E:22131 ||| DT
selective  ||| S:22131 E:22141 ||| JJ
activation  ||| S:22141 E:22152 ||| NN
of  ||| S:22152 E:22155 ||| IN
either  ||| S:22155 E:22162 ||| DT
a  ||| S:22162 E:22164 ||| FW
PI3K-dependent  ||| S:22164 E:22187 ||| FW
survival  ||| S:22187 E:22196 ||| FW
pathway  ||| S:22196 E:22204 ||| FW
[  ||| S:22204 E:22206 ||| -LRB-
22  ||| S:22206 E:22209 ||| CD
23  ||| S:22209 E:22212 ||| CD
]  ||| S:22212 E:22214 ||| -RRB-
or  ||| S:22214 E:22217 ||| CC
caspase-dependent  ||| S:22217 E:22235 ||| JJ
death  ||| S:22235 E:22249 ||| NN
pathway  ||| S:22249 E:22257 ||| NNS
[  ||| S:22257 E:22259 ||| -LRB-
32  ||| S:22259 E:22262 ||| CD
]  ||| S:22262 E:22264 ||| -RRB-
.  ||| S:22264 E:22266 ||| .
Indeed ||| S:22266 E:22272 ||| RB
,  ||| S:22272 E:22274 ||| ,
neither  ||| S:22274 E:22282 ||| DT
taurine-  ||| S:22282 E:22291 ||| JJ
nor  ||| S:22291 E:22303 ||| CC
glycine-conjugated  ||| S:22303 E:22322 ||| JJ
bile  ||| S:22322 E:22327 ||| NNS
acids  ||| S:22327 E:22333 ||| VBP
stimulated  ||| S:22333 E:22344 ||| VBN
PI3K  ||| S:22344 E:22349 ||| CD
activity  ||| S:22349 E:22358 ||| NN
in  ||| S:22358 E:22369 ||| IN
CHO.asbt.35  ||| S:22369 E:22381 ||| CD
cells  ||| S:22381 E:22387 ||| NNS
and  ||| S:22387 E:22391 ||| CC
both  ||| S:22391 E:22396 ||| DT
classes  ||| S:22396 E:22404 ||| NNS
of  ||| S:22404 E:22407 ||| IN
bile  ||| S:22407 E:22412 ||| JJ
acids  ||| S:22412 E:22418 ||| NNS
were  ||| S:22418 E:22431 ||| VBD
toxic ||| S:22431 E:22436 ||| JJ
.  ||| S:22436 E:22438 ||| .
In  ||| S:22438 E:22441 ||| IN
addition ||| S:22441 E:22449 ||| NN
,  ||| S:22449 E:22451 ||| ,
pre-treatment  ||| S:22451 E:22465 ||| JJ
of  ||| S:22465 E:22468 ||| IN
McNtcp.24  ||| S:22468 E:22478 ||| CD
cells  ||| S:22478 E:22484 ||| NNS
with  ||| S:22484 E:22489 ||| IN
a  ||| S:22489 E:22499 ||| DT
PI3K  ||| S:22499 E:22504 ||| CD
inhibitor  ||| S:22504 E:22514 ||| NNS
rendered  ||| S:22514 E:22523 ||| VBD
these  ||| S:22523 E:22529 ||| DT
cells  ||| S:22529 E:22535 ||| NNS
susceptible  ||| S:22535 E:22547 ||| JJ
to  ||| S:22547 E:22550 ||| TO
TCA-  ||| S:22550 E:22555 ||| JJ
and  ||| S:22555 E:22567 ||| CC
TCDCA-  ||| S:22567 E:22574 ||| JJ
mediated  ||| S:22574 E:22583 ||| JJ
cell  ||| S:22583 E:22588 ||| NN
death ||| S:22588 E:22593 ||| NN
.  ||| S:22593 E:22595 ||| .
The  ||| S:22595 E:22599 ||| DT
latter  ||| S:22599 E:22606 ||| JJ
finding  ||| S:22606 E:22614 ||| NN
indicates  ||| S:22614 E:22632 ||| VBZ
that  ||| S:22632 E:22637 ||| DT
taurine-conjugated  ||| S:22637 E:22656 ||| JJ
bile  ||| S:22656 E:22661 ||| JJ
acids  ||| S:22661 E:22667 ||| NNS
are  ||| S:22667 E:22671 ||| VBP
capable  ||| S:22671 E:22679 ||| JJ
of  ||| S:22679 E:22682 ||| IN
inducing  ||| S:22682 E:22699 ||| JJ
apoptosis  ||| S:22699 E:22709 ||| NN
when  ||| S:22709 E:22714 ||| WRB
PI3K  ||| S:22714 E:22719 ||| NNP
is  ||| S:22719 E:22722 ||| VBZ
inhibited ||| S:22722 E:22731 ||| VBN
,  ||| S:22731 E:22733 ||| ,
probably  ||| S:22733 E:22742 ||| RB
by  ||| S:22742 E:22745 ||| IN
utilizing  ||| S:22745 E:22755 ||| VBG
the  ||| S:22755 E:22767 ||| DT
same  ||| S:22767 E:22772 ||| JJ
mechanism  ||| S:22772 E:22782 ||| NN
activated  ||| S:22782 E:22792 ||| VBN
by  ||| S:22792 E:22795 ||| IN
glycine-conjugated  ||| S:22795 E:22814 ||| JJ
bile  ||| S:22814 E:22819 ||| JJ
acids ||| S:22819 E:22824 ||| NNS
.  ||| S:22824 E:22834 ||| .
That  ||| S:22834 E:22839 ||| IN
TCA  ||| S:22839 E:22843 ||| NNP
is  ||| S:22843 E:22846 ||| VBZ
able  ||| S:22846 E:22851 ||| JJ
to  ||| S:22851 E:22854 ||| TO
activate  ||| S:22854 E:22863 ||| CD
PI3K  ||| S:22863 E:22868 ||| CD
in  ||| S:22868 E:22871 ||| IN
plasma  ||| S:22871 E:22878 ||| JJ
membrane  ||| S:22878 E:22895 ||| JJ
fractions  ||| S:22895 E:22905 ||| NNS
from  ||| S:22905 E:22910 ||| IN
McNtpc.24  ||| S:22910 E:22920 ||| NNP
agrees  ||| S:22920 E:22927 ||| VBZ
with  ||| S:22927 E:22932 ||| IN
a  ||| S:22932 E:22934 ||| DT
previous  ||| S:22934 E:22943 ||| JJ
study  ||| S:22943 E:22957 ||| NN
showing  ||| S:22957 E:22965 ||| VBG
that  ||| S:22965 E:22970 ||| IN
TCA  ||| S:22970 E:22974 ||| NNP
increases  ||| S:22974 E:22984 ||| VBZ
PI3K  ||| S:22984 E:22989 ||| CD
activity  ||| S:22989 E:22998 ||| NN
in  ||| S:22998 E:23001 ||| IN
canalicular  ||| S:23001 E:23013 ||| NN
and  ||| S:23013 E:23025 ||| CC
sinusoidal  ||| S:23025 E:23036 ||| FW
membrane  ||| S:23036 E:23045 ||| FW
vesicles  ||| S:23045 E:23054 ||| FW
[  ||| S:23054 E:23056 ||| -LRB-
16  ||| S:23056 E:23059 ||| CD
]  ||| S:23059 E:23061 ||| -RRB-
.  ||| S:23061 E:23063 ||| .
The  ||| S:23063 E:23067 ||| DT
activation  ||| S:23067 E:23078 ||| NN
of  ||| S:23078 E:23089 ||| IN
PI3K  ||| S:23089 E:23094 ||| CD
in  ||| S:23094 E:23097 ||| IN
that  ||| S:23097 E:23102 ||| DT
report  ||| S:23102 E:23109 ||| NN
was  ||| S:23109 E:23113 ||| VBD
also  ||| S:23113 E:23118 ||| RB
associated  ||| S:23118 E:23129 ||| VBN
with  ||| S:23129 E:23134 ||| IN
recruitment  ||| S:23134 E:23146 ||| NN
of  ||| S:23146 E:23157 ||| IN
sister  ||| S:23157 E:23164 ||| NN
of  ||| S:23164 E:23167 ||| IN
P-glycoprotein  ||| S:23167 E:23182 ||| NNP
( ||| S:23182 E:23183 ||| -LRB-
the  ||| S:23183 E:23187 ||| DT
bile  ||| S:23187 E:23192 ||| JJ
acid  ||| S:23192 E:23197 ||| NN
export  ||| S:23197 E:23204 ||| NN
pump ||| S:23204 E:23208 ||| NN
)  ||| S:23208 E:23210 ||| -RRB-
and  ||| S:23210 E:23222 ||| CC
other  ||| S:23222 E:23228 ||| JJ
multidrug  ||| S:23228 E:23238 ||| JJ
resistance  ||| S:23238 E:23249 ||| NN
proteins  ||| S:23249 E:23258 ||| NNS
to  ||| S:23258 E:23261 ||| TO
the  ||| S:23261 E:23265 ||| DT
canalicular  ||| S:23265 E:23285 ||| JJ
membrane  ||| S:23285 E:23294 ||| NNS
[  ||| S:23294 E:23296 ||| -LRB-
16  ||| S:23296 E:23299 ||| CD
]  ||| S:23299 E:23301 ||| -RRB-
.  ||| S:23301 E:23303 ||| .
Extended  ||| S:23303 E:23312 ||| JJ
treatment  ||| S:23312 E:23322 ||| NN
of  ||| S:23322 E:23325 ||| IN
McNtcp.24  ||| S:23325 E:23335 ||| CD
cells  ||| S:23335 E:23349 ||| NNS
does  ||| S:23349 E:23354 ||| VBZ
not  ||| S:23354 E:23358 ||| RB
appear  ||| S:23358 E:23365 ||| VB
to  ||| S:23365 E:23368 ||| TO
have  ||| S:23368 E:23373 ||| VB
detrimental  ||| S:23373 E:23385 ||| JJ
and  ||| S:23385 E:23389 ||| CC
permanent  ||| S:23389 E:23407 ||| JJ
consequences  ||| S:23407 E:23420 ||| NNS
on  ||| S:23420 E:23423 ||| IN
cellular  ||| S:23423 E:23432 ||| JJ
function ||| S:23432 E:23440 ||| NN
.  ||| S:23440 E:23442 ||| .
The  ||| S:23442 E:23446 ||| DT
marked  ||| S:23446 E:23453 ||| JJ
morphological  ||| S:23453 E:23475 ||| JJ
changes  ||| S:23475 E:23483 ||| NNS
that  ||| S:23483 E:23488 ||| WDT
occur  ||| S:23488 E:23494 ||| VBP
during  ||| S:23494 E:23501 ||| IN
long  ||| S:23501 E:23506 ||| JJ
term  ||| S:23506 E:23511 ||| NN
incubation  ||| S:23511 E:23522 ||| NN
with  ||| S:23522 E:23527 ||| IN
TCA  ||| S:23527 E:23531 ||| NNP
[  ||| S:23531 E:23541 ||| -LRB-
18  ||| S:23541 E:23544 ||| CD
]  ||| S:23544 E:23546 ||| -RRB-
dissipate  ||| S:23546 E:23556 ||| NN
after  ||| S:23556 E:23562 ||| IN
the  ||| S:23562 E:23566 ||| DT
withdrawal  ||| S:23566 E:23577 ||| NN
of  ||| S:23577 E:23580 ||| IN
the  ||| S:23580 E:23584 ||| DT
bile  ||| S:23584 E:23589 ||| JJ
acid  ||| S:23589 E:23594 ||| NN
from  ||| S:23594 E:23607 ||| IN
the  ||| S:23607 E:23611 ||| DT
culture  ||| S:23611 E:23619 ||| NN
medium ||| S:23619 E:23625 ||| NN
,  ||| S:23625 E:23627 ||| ,
and  ||| S:23627 E:23631 ||| CC
the  ||| S:23631 E:23635 ||| DT
cells  ||| S:23635 E:23641 ||| NNS
remain  ||| S:23641 E:23648 ||| VBP
viable ||| S:23648 E:23654 ||| JJ
.  ||| S:23654 E:23664 ||| .
The  ||| S:23664 E:23668 ||| DT
significance  ||| S:23668 E:23681 ||| NN
of  ||| S:23681 E:23684 ||| IN
an  ||| S:23684 E:23687 ||| DT
intracellular  ||| S:23687 E:23701 ||| NN
and  ||| S:23701 E:23705 ||| CC
high  ||| S:23705 E:23710 ||| JJ
affinity  ||| S:23710 E:23727 ||| FW
bile  ||| S:23727 E:23732 ||| FW
acid  ||| S:23732 E:23737 ||| FW
binder  ||| S:23737 E:23744 ||| FW
in  ||| S:23744 E:23747 ||| FW
bile  ||| S:23747 E:23752 ||| FW
acid  ||| S:23752 E:23757 ||| FW
mediated  ||| S:23757 E:23766 ||| FW
cytotoxicity  ||| S:23766 E:23779 ||| NN
was  ||| S:23779 E:23791 ||| VBD
also  ||| S:23791 E:23796 ||| RB
evaluated ||| S:23796 E:23805 ||| VBN
.  ||| S:23805 E:23807 ||| .
Several  ||| S:23807 E:23815 ||| JJ
proteins  ||| S:23815 E:23824 ||| NNS
capable  ||| S:23824 E:23832 ||| JJ
of  ||| S:23832 E:23835 ||| IN
binding  ||| S:23835 E:23843 ||| JJ
bile  ||| S:23843 E:23856 ||| JJ
acids  ||| S:23856 E:23862 ||| NNS
in  ||| S:23862 E:23865 ||| IN
vitro  ||| S:23865 E:23871 ||| NNS
have  ||| S:23871 E:23876 ||| VBP
been  ||| S:23876 E:23881 ||| VBN
identified  ||| S:23881 E:23892 ||| VBN
( ||| S:23892 E:23893 ||| -LRB-
reviewed  ||| S:23893 E:23902 ||| VBN
in  ||| S:23902 E:23905 ||| IN
ref.  ||| S:23905 E:23910 ||| NNP
[  ||| S:23910 E:23912 ||| -LRB-
1  ||| S:23912 E:23914 ||| LS
]  ||| S:23914 E:23924 ||| -RRB-
) ||| S:23924 E:23925 ||| -RRB-
.  ||| S:23925 E:23927 ||| .
It  ||| S:23927 E:23930 ||| PRP
is  ||| S:23930 E:23933 ||| VBZ
thought  ||| S:23933 E:23941 ||| VBN
that  ||| S:23941 E:23946 ||| IN
the  ||| S:23946 E:23950 ||| DT
major  ||| S:23950 E:23956 ||| JJ
bile  ||| S:23956 E:23961 ||| JJ
acid  ||| S:23961 E:23966 ||| JJ
binding  ||| S:23966 E:23974 ||| JJ
protein  ||| S:23974 E:23990 ||| NN
in  ||| S:23990 E:23993 ||| IN
the  ||| S:23993 E:23997 ||| DT
cytosol  ||| S:23997 E:24005 ||| NN
of  ||| S:24005 E:24008 ||| IN
rat  ||| S:24008 E:24012 ||| JJ
hepatocytes  ||| S:24012 E:24024 ||| NN
is  ||| S:24024 E:24027 ||| VBZ
3Î±-hydroxysteroid  ||| S:24027 E:24053 ||| CD
dehydrogenase ||| S:24053 E:24066 ||| NN
,  ||| S:24066 E:24068 ||| ,
a  ||| S:24068 E:24070 ||| DT
member  ||| S:24070 E:24077 ||| NN
of  ||| S:24077 E:24080 ||| IN
the  ||| S:24080 E:24084 ||| DT
aldo  ||| S:24084 E:24089 ||| FW
keto  ||| S:24089 E:24094 ||| FW
reductase  ||| S:24094 E:24112 ||| FW
supergene  ||| S:24112 E:24122 ||| FW
family  ||| S:24122 E:24129 ||| FW
[  ||| S:24129 E:24131 ||| -LRB-
33  ||| S:24131 E:24134 ||| CD
]  ||| S:24134 E:24136 ||| -RRB-
.  ||| S:24136 E:24138 ||| .
However ||| S:24138 E:24145 ||| RB
,  ||| S:24145 E:24147 ||| ,
the  ||| S:24147 E:24151 ||| DT
exact  ||| S:24151 E:24157 ||| JJ
role  ||| S:24157 E:24162 ||| NN
of  ||| S:24162 E:24165 ||| IN
this  ||| S:24165 E:24178 ||| DT
protein  ||| S:24178 E:24186 ||| NN
in  ||| S:24186 E:24189 ||| IN
intracellular  ||| S:24189 E:24203 ||| JJ
transport  ||| S:24203 E:24213 ||| NN
of  ||| S:24213 E:24216 ||| IN
bile  ||| S:24216 E:24221 ||| JJ
acids  ||| S:24221 E:24227 ||| NNS
and  ||| S:24227 E:24239 ||| CC
cytoprotection  ||| S:24239 E:24254 ||| NNS
was  ||| S:24254 E:24258 ||| VBD
undefined ||| S:24258 E:24267 ||| JJ
.  ||| S:24267 E:24269 ||| .
HBAB ||| S:24269 E:24273 ||| NNP
,  ||| S:24273 E:24275 ||| ,
a  ||| S:24275 E:24277 ||| DT
member  ||| S:24277 E:24284 ||| NN
of  ||| S:24284 E:24287 ||| IN
the  ||| S:24287 E:24291 ||| DT
human  ||| S:24291 E:24305 ||| JJ
aldo  ||| S:24305 E:24310 ||| NNS
keto  ||| S:24310 E:24315 ||| VBP
reductase  ||| S:24315 E:24325 ||| JJ
gene  ||| S:24325 E:24330 ||| NN
family ||| S:24330 E:24336 ||| NN
,  ||| S:24336 E:24338 ||| ,
has  ||| S:24338 E:24342 ||| VBZ
been  ||| S:24342 E:24347 ||| VBN
shown  ||| S:24347 E:24353 ||| VBN
to  ||| S:24353 E:24356 ||| TO
bind  ||| S:24356 E:24369 ||| VB
bile  ||| S:24369 E:24374 ||| JJ
acids  ||| S:24374 E:24380 ||| NNS
with  ||| S:24380 E:24385 ||| IN
high  ||| S:24385 E:24390 ||| JJ
affinity  ||| S:24390 E:24399 ||| NNS
(  ||| S:24399 E:24400 ||| -LRB-
< ||| S:24400 E:24401 ||| SYM
1  ||| S:24401 E:24403 ||| CD
Î¼M ||| S:24403 E:24405 ||| NN
)  ||| S:24405 E:24407 ||| -RRB-
and  ||| S:24407 E:24411 ||| CC
is  ||| S:24411 E:24414 ||| VBZ
postulated  ||| S:24414 E:24433 ||| VBN
to  ||| S:24433 E:24436 ||| TO
play  ||| S:24436 E:24441 ||| VB
a  ||| S:24441 E:24443 ||| DT
similar  ||| S:24443 E:24451 ||| JJ
role  ||| S:24451 E:24456 ||| NN
as  ||| S:24456 E:24459 ||| IN
3Î±-hydroxysteroid  ||| S:24459 E:24477 ||| CD
dehydrogenase  ||| S:24477 E:24499 ||| NN
in  ||| S:24499 E:24502 ||| IN
human  ||| S:24502 E:24508 ||| JJ
hepatocytes  ||| S:24508 E:24520 ||| NNS
[  ||| S:24520 E:24522 ||| -LRB-
33  ||| S:24522 E:24525 ||| CD
]  ||| S:24525 E:24527 ||| -RRB-
.  ||| S:24527 E:24529 ||| .
Expression  ||| S:24529 E:24540 ||| NN
of  ||| S:24540 E:24543 ||| IN
HBAB  ||| S:24543 E:24548 ||| NNP
in  ||| S:24548 E:24559 ||| IN
McNtcp.24  ||| S:24559 E:24569 ||| CD
cells  ||| S:24569 E:24575 ||| NNS
was  ||| S:24575 E:24579 ||| VBD
expected  ||| S:24579 E:24588 ||| VBN
to  ||| S:24588 E:24591 ||| TO
increase  ||| S:24591 E:24600 ||| VB
the  ||| S:24600 E:24604 ||| DT
capacity  ||| S:24604 E:24613 ||| NN
of  ||| S:24613 E:24624 ||| IN
these  ||| S:24624 E:24630 ||| DT
cells  ||| S:24630 E:24636 ||| NNS
to  ||| S:24636 E:24639 ||| TO
sequester  ||| S:24639 E:24649 ||| VB
bile  ||| S:24649 E:24654 ||| JJ
acids  ||| S:24654 E:24660 ||| NNS
in  ||| S:24660 E:24663 ||| IN
the  ||| S:24663 E:24667 ||| DT
cytoplasm ||| S:24667 E:24676 ||| NN
,  ||| S:24676 E:24678 ||| ,
and  ||| S:24678 E:24690 ||| CC
thereby  ||| S:24690 E:24698 ||| RB
reduce  ||| S:24698 E:24705 ||| VB
their  ||| S:24705 E:24711 ||| PRP$
toxicity ||| S:24711 E:24719 ||| NN
.  ||| S:24719 E:24721 ||| .
High  ||| S:24721 E:24726 ||| JJ
level  ||| S:24726 E:24732 ||| NN
expression  ||| S:24732 E:24743 ||| NN
of  ||| S:24743 E:24754 ||| IN
HBAB  ||| S:24754 E:24759 ||| NNP
had  ||| S:24759 E:24763 ||| VBD
a  ||| S:24763 E:24765 ||| DT
negligible  ||| S:24765 E:24776 ||| JJ
effect  ||| S:24776 E:24783 ||| NN
on  ||| S:24783 E:24786 ||| IN
the  ||| S:24786 E:24790 ||| DT
ability  ||| S:24790 E:24798 ||| NN
of  ||| S:24798 E:24801 ||| IN
the  ||| S:24801 E:24805 ||| DT
BN  ||| S:24805 E:24816 ||| NNP
clones  ||| S:24816 E:24823 ||| NNS
to  ||| S:24823 E:24826 ||| TO
take  ||| S:24826 E:24831 ||| VB
up  ||| S:24831 E:24834 ||| RP
or  ||| S:24834 E:24837 ||| CC
secrete  ||| S:24837 E:24845 ||| JJ
bile  ||| S:24845 E:24850 ||| JJ
acids ||| S:24850 E:24855 ||| NNS
,  ||| S:24855 E:24857 ||| ,
suggesting  ||| S:24857 E:24868 ||| VBG
that  ||| S:24868 E:24881 ||| IN
HBAB  ||| S:24881 E:24886 ||| NNP
has  ||| S:24886 E:24890 ||| VBZ
a  ||| S:24890 E:24892 ||| DT
minor  ||| S:24892 E:24898 ||| JJ
role  ||| S:24898 E:24903 ||| NN
in  ||| S:24903 E:24906 ||| IN
the  ||| S:24906 E:24910 ||| DT
net  ||| S:24910 E:24914 ||| JJ
transport  ||| S:24914 E:24924 ||| NN
of  ||| S:24924 E:24927 ||| IN
bile  ||| S:24927 E:24932 ||| JJ
acids  ||| S:24932 E:24938 ||| NNS
in  ||| S:24938 E:24949 ||| IN
these  ||| S:24949 E:24955 ||| DT
cells ||| S:24955 E:24960 ||| NNS
.  ||| S:24960 E:24962 ||| .
More  ||| S:24962 E:24967 ||| RBR
importantly  ||| S:24967 E:24979 ||| RB
however ||| S:24979 E:24986 ||| RB
,  ||| S:24986 E:24988 ||| ,
expression  ||| S:24988 E:24999 ||| NN
of  ||| S:24999 E:25002 ||| IN
HBAB  ||| S:25002 E:25015 ||| NNP
in  ||| S:25015 E:25018 ||| IN
McNtcp.24  ||| S:25018 E:25028 ||| CD
cells  ||| S:25028 E:25034 ||| NNS
had  ||| S:25034 E:25038 ||| VBD
no  ||| S:25038 E:25041 ||| DT
effect  ||| S:25041 E:25048 ||| NN
on  ||| S:25048 E:25051 ||| IN
GCDCA-induced  ||| S:25051 E:25065 ||| JJ
cell  ||| S:25065 E:25078 ||| NN
death ||| S:25078 E:25083 ||| NN
,  ||| S:25083 E:25085 ||| ,
even  ||| S:25085 E:25090 ||| RB
at  ||| S:25090 E:25093 ||| IN
low  ||| S:25093 E:25097 ||| JJ
bile  ||| S:25097 E:25102 ||| JJ
acid  ||| S:25102 E:25107 ||| NN
concentrations ||| S:25107 E:25121 ||| NNS
,  ||| S:25121 E:25123 ||| ,
indicating  ||| S:25123 E:25142 ||| VBG
that  ||| S:25142 E:25147 ||| IN
this  ||| S:25147 E:25152 ||| DT
class  ||| S:25152 E:25158 ||| NN
of  ||| S:25158 E:25161 ||| IN
protein  ||| S:25161 E:25169 ||| NN
does  ||| S:25169 E:25174 ||| VBZ
not  ||| S:25174 E:25178 ||| RB
provide  ||| S:25178 E:25186 ||| VB
cytoprotection  ||| S:25186 E:25209 ||| VBN
against  ||| S:25209 E:25217 ||| IN
toxic  ||| S:25217 E:25223 ||| JJ
bile  ||| S:25223 E:25228 ||| JJ
acids  ||| S:25228 E:25234 ||| NNS
as  ||| S:25234 E:25237 ||| IN
previously  ||| S:25237 E:25248 ||| RB
suspected ||| S:25248 E:25257 ||| VBN
.  ||| S:25257 E:25259 ||| .
This  ||| S:25259 E:25272 ||| DT
finding  ||| S:25272 E:25280 ||| NN
is  ||| S:25280 E:25283 ||| VBZ
consistent  ||| S:25283 E:25294 ||| JJ
with  ||| S:25294 E:25299 ||| IN
the  ||| S:25299 E:25303 ||| DT
idea  ||| S:25303 E:25308 ||| NN
that  ||| S:25308 E:25313 ||| IN
bile  ||| S:25313 E:25318 ||| JJ
acids  ||| S:25318 E:25332 ||| NNS
directly  ||| S:25332 E:25341 ||| RB
modulate  ||| S:25341 E:25350 ||| VBP
specific  ||| S:25350 E:25359 ||| JJ
signaling  ||| S:25359 E:25369 ||| JJ
cascades  ||| S:25369 E:25378 ||| NN
that  ||| S:25378 E:25383 ||| WDT
control  ||| S:25383 E:25399 ||| VBP
cellular  ||| S:25399 E:25408 ||| JJ
death  ||| S:25408 E:25414 ||| NN
and  ||| S:25414 E:25418 ||| CC
survival ||| S:25418 E:25426 ||| NN
.  ||| S:25426 E:25436 ||| .
In  ||| S:25436 E:25439 ||| IN
summary ||| S:25439 E:25446 ||| NN
,  ||| S:25446 E:25448 ||| ,
the  ||| S:25448 E:25452 ||| DT
failure  ||| S:25452 E:25460 ||| NN
of  ||| S:25460 E:25463 ||| IN
CHO.asbt  ||| S:25463 E:25472 ||| CD
cells  ||| S:25472 E:25478 ||| NNS
to  ||| S:25478 E:25481 ||| TO
tolerate  ||| S:25481 E:25498 ||| VB
taurine-conjugated  ||| S:25498 E:25517 ||| JJ
bile  ||| S:25517 E:25522 ||| JJ
acids  ||| S:25522 E:25528 ||| NN
has  ||| S:25528 E:25532 ||| VBZ
revealed  ||| S:25532 E:25541 ||| VBN
the  ||| S:25541 E:25545 ||| DT
existence  ||| S:25545 E:25555 ||| NN
of  ||| S:25555 E:25566 ||| IN
a  ||| S:25566 E:25568 ||| DT
mechanism  ||| S:25568 E:25578 ||| NN
that  ||| S:25578 E:25583 ||| WDT
may  ||| S:25583 E:25587 ||| MD
be  ||| S:25587 E:25590 ||| VB
specific  ||| S:25590 E:25599 ||| JJ
for  ||| S:25599 E:25603 ||| IN
cells  ||| S:25603 E:25609 ||| NNS
that  ||| S:25609 E:25614 ||| WDT
normally  ||| S:25614 E:25631 ||| RB
metabolize  ||| S:25631 E:25642 ||| JJ
bile  ||| S:25642 E:25647 ||| JJ
acids ||| S:25647 E:25652 ||| NNS
.  ||| S:25652 E:25654 ||| .
Since  ||| S:25654 E:25660 ||| IN
bile  ||| S:25660 E:25665 ||| JJ
acids  ||| S:25665 E:25671 ||| NNS
undergo  ||| S:25671 E:25687 ||| VBP
enterohepatic  ||| S:25687 E:25701 ||| JJ
circulation ||| S:25701 E:25712 ||| NN
,  ||| S:25712 E:25714 ||| ,
it  ||| S:25714 E:25717 ||| PRP
would  ||| S:25717 E:25723 ||| MD
be  ||| S:25723 E:25726 ||| VB
reasonable  ||| S:25726 E:25737 ||| JJ
to  ||| S:25737 E:25740 ||| TO
expect  ||| S:25740 E:25755 ||| VB
the  ||| S:25755 E:25759 ||| DT
existence  ||| S:25759 E:25769 ||| NN
of  ||| S:25769 E:25772 ||| IN
the  ||| S:25772 E:25776 ||| DT
same  ||| S:25776 E:25781 ||| JJ
mechanism  ||| S:25781 E:25791 ||| NN
in  ||| S:25791 E:25794 ||| IN
other  ||| S:25794 E:25800 ||| JJ
cell  ||| S:25800 E:25805 ||| NN
types  ||| S:25805 E:25819 ||| NNS
that  ||| S:25819 E:25824 ||| WDT
naturally  ||| S:25824 E:25834 ||| RB
transport  ||| S:25834 E:25844 ||| VB
bile  ||| S:25844 E:25849 ||| JJ
acids ||| S:25849 E:25854 ||| NNS
,  ||| S:25854 E:25856 ||| ,
such  ||| S:25856 E:25861 ||| JJ
as  ||| S:25861 E:25864 ||| IN
ileocytes  ||| S:25864 E:25874 ||| NN
and  ||| S:25874 E:25886 ||| CC
cholangiocytes  ||| S:25886 E:25901 ||| NNS
[  ||| S:25901 E:25903 ||| -LRB-
34  ||| S:25903 E:25906 ||| CD
35  ||| S:25906 E:25909 ||| CD
]  ||| S:25909 E:25911 ||| -RRB-
.  ||| S:25911 E:25913 ||| .
The  ||| S:25913 E:25917 ||| DT
last  ||| S:25917 E:25922 ||| JJ
few  ||| S:25922 E:25926 ||| JJ
years  ||| S:25926 E:25932 ||| NNS
have  ||| S:25932 E:25937 ||| VBP
brought  ||| S:25937 E:25953 ||| VBN
significant  ||| S:25953 E:25965 ||| JJ
advances  ||| S:25965 E:25974 ||| NNS
in  ||| S:25974 E:25977 ||| IN
our  ||| S:25977 E:25981 ||| PRP$
understanding  ||| S:25981 E:25995 ||| NN
of  ||| S:25995 E:25998 ||| IN
bile  ||| S:25998 E:26003 ||| JJ
acid  ||| S:26003 E:26016 ||| NN
transport  ||| S:26016 E:26026 ||| NN
in  ||| S:26026 E:26029 ||| IN
liver  ||| S:26029 E:26035 ||| NN
and  ||| S:26035 E:26039 ||| CC
intestinal  ||| S:26039 E:26050 ||| JJ
cells ||| S:26050 E:26055 ||| NNS
.  ||| S:26055 E:26057 ||| .
However ||| S:26057 E:26064 ||| RB
,  ||| S:26064 E:26066 ||| ,
the  ||| S:26066 E:26078 ||| DT
regulatory  ||| S:26078 E:26089 ||| JJ
potential  ||| S:26089 E:26099 ||| NN
of  ||| S:26099 E:26102 ||| IN
bile  ||| S:26102 E:26107 ||| JJ
acids  ||| S:26107 E:26113 ||| NN
is  ||| S:26113 E:26116 ||| VBZ
only  ||| S:26116 E:26121 ||| RB
beginning  ||| S:26121 E:26131 ||| VBG
to  ||| S:26131 E:26134 ||| TO
be  ||| S:26134 E:26145 ||| VB
realized ||| S:26145 E:26153 ||| VBN
.  ||| S:26153 E:26155 ||| .
With  ||| S:26155 E:26160 ||| IN
the  ||| S:26160 E:26164 ||| DT
recent  ||| S:26164 E:26171 ||| JJ
discovery  ||| S:26171 E:26181 ||| NN
that  ||| S:26181 E:26186 ||| IN
bile  ||| S:26186 E:26191 ||| JJ
acids  ||| S:26191 E:26205 ||| NNS
represent  ||| S:26205 E:26215 ||| VBP
the  ||| S:26215 E:26219 ||| DT
natural  ||| S:26219 E:26227 ||| JJ
ligands  ||| S:26227 E:26235 ||| NN
for  ||| S:26235 E:26239 ||| IN
the  ||| S:26239 E:26243 ||| DT
nuclear  ||| S:26243 E:26251 ||| JJ
receptor  ||| S:26251 E:26260 ||| NN
FXR  ||| S:26260 E:26272 ||| NNP
[  ||| S:26272 E:26274 ||| -LRB-
10  ||| S:26274 E:26277 ||| CD
11  ||| S:26277 E:26280 ||| CD
12  ||| S:26280 E:26283 ||| CD
]  ||| S:26283 E:26285 ||| -RRB-
,  ||| S:26285 E:26287 ||| ,
there  ||| S:26287 E:26293 ||| EX
is  ||| S:26293 E:26296 ||| VBZ
heightened  ||| S:26296 E:26307 ||| VBN
interest  ||| S:26307 E:26316 ||| NN
in  ||| S:26316 E:26319 ||| IN
identifying  ||| S:26319 E:26339 ||| VBG
the  ||| S:26339 E:26343 ||| DT
genes  ||| S:26343 E:26349 ||| NNS
that  ||| S:26349 E:26354 ||| WDT
are  ||| S:26354 E:26358 ||| VBP
regulated  ||| S:26358 E:26368 ||| VBN
by  ||| S:26368 E:26371 ||| IN
bile  ||| S:26371 E:26376 ||| JJ
acids ||| S:26376 E:26381 ||| NNS
.  ||| S:26381 E:26383 ||| .
Insight  ||| S:26383 E:26391 ||| NNP
into  ||| S:26391 E:26404 ||| IN
how  ||| S:26404 E:26408 ||| WRB
bile  ||| S:26408 E:26413 ||| JJ
acids  ||| S:26413 E:26419 ||| NNS
directly  ||| S:26419 E:26428 ||| RB
modulate  ||| S:26428 E:26437 ||| VBP
a  ||| S:26437 E:26439 ||| DT
variety  ||| S:26439 E:26447 ||| NN
of  ||| S:26447 E:26450 ||| IN
other  ||| S:26450 E:26464 ||| JJ
cellular  ||| S:26464 E:26473 ||| JJ
functions  ||| S:26473 E:26483 ||| NNS
will  ||| S:26483 E:26488 ||| MD
be  ||| S:26488 E:26491 ||| VB
important  ||| S:26491 E:26501 ||| JJ
in  ||| S:26501 E:26504 ||| IN
understanding  ||| S:26504 E:26518 ||| VBG
the  ||| S:26518 E:26530 ||| DT
significance  ||| S:26530 E:26543 ||| NN
of  ||| S:26543 E:26546 ||| IN
cellular  ||| S:26546 E:26555 ||| JJ
responses  ||| S:26555 E:26565 ||| NNS
to  ||| S:26565 E:26568 ||| TO
bile  ||| S:26568 E:26573 ||| VB
acids ||| S:26573 E:26578 ||| NNS
.  ||| S:26578 E:26602 ||| .
Materials  ||| S:26602 E:26612 ||| NNS
and  ||| S:26612 E:26616 ||| CC
Methods  ||| S:26616 E:26643 ||| NNP
Materials  ||| S:26643 E:26663 ||| NNPS
Tissue  ||| S:26663 E:26670 ||| NNP
culture  ||| S:26670 E:26678 ||| NN
reagents  ||| S:26678 E:26687 ||| NNS
were  ||| S:26687 E:26692 ||| VBD
purchased  ||| S:26692 E:26702 ||| VBN
from  ||| S:26702 E:26707 ||| IN
Canadian  ||| S:26707 E:26726 ||| NNP
Life  ||| S:26726 E:26731 ||| NNP
Technologies  ||| S:26731 E:26744 ||| NNPS
( ||| S:26744 E:26745 ||| -LRB-
Burlington ||| S:26745 E:26755 ||| NNP
,  ||| S:26755 E:26757 ||| ,
ON ||| S:26757 E:26759 ||| NNP
,  ||| S:26759 E:26761 ||| ,
Canada ||| S:26761 E:26767 ||| NNP
) ||| S:26767 E:26768 ||| -RRB-
.  ||| S:26768 E:26770 ||| .
[  ||| S:26770 E:26782 ||| -LRB-
3H ||| S:26782 E:26784 ||| NNP
] ||| S:26784 E:26785 ||| -RRB-
-Taurocholic  ||| S:26785 E:26798 ||| JJ
acid  ||| S:26798 E:26803 ||| NN
( ||| S:26803 E:26804 ||| -LRB-
2.6  ||| S:26804 E:26808 ||| CD
Ci ||| S:26808 E:26810 ||| CD
/ ||| S:26810 E:26811 ||| CD
mmol ||| S:26811 E:26815 ||| CD
) ||| S:26815 E:26816 ||| -RRB-
,  ||| S:26816 E:26818 ||| ,
[  ||| S:26818 E:26820 ||| -LRB-
32P ||| S:26820 E:26823 ||| NNP
] ||| S:26823 E:26824 ||| -RRB-
-dCTP  ||| S:26824 E:26830 ||| NNP
( ||| S:26830 E:26831 ||| -LRB-
3000  ||| S:26831 E:26846 ||| CD
Ci ||| S:26846 E:26848 ||| CD
/ ||| S:26848 E:26849 ||| CD
mmol ||| S:26849 E:26853 ||| CD
) ||| S:26853 E:26854 ||| -RRB-
,  ||| S:26854 E:26856 ||| ,
and  ||| S:26856 E:26860 ||| CC
[  ||| S:26860 E:26862 ||| -LRB-
32P ||| S:26862 E:26865 ||| NNP
] ||| S:26865 E:26866 ||| -RRB-
-ATP  ||| S:26866 E:26871 ||| NNP
( ||| S:26871 E:26872 ||| -LRB-
3000  ||| S:26872 E:26877 ||| CD
Ci ||| S:26877 E:26879 ||| CD
/ ||| S:26879 E:26880 ||| CD
mmol ||| S:26880 E:26884 ||| CD
)  ||| S:26884 E:26886 ||| -RRB-
were  ||| S:26886 E:26891 ||| VBD
purchased  ||| S:26891 E:26911 ||| VBN
from  ||| S:26911 E:26916 ||| IN
Amersham  ||| S:26916 E:26925 ||| NNP
Pharmacia  ||| S:26925 E:26935 ||| NNP
Biotech  ||| S:26935 E:26943 ||| NNP
( ||| S:26943 E:26944 ||| -LRB-
Baie  ||| S:26944 E:26949 ||| NNP
d ||| S:26949 E:26950 ||| NN
' ||| S:26950 E:26951 ||| POS
Urfe ||| S:26951 E:26955 ||| NNP
,  ||| S:26955 E:26957 ||| ,
QC ||| S:26957 E:26959 ||| NNP
,  ||| S:26959 E:26971 ||| ,
Canada ||| S:26971 E:26977 ||| NNP
) ||| S:26977 E:26978 ||| -RRB-
.  ||| S:26978 E:26980 ||| .
Bile  ||| S:26980 E:26985 ||| JJ
acids  ||| S:26985 E:26991 ||| NNS
were  ||| S:26991 E:26996 ||| VBD
obtained  ||| S:26996 E:27005 ||| VBN
from  ||| S:27005 E:27010 ||| IN
Sigma-Aldrich  ||| S:27010 E:27034 ||| NNP
Canada  ||| S:27034 E:27041 ||| NNP
Ltd ||| S:27041 E:27044 ||| NNP
.  ||| S:27044 E:27046 ||| .
( ||| S:27046 E:27047 ||| -LRB-
Oakville ||| S:27047 E:27055 ||| NNP
,  ||| S:27055 E:27057 ||| ,
ON ||| S:27057 E:27059 ||| NNP
,  ||| S:27059 E:27061 ||| ,
Canada ||| S:27061 E:27067 ||| NNP
)  ||| S:27067 E:27069 ||| -RRB-
and  ||| S:27069 E:27083 ||| CC
Calbiochem-NovaBiochem  ||| S:27083 E:27106 ||| NNP
Corp ||| S:27106 E:27110 ||| NNP
.  ||| S:27110 E:27112 ||| .
( ||| S:27112 E:27113 ||| -LRB-
San  ||| S:27113 E:27117 ||| NNP
Diego ||| S:27117 E:27122 ||| NNP
,  ||| S:27122 E:27124 ||| ,
CA ||| S:27124 E:27126 ||| NNP
,  ||| S:27126 E:27128 ||| ,
USA ||| S:27128 E:27131 ||| NNP
) ||| S:27131 E:27132 ||| -RRB-
.  ||| S:27132 E:27134 ||| .
Other  ||| S:27134 E:27150 ||| JJ
reagents  ||| S:27150 E:27159 ||| NNS
purchased  ||| S:27159 E:27169 ||| VBN
from  ||| S:27169 E:27174 ||| IN
various  ||| S:27174 E:27182 ||| JJ
commercial  ||| S:27182 E:27193 ||| JJ
suppliers  ||| S:27193 E:27203 ||| NNS
were  ||| S:27203 E:27218 ||| VBD
of  ||| S:27218 E:27221 ||| IN
analytical  ||| S:27221 E:27232 ||| JJ
grade ||| S:27232 E:27237 ||| NN
.  ||| S:27237 E:27267 ||| .
Cell  ||| S:27267 E:27272 ||| NN
lines  ||| S:27272 E:27288 ||| NNS
McNtcp.24  ||| S:27288 E:27298 ||| CD
cells  ||| S:27298 E:27304 ||| NNS
were  ||| S:27304 E:27309 ||| VBD
cultured  ||| S:27309 E:27318 ||| VBN
as  ||| S:27318 E:27321 ||| RB
described  ||| S:27321 E:27331 ||| VBN
previously  ||| S:27331 E:27352 ||| RB
[ ||| S:27352 E:27353 ||| -LRB-
17 ||| S:27353 E:27355 ||| CD
] ||| S:27355 E:27356 ||| -RRB-
.  ||| S:27356 E:27358 ||| .
Chinese  ||| S:27358 E:27366 ||| JJ
hamster  ||| S:27366 E:27374 ||| NN
ovary  ||| S:27374 E:27380 ||| VBD
K1  ||| S:27380 E:27383 ||| CD
cells  ||| S:27383 E:27389 ||| NNS
were  ||| S:27389 E:27394 ||| VBD
cultured  ||| S:27394 E:27403 ||| VBN
in  ||| S:27403 E:27416 ||| IN
Ham ||| S:27416 E:27419 ||| NNP
's  ||| S:27419 E:27422 ||| POS
F12  ||| S:27422 E:27426 ||| JJ
medium  ||| S:27426 E:27433 ||| NN
supplemented  ||| S:27433 E:27446 ||| NN
with  ||| S:27446 E:27451 ||| IN
10 ||| S:27451 E:27453 ||| CD
%  ||| S:27453 E:27455 ||| NN
fetal  ||| S:27455 E:27461 ||| JJ
bovine  ||| S:27461 E:27478 ||| JJ
serum ||| S:27478 E:27483 ||| NN
.  ||| S:27483 E:27485 ||| .
To  ||| S:27485 E:27488 ||| TO
establish  ||| S:27488 E:27498 ||| VB
cell  ||| S:27498 E:27503 ||| NN
lines  ||| S:27503 E:27509 ||| NNS
stably  ||| S:27509 E:27516 ||| VBP
expressing  ||| S:27516 E:27527 ||| VBG
asbt ||| S:27527 E:27531 ||| NN
,  ||| S:27531 E:27533 ||| ,
a  ||| S:27533 E:27545 ||| DT
cDNA  ||| S:27545 E:27550 ||| JJ
encoding  ||| S:27550 E:27559 ||| NNS
the  ||| S:27559 E:27563 ||| DT
hamster  ||| S:27563 E:27571 ||| JJ
asbt  ||| S:27571 E:27576 ||| NNS
[  ||| S:27576 E:27578 ||| -LRB-
36  ||| S:27578 E:27581 ||| CD
]  ||| S:27581 E:27583 ||| -RRB-
was  ||| S:27583 E:27587 ||| VBD
cloned  ||| S:27587 E:27594 ||| VBN
into  ||| S:27594 E:27609 ||| IN
pBK-CMV  ||| S:27609 E:27617 ||| JJ
expression  ||| S:27617 E:27628 ||| NN
vector  ||| S:27628 E:27635 ||| NN
( ||| S:27635 E:27636 ||| -LRB-
Stratagene ||| S:27636 E:27646 ||| NNP
,  ||| S:27646 E:27648 ||| ,
La  ||| S:27648 E:27651 ||| NNP
Jolla ||| S:27651 E:27656 ||| NNP
,  ||| S:27656 E:27658 ||| ,
CA ||| S:27658 E:27660 ||| NNP
) ||| S:27660 E:27661 ||| -RRB-
.  ||| S:27661 E:27663 ||| .
The  ||| S:27663 E:27677 ||| DT
prokaryotic  ||| S:27677 E:27689 ||| JJ
promoter  ||| S:27689 E:27698 ||| NN
embedded  ||| S:27698 E:27707 ||| NN
in  ||| S:27707 E:27710 ||| IN
the  ||| S:27710 E:27714 ||| DT
5 ||| S:27714 E:27715 ||| CD
' ||| S:27715 E:27716 ||| POS
-untranslated  ||| S:27716 E:27740 ||| JJ
region  ||| S:27740 E:27747 ||| NN
of  ||| S:27747 E:27750 ||| IN
the  ||| S:27750 E:27754 ||| DT
encoded  ||| S:27754 E:27762 ||| JJ
recombinant  ||| S:27762 E:27774 ||| JJ
eukaryotic  ||| S:27774 E:27785 ||| JJ
mRNA  ||| S:27785 E:27790 ||| NN
was  ||| S:27790 E:27804 ||| VBD
removed  ||| S:27804 E:27812 ||| VBN
from  ||| S:27812 E:27817 ||| IN
the  ||| S:27817 E:27821 ||| DT
resulting  ||| S:27821 E:27831 ||| JJ
plasmid ||| S:27831 E:27838 ||| NN
.  ||| S:27838 E:27840 ||| .
The  ||| S:27840 E:27844 ||| DT
human  ||| S:27844 E:27850 ||| JJ
bile  ||| S:27850 E:27855 ||| JJ
acid  ||| S:27855 E:27870 ||| NN
binder  ||| S:27870 E:27877 ||| NNS
( ||| S:27877 E:27878 ||| -LRB-
HBAB ||| S:27878 E:27882 ||| NNP
)  ||| S:27882 E:27884 ||| -RRB-
cDNA  ||| S:27884 E:27889 ||| NNP
[  ||| S:27889 E:27891 ||| -LRB-
37  ||| S:27891 E:27894 ||| CD
]  ||| S:27894 E:27896 ||| -RRB-
was  ||| S:27896 E:27900 ||| VBD
cloned  ||| S:27900 E:27907 ||| VBN
into  ||| S:27907 E:27912 ||| IN
a  ||| S:27912 E:27914 ||| DT
derivative  ||| S:27914 E:27925 ||| JJ
of  ||| S:27925 E:27938 ||| IN
pCep4  ||| S:27938 E:27944 ||| NNP
( ||| S:27944 E:27945 ||| -LRB-
Invitrogen  ||| S:27945 E:27956 ||| NNP
Corp. ||| S:27956 E:27961 ||| NNP
,  ||| S:27961 E:27963 ||| ,
Carlsbad ||| S:27963 E:27971 ||| NNP
,  ||| S:27971 E:27973 ||| ,
CA ||| S:27973 E:27975 ||| NNP
) ||| S:27975 E:27976 ||| -RRB-
,  ||| S:27976 E:27978 ||| ,
that  ||| S:27978 E:27983 ||| WDT
had  ||| S:27983 E:27987 ||| VBD
been  ||| S:27987 E:28002 ||| VBN
previously  ||| S:28002 E:28013 ||| RB
modified  ||| S:28013 E:28022 ||| VBN
by  ||| S:28022 E:28025 ||| IN
deleting  ||| S:28025 E:28034 ||| VBG
the  ||| S:28034 E:28038 ||| DT
EBNA  ||| S:28038 E:28043 ||| NNP
1  ||| S:28043 E:28045 ||| CD
gene  ||| S:28045 E:28050 ||| NN
[  ||| S:28050 E:28052 ||| -LRB-
38  ||| S:28052 E:28055 ||| CD
]  ||| S:28055 E:28057 ||| -RRB-
.  ||| S:28057 E:28069 ||| .
The  ||| S:28069 E:28073 ||| DT
lipofectamine  ||| S:28073 E:28087 ||| JJ
reagent  ||| S:28087 E:28095 ||| NNS
( ||| S:28095 E:28096 ||| -LRB-
Canadian  ||| S:28096 E:28105 ||| NNP
Life  ||| S:28105 E:28110 ||| NNP
Technologies ||| S:28110 E:28122 ||| NNPS
)  ||| S:28122 E:28134 ||| -RRB-
was  ||| S:28134 E:28138 ||| VBD
used  ||| S:28138 E:28143 ||| VBN
to  ||| S:28143 E:28146 ||| TO
transfect  ||| S:28146 E:28156 ||| VB
the  ||| S:28156 E:28160 ||| DT
expression  ||| S:28160 E:28171 ||| NN
plasmid  ||| S:28171 E:28179 ||| NN
into  ||| S:28179 E:28184 ||| IN
CHO ||| S:28184 E:28187 ||| NNP
,  ||| S:28187 E:28199 ||| ,
McArdle  ||| S:28199 E:28207 ||| NNP
RH7777 ||| S:28207 E:28213 ||| NNP
,  ||| S:28213 E:28215 ||| ,
and  ||| S:28215 E:28219 ||| CC
McNtcp.24  ||| S:28219 E:28229 ||| CD
cells ||| S:28229 E:28234 ||| NNS
.  ||| S:28234 E:28236 ||| .
The  ||| S:28236 E:28240 ||| DT
cell  ||| S:28240 E:28245 ||| NN
medium  ||| S:28245 E:28252 ||| NN
was  ||| S:28252 E:28266 ||| VBD
replaced  ||| S:28266 E:28275 ||| VBN
24  ||| S:28275 E:28278 ||| CD
h  ||| S:28278 E:28280 ||| JJ
post-transfection  ||| S:28280 E:28298 ||| NN
with  ||| S:28298 E:28303 ||| IN
medium  ||| S:28303 E:28310 ||| NN
containing  ||| S:28310 E:28331 ||| VBG
G418  ||| S:28331 E:28336 ||| NNP
( ||| S:28336 E:28337 ||| -LRB-
400  ||| S:28337 E:28341 ||| CD
Î¼g ||| S:28341 E:28343 ||| CD
/ ||| S:28343 E:28344 ||| CD
ml ||| S:28344 E:28346 ||| CD
)  ||| S:28346 E:28348 ||| -RRB-
or  ||| S:28348 E:28351 ||| CC
hygromycin  ||| S:28351 E:28362 ||| NNS
( ||| S:28362 E:28363 ||| -LRB-
500  ||| S:28363 E:28367 ||| CD
Î¼g ||| S:28367 E:28369 ||| CD
/ ||| S:28369 E:28370 ||| CD
ml ||| S:28370 E:28372 ||| CD
)  ||| S:28372 E:28374 ||| -RRB-
to  ||| S:28374 E:28377 ||| TO
select  ||| S:28377 E:28384 ||| VB
for  ||| S:28384 E:28398 ||| IN
stable  ||| S:28398 E:28405 ||| JJ
transfectants ||| S:28405 E:28418 ||| NN
.  ||| S:28418 E:28420 ||| .
Surviving  ||| S:28420 E:28430 ||| VBG
colonies  ||| S:28430 E:28439 ||| NNS
were  ||| S:28439 E:28444 ||| VBD
expanded  ||| S:28444 E:28463 ||| VBN
and  ||| S:28463 E:28467 ||| CC
assayed  ||| S:28467 E:28475 ||| NN
for  ||| S:28475 E:28479 ||| IN
the  ||| S:28479 E:28483 ||| DT
ability  ||| S:28483 E:28491 ||| NN
to  ||| S:28491 E:28494 ||| TO
take  ||| S:28494 E:28499 ||| VB
up  ||| S:28499 E:28502 ||| RP
[  ||| S:28502 E:28504 ||| -LRB-
3H ||| S:28504 E:28506 ||| NNP
] ||| S:28506 E:28507 ||| -RRB-
-TCA  ||| S:28507 E:28512 ||| JJ
from  ||| S:28512 E:28517 ||| IN
the  ||| S:28517 E:28531 ||| DT
culture  ||| S:28531 E:28539 ||| NN
medium  ||| S:28539 E:28546 ||| NN
as  ||| S:28546 E:28549 ||| IN
described  ||| S:28549 E:28559 ||| VBN
previously  ||| S:28559 E:28570 ||| RB
[  ||| S:28570 E:28572 ||| -LRB-
17  ||| S:28572 E:28575 ||| CD
]  ||| S:28575 E:28577 ||| -RRB-
or  ||| S:28577 E:28580 ||| CC
assayed  ||| S:28580 E:28598 ||| NN
for  ||| S:28598 E:28602 ||| IN
the  ||| S:28602 E:28606 ||| DT
expression  ||| S:28606 E:28617 ||| NN
of  ||| S:28617 E:28620 ||| IN
HBAB  ||| S:28620 E:28625 ||| NNP
by  ||| S:28625 E:28628 ||| IN
immunoblotting ||| S:28628 E:28642 ||| NN
.  ||| S:28642 E:28672 ||| .
RNA  ||| S:28672 E:28676 ||| NNP
and  ||| S:28676 E:28680 ||| CC
immunoblot  ||| S:28680 E:28691 ||| JJ
analyses  ||| S:28691 E:28710 ||| NNS
Total  ||| S:28710 E:28716 ||| JJ
RNA  ||| S:28716 E:28720 ||| NNP
from  ||| S:28720 E:28725 ||| IN
CHO.asbt  ||| S:28725 E:28734 ||| NNP
and  ||| S:28734 E:28738 ||| CC
BN  ||| S:28738 E:28741 ||| NNP
cells  ||| S:28741 E:28747 ||| NNS
was  ||| S:28747 E:28751 ||| VBD
prepared  ||| S:28751 E:28760 ||| VBN
and  ||| S:28760 E:28774 ||| CC
analyzed  ||| S:28774 E:28783 ||| VBD
by  ||| S:28783 E:28786 ||| IN
RNA  ||| S:28786 E:28790 ||| NNP
blotting  ||| S:28790 E:28799 ||| NN
as  ||| S:28799 E:28802 ||| IN
previously  ||| S:28802 E:28813 ||| RB
described  ||| S:28813 E:28823 ||| VBN
[  ||| S:28823 E:28825 ||| -LRB-
17  ||| S:28825 E:28828 ||| CD
]  ||| S:28828 E:28830 ||| -RRB-
.  ||| S:28830 E:28842 ||| .
Cell  ||| S:28842 E:28847 ||| NN
lysates  ||| S:28847 E:28855 ||| NNS
were  ||| S:28855 E:28860 ||| VBD
prepared  ||| S:28860 E:28869 ||| VBN
by  ||| S:28869 E:28872 ||| IN
lysing  ||| S:28872 E:28879 ||| JJ
cells  ||| S:28879 E:28885 ||| NNS
in  ||| S:28885 E:28888 ||| IN
50  ||| S:28888 E:28891 ||| CD
mM  ||| S:28891 E:28904 ||| JJ
Tris-HCl  ||| S:28904 E:28913 ||| NN
( ||| S:28913 E:28914 ||| -LRB-
pH  ||| S:28914 E:28917 ||| NNP
7.4 ||| S:28917 E:28920 ||| CD
) ||| S:28920 E:28921 ||| -RRB-
,  ||| S:28921 E:28923 ||| ,
1 ||| S:28923 E:28924 ||| CD
%  ||| S:28924 E:28926 ||| NN
NP-40 ||| S:28926 E:28931 ||| CD
% ||| S:28931 E:28932 ||| NN
,  ||| S:28932 E:28934 ||| ,
0.25 ||| S:28934 E:28938 ||| CD
%  ||| S:28938 E:28940 ||| NN
sodium  ||| S:28940 E:28947 ||| NN
deoxycholate ||| S:28947 E:28959 ||| NNS
;  ||| S:28959 E:28971 ||| :
150  ||| S:28971 E:28975 ||| CD
mM  ||| S:28975 E:28978 ||| JJ
NaCl ||| S:28978 E:28982 ||| NN
,  ||| S:28982 E:28984 ||| ,
1  ||| S:28984 E:28986 ||| CD
mM  ||| S:28986 E:28989 ||| JJ
EGTA ||| S:28989 E:28993 ||| NNP
,  ||| S:28993 E:28995 ||| ,
1  ||| S:28995 E:28997 ||| CD
mM  ||| S:28997 E:29000 ||| JJ
Na  ||| S:29000 E:29014 ||| NNP
3  ||| S:29014 E:29016 ||| CD
VO  ||| S:29016 E:29030 ||| CD
4  ||| S:29030 E:29032 ||| CD
,  ||| S:29032 E:29034 ||| ,
1  ||| S:29034 E:29036 ||| CD
mM  ||| S:29036 E:29039 ||| JJ
sodium  ||| S:29039 E:29046 ||| JJ
fluoride ||| S:29046 E:29054 ||| NN
,  ||| S:29054 E:29056 ||| ,
containing  ||| S:29056 E:29067 ||| VBG
a  ||| S:29067 E:29079 ||| DT
protease  ||| S:29079 E:29088 ||| JJ
inhibitor  ||| S:29088 E:29098 ||| JJ
cocktail  ||| S:29098 E:29107 ||| NN
( ||| S:29107 E:29108 ||| -LRB-
Sigma-Aldrich  ||| S:29108 E:29122 ||| NNP
Canada  ||| S:29122 E:29129 ||| NNP
Ltd. ||| S:29129 E:29133 ||| NNP
) ||| S:29133 E:29134 ||| -RRB-
.  ||| S:29134 E:29146 ||| .
The  ||| S:29146 E:29150 ||| DT
lysates  ||| S:29150 E:29158 ||| NN
were  ||| S:29158 E:29163 ||| VBD
fractionated  ||| S:29163 E:29176 ||| VBN
by  ||| S:29176 E:29179 ||| IN
polyacrylamide  ||| S:29179 E:29194 ||| JJ
gel  ||| S:29194 E:29208 ||| JJ
electrophoresis  ||| S:29208 E:29224 ||| NN
and  ||| S:29224 E:29228 ||| CC
then  ||| S:29228 E:29233 ||| RB
transferred  ||| S:29233 E:29245 ||| VBN
to  ||| S:29245 E:29248 ||| TO
Immobilon-P  ||| S:29248 E:29270 ||| JJ
membrane  ||| S:29270 E:29279 ||| NNS
( ||| S:29279 E:29280 ||| -LRB-
Millipore  ||| S:29280 E:29290 ||| NNP
Ltd. ||| S:29290 E:29294 ||| NNP
,  ||| S:29294 E:29296 ||| ,
Nepean ||| S:29296 E:29302 ||| NNP
,  ||| S:29302 E:29304 ||| ,
ON ||| S:29304 E:29306 ||| NNP
) ||| S:29306 E:29307 ||| -RRB-
.  ||| S:29307 E:29309 ||| .
Asbt  ||| S:29309 E:29314 ||| NNP
was  ||| S:29314 E:29318 ||| VBD
detected  ||| S:29318 E:29337 ||| VBN
using  ||| S:29337 E:29343 ||| VBG
a  ||| S:29343 E:29345 ||| DT
rabbit  ||| S:29345 E:29352 ||| NN
antiserum  ||| S:29352 E:29362 ||| VBZ
directed  ||| S:29362 E:29371 ||| VBN
against  ||| S:29371 E:29379 ||| IN
the  ||| S:29379 E:29383 ||| DT
last  ||| S:29383 E:29388 ||| JJ
14  ||| S:29388 E:29401 ||| CD
amino  ||| S:29401 E:29407 ||| CD
acids  ||| S:29407 E:29413 ||| NNS
of  ||| S:29413 E:29416 ||| IN
the  ||| S:29416 E:29420 ||| DT
carboxyl  ||| S:29420 E:29429 ||| JJ
terminal  ||| S:29429 E:29438 ||| NN
of  ||| S:29438 E:29441 ||| IN
the  ||| S:29441 E:29445 ||| DT
hamster  ||| S:29445 E:29453 ||| JJ
asbt  ||| S:29453 E:29468 ||| JJ
protein ||| S:29468 E:29475 ||| NN
.  ||| S:29475 E:29477 ||| .
HBAB  ||| S:29477 E:29482 ||| NNP
protein  ||| S:29482 E:29490 ||| NN
was  ||| S:29490 E:29494 ||| VBD
detected  ||| S:29494 E:29503 ||| VBN
as  ||| S:29503 E:29506 ||| IN
previously  ||| S:29506 E:29527 ||| RB
described  ||| S:29527 E:29537 ||| VBN
[  ||| S:29537 E:29539 ||| -LRB-
37  ||| S:29539 E:29542 ||| CD
]  ||| S:29542 E:29544 ||| -RRB-
.  ||| S:29544 E:29574 ||| .
Bile  ||| S:29574 E:29579 ||| FW
acid  ||| S:29579 E:29584 ||| FW
uptake  ||| S:29584 E:29591 ||| FW
activity  ||| S:29591 E:29600 ||| FW
assay  ||| S:29600 E:29616 ||| FW
Uptake  ||| S:29616 E:29623 ||| FW
studies  ||| S:29623 E:29631 ||| NNS
in  ||| S:29631 E:29634 ||| IN
CHO.asbt ||| S:29634 E:29642 ||| NNP
,  ||| S:29642 E:29644 ||| ,
BN  ||| S:29644 E:29647 ||| NNP
and  ||| S:29647 E:29651 ||| CC
McNtcp.24  ||| S:29651 E:29661 ||| CD
cells  ||| S:29661 E:29677 ||| NNS
were  ||| S:29677 E:29682 ||| VBD
done  ||| S:29682 E:29687 ||| VBN
as  ||| S:29687 E:29690 ||| IN
previously  ||| S:29690 E:29701 ||| RB
described  ||| S:29701 E:29711 ||| VBN
[  ||| S:29711 E:29713 ||| -LRB-
17  ||| S:29713 E:29716 ||| CD
]  ||| S:29716 E:29718 ||| -RRB-
.  ||| S:29718 E:29720 ||| .
Protein  ||| S:29720 E:29738 ||| NN
content  ||| S:29738 E:29746 ||| NN
was  ||| S:29746 E:29750 ||| VBD
determined  ||| S:29750 E:29761 ||| VBN
using  ||| S:29761 E:29767 ||| VBG
the  ||| S:29767 E:29771 ||| DT
Bradford  ||| S:29771 E:29780 ||| NNP
method  ||| S:29780 E:29787 ||| NN
[  ||| S:29787 E:29789 ||| -LRB-
39  ||| S:29789 E:29792 ||| CD
]  ||| S:29792 E:29804 ||| -RRB-
with  ||| S:29804 E:29809 ||| IN
bovine  ||| S:29809 E:29816 ||| JJ
serum  ||| S:29816 E:29822 ||| JJ
albumin  ||| S:29822 E:29830 ||| NN
as  ||| S:29830 E:29833 ||| IN
the  ||| S:29833 E:29837 ||| DT
standard ||| S:29837 E:29845 ||| NN
.  ||| S:29845 E:29875 ||| .
Lactate  ||| S:29875 E:29883 ||| JJ
dehydrogenase  ||| S:29883 E:29897 ||| NNS
( ||| S:29897 E:29898 ||| -LRB-
LDH ||| S:29898 E:29901 ||| NNP
)  ||| S:29901 E:29903 ||| -RRB-
assay  ||| S:29903 E:29919 ||| FW
Cells  ||| S:29919 E:29925 ||| FW
( ||| S:29925 E:29926 ||| -LRB-
10  ||| S:29926 E:29929 ||| CD
4per  ||| S:29929 E:29934 ||| CD
well ||| S:29934 E:29938 ||| RB
)  ||| S:29938 E:29940 ||| -RRB-
were  ||| S:29940 E:29945 ||| VBD
grown  ||| S:29945 E:29951 ||| VBN
on  ||| S:29951 E:29954 ||| IN
24  ||| S:29954 E:29957 ||| CD
well  ||| S:29957 E:29962 ||| RB
multiwell  ||| S:29962 E:29982 ||| JJ
plates  ||| S:29982 E:29989 ||| NN
for  ||| S:29989 E:29993 ||| IN
16  ||| S:29993 E:29996 ||| CD
h ||| S:29996 E:29997 ||| NNS
.  ||| S:29997 E:29999 ||| .
The  ||| S:29999 E:30003 ||| DT
cells  ||| S:30003 E:30009 ||| NNS
were  ||| S:30009 E:30014 ||| VBD
then  ||| S:30014 E:30019 ||| RB
washed  ||| S:30019 E:30026 ||| VBN
with  ||| S:30026 E:30041 ||| IN
phosphate  ||| S:30041 E:30051 ||| FW
buffered  ||| S:30051 E:30060 ||| FW
saline  ||| S:30060 E:30067 ||| FW
( ||| S:30067 E:30068 ||| -LRB-
PBS ||| S:30068 E:30071 ||| NNP
)  ||| S:30071 E:30073 ||| -RRB-
and  ||| S:30073 E:30077 ||| CC
then  ||| S:30077 E:30082 ||| RB
incubated  ||| S:30082 E:30092 ||| VBN
in  ||| S:30092 E:30105 ||| IN
medium  ||| S:30105 E:30112 ||| NN
( ||| S:30112 E:30113 ||| -LRB-
Ham ||| S:30113 E:30116 ||| NNP
's  ||| S:30116 E:30119 ||| POS
F12  ||| S:30119 E:30123 ||| NNP
or  ||| S:30123 E:30126 ||| CC
Dulbecco ||| S:30126 E:30134 ||| NNP
's  ||| S:30134 E:30137 ||| POS
modified  ||| S:30137 E:30146 ||| JJ
Eagle ||| S:30146 E:30151 ||| NNP
's  ||| S:30151 E:30154 ||| POS
medium  ||| S:30154 E:30171 ||| NN
( ||| S:30171 E:30172 ||| -LRB-
DMEM ||| S:30172 E:30176 ||| NNP
) ||| S:30176 E:30177 ||| -RRB-
)  ||| S:30177 E:30179 ||| -RRB-
containing  ||| S:30179 E:30190 ||| VBG
100  ||| S:30190 E:30194 ||| CD
Î¼M  ||| S:30194 E:30197 ||| JJ
bile  ||| S:30197 E:30202 ||| JJ
acids  ||| S:30202 E:30208 ||| NNS
for  ||| S:30208 E:30212 ||| IN
1  ||| S:30212 E:30214 ||| CD
to  ||| S:30214 E:30217 ||| TO
5  ||| S:30217 E:30219 ||| CD
h  ||| S:30219 E:30221 ||| NN
as  ||| S:30221 E:30234 ||| IN
detailed  ||| S:30234 E:30243 ||| JJ
in  ||| S:30243 E:30246 ||| IN
the  ||| S:30246 E:30250 ||| DT
Figure  ||| S:30250 E:30257 ||| NN
legends ||| S:30257 E:30264 ||| NN
.  ||| S:30264 E:30266 ||| .
The  ||| S:30266 E:30270 ||| DT
media  ||| S:30270 E:30276 ||| NNS
was  ||| S:30276 E:30280 ||| VBD
collected  ||| S:30280 E:30300 ||| VBN
and  ||| S:30300 E:30304 ||| CC
adjusted  ||| S:30304 E:30313 ||| VBN
to  ||| S:30313 E:30316 ||| TO
0.1 ||| S:30316 E:30319 ||| CD
%  ||| S:30319 E:30321 ||| NN
Triton  ||| S:30321 E:30328 ||| NNP
X-100 ||| S:30328 E:30333 ||| NNP
.  ||| S:30333 E:30335 ||| .
Cells  ||| S:30335 E:30341 ||| NNS
remaining  ||| S:30341 E:30351 ||| VBG
on  ||| S:30351 E:30354 ||| IN
the  ||| S:30354 E:30368 ||| DT
dish  ||| S:30368 E:30373 ||| NN
were  ||| S:30373 E:30378 ||| VBD
dissolved  ||| S:30378 E:30388 ||| VBN
in  ||| S:30388 E:30391 ||| IN
medium  ||| S:30391 E:30398 ||| NN
( ||| S:30398 E:30399 ||| -LRB-
Ham ||| S:30399 E:30402 ||| NNP
's  ||| S:30402 E:30405 ||| POS
F12  ||| S:30405 E:30409 ||| NNP
or  ||| S:30409 E:30412 ||| CC
DMEM ||| S:30412 E:30416 ||| NNP
)  ||| S:30416 E:30428 ||| -RRB-
containing  ||| S:30428 E:30439 ||| VBG
0.1 ||| S:30439 E:30442 ||| CD
%  ||| S:30442 E:30444 ||| NN
Triton  ||| S:30444 E:30451 ||| NNP
X-100 ||| S:30451 E:30456 ||| NNP
.  ||| S:30456 E:30458 ||| .
LDH  ||| S:30458 E:30462 ||| NNP
activities  ||| S:30462 E:30473 ||| NNS
in  ||| S:30473 E:30476 ||| IN
both  ||| S:30476 E:30481 ||| PDT
the  ||| S:30481 E:30495 ||| DT
cell  ||| S:30495 E:30500 ||| NN
lysates  ||| S:30500 E:30508 ||| NNS
and  ||| S:30508 E:30512 ||| CC
media  ||| S:30512 E:30518 ||| NNS
were  ||| S:30518 E:30523 ||| VBD
measured  ||| S:30523 E:30532 ||| VBN
as  ||| S:30532 E:30535 ||| RB
described  ||| S:30535 E:30555 ||| VBN
previously  ||| S:30555 E:30566 ||| RB
[  ||| S:30566 E:30568 ||| -LRB-
40  ||| S:30568 E:30571 ||| CD
]  ||| S:30571 E:30573 ||| -RRB-
.  ||| S:30573 E:30603 ||| .
Visualization  ||| S:30603 E:30617 ||| NNP
of  ||| S:30617 E:30620 ||| IN
genomic  ||| S:30620 E:30628 ||| JJ
DNA  ||| S:30628 E:30632 ||| NN
fragmentation  ||| S:30632 E:30656 ||| VBD
Cells  ||| S:30656 E:30662 ||| NNP
( ||| S:30662 E:30663 ||| -LRB-
10  ||| S:30663 E:30666 ||| CD
6per  ||| S:30666 E:30671 ||| CD
60  ||| S:30671 E:30674 ||| CD
mm  ||| S:30674 E:30677 ||| CD
dish ||| S:30677 E:30681 ||| CD
)  ||| S:30681 E:30683 ||| -RRB-
were  ||| S:30683 E:30688 ||| VBD
grown  ||| S:30688 E:30694 ||| VBN
for  ||| S:30694 E:30698 ||| IN
16  ||| S:30698 E:30701 ||| CD
h ||| S:30701 E:30702 ||| NNS
.  ||| S:30702 E:30704 ||| .
After  ||| S:30704 E:30720 ||| IN
washing  ||| S:30720 E:30728 ||| VBG
with  ||| S:30728 E:30733 ||| IN
PBS ||| S:30733 E:30736 ||| NNP
,  ||| S:30736 E:30738 ||| ,
the  ||| S:30738 E:30742 ||| DT
cells  ||| S:30742 E:30748 ||| NNS
were  ||| S:30748 E:30753 ||| VBD
incubated  ||| S:30753 E:30763 ||| VBN
with  ||| S:30763 E:30768 ||| IN
50  ||| S:30768 E:30771 ||| CD
Î¼M  ||| S:30771 E:30784 ||| JJ
bile  ||| S:30784 E:30789 ||| JJ
acids  ||| S:30789 E:30795 ||| NNS
for  ||| S:30795 E:30799 ||| IN
3  ||| S:30799 E:30801 ||| CD
h  ||| S:30801 E:30803 ||| NN
at  ||| S:30803 E:30806 ||| IN
37Â°C ||| S:30806 E:30810 ||| CD
.  ||| S:30810 E:30812 ||| .
Adherent  ||| S:30812 E:30821 ||| NNP
and  ||| S:30821 E:30825 ||| CC
non-adherent  ||| S:30825 E:30848 ||| JJ
cells  ||| S:30848 E:30854 ||| NNS
were  ||| S:30854 E:30859 ||| VBD
dissolved  ||| S:30859 E:30869 ||| VBN
in  ||| S:30869 E:30872 ||| IN
Tris-buffered  ||| S:30872 E:30886 ||| JJ
saline  ||| S:30886 E:30893 ||| NNS
( ||| S:30893 E:30894 ||| -LRB-
pH  ||| S:30894 E:30897 ||| NNP
7.6 ||| S:30897 E:30900 ||| CD
)  ||| S:30900 E:30912 ||| -RRB-
containing  ||| S:30912 E:30923 ||| VBG
10  ||| S:30923 E:30926 ||| CD
mM  ||| S:30926 E:30929 ||| JJ
EDTA  ||| S:30929 E:30934 ||| NNP
and  ||| S:30934 E:30938 ||| CC
0.5 ||| S:30938 E:30941 ||| CD
%  ||| S:30941 E:30943 ||| NN
sarkosyl ||| S:30943 E:30951 ||| NN
,  ||| S:30951 E:30953 ||| ,
and  ||| S:30953 E:30957 ||| CC
1  ||| S:30957 E:30959 ||| CD
mg ||| S:30959 E:30961 ||| FW
/ ||| S:30961 E:30962 ||| FW
ml  ||| S:30962 E:30975 ||| FW
proteinase  ||| S:30975 E:30986 ||| FW
K.  ||| S:30986 E:30989 ||| NNP
After  ||| S:30989 E:30995 ||| IN
digestion  ||| S:30995 E:31005 ||| NNS
( ||| S:31005 E:31006 ||| -LRB-
~16  ||| S:31006 E:31010 ||| FW
h ||| S:31010 E:31011 ||| FW
)  ||| S:31011 E:31013 ||| -RRB-
of  ||| S:31013 E:31016 ||| IN
cellular  ||| S:31016 E:31035 ||| JJ
proteins  ||| S:31035 E:31044 ||| NNS
at  ||| S:31044 E:31047 ||| IN
55Â°C ||| S:31047 E:31051 ||| NNP
,  ||| S:31051 E:31053 ||| ,
DNA  ||| S:31053 E:31057 ||| NNP
was  ||| S:31057 E:31061 ||| VBD
sequentially  ||| S:31061 E:31074 ||| VBN
extracted  ||| S:31074 E:31084 ||| VBN
with  ||| S:31084 E:31099 ||| IN
phenol ||| S:31099 E:31105 ||| CD
/ ||| S:31105 E:31106 ||| CD
chloroform  ||| S:31106 E:31117 ||| NNS
and  ||| S:31117 E:31121 ||| CC
chloroform ||| S:31121 E:31131 ||| NN
.  ||| S:31131 E:31133 ||| .
The  ||| S:31133 E:31137 ||| DT
DNA  ||| S:31137 E:31141 ||| NN
was  ||| S:31141 E:31155 ||| VBD
precipitated ||| S:31155 E:31167 ||| CD
,  ||| S:31167 E:31169 ||| ,
washed  ||| S:31169 E:31176 ||| VBN
in  ||| S:31176 E:31179 ||| IN
70 ||| S:31179 E:31181 ||| CD
%  ||| S:31181 E:31183 ||| NN
ethanol ||| S:31183 E:31190 ||| NN
,  ||| S:31190 E:31192 ||| ,
and  ||| S:31192 E:31196 ||| CC
dissolved  ||| S:31196 E:31206 ||| VBN
in  ||| S:31206 E:31219 ||| IN
buffer  ||| S:31219 E:31226 ||| NN
containing  ||| S:31226 E:31237 ||| VBG
10  ||| S:31237 E:31240 ||| CD
mM  ||| S:31240 E:31243 ||| JJ
Tris-HCL  ||| S:31243 E:31252 ||| NN
( ||| S:31252 E:31253 ||| -LRB-
pH  ||| S:31253 E:31256 ||| NNP
7.5 ||| S:31256 E:31259 ||| CD
)  ||| S:31259 E:31261 ||| -RRB-
and  ||| S:31261 E:31265 ||| CC
1  ||| S:31265 E:31267 ||| CD
mM  ||| S:31267 E:31270 ||| JJ
EDTA ||| S:31270 E:31274 ||| NNP
.  ||| S:31274 E:31286 ||| .
The  ||| S:31286 E:31290 ||| DT
isolated  ||| S:31290 E:31299 ||| JJ
DNA  ||| S:31299 E:31303 ||| NN
was  ||| S:31303 E:31307 ||| VBD
treated  ||| S:31307 E:31315 ||| VBN
with  ||| S:31315 E:31320 ||| IN
RNase  ||| S:31320 E:31326 ||| NNP
A  ||| S:31326 E:31328 ||| NNP
and  ||| S:31328 E:31332 ||| CC
then  ||| S:31332 E:31347 ||| RB
analyzed  ||| S:31347 E:31356 ||| VBN
by  ||| S:31356 E:31359 ||| IN
conventional  ||| S:31359 E:31372 ||| JJ
agarose  ||| S:31372 E:31380 ||| FW
gel  ||| S:31380 E:31384 ||| FW
electrophoresis  ||| S:31384 E:31400 ||| FW
[  ||| S:31400 E:31402 ||| -LRB-
41  ||| S:31402 E:31415 ||| CD
]  ||| S:31415 E:31417 ||| -RRB-
.  ||| S:31417 E:31419 ||| .
DNA  ||| S:31419 E:31423 ||| NNP
was  ||| S:31423 E:31427 ||| VBD
visualized  ||| S:31427 E:31438 ||| VBN
with  ||| S:31438 E:31443 ||| IN
ultraviolet  ||| S:31443 E:31455 ||| JJ
light  ||| S:31455 E:31461 ||| NN
after  ||| S:31461 E:31477 ||| IN
ethidium  ||| S:31477 E:31486 ||| JJ
bromide  ||| S:31486 E:31494 ||| JJ
staining ||| S:31494 E:31502 ||| NN
.  ||| S:31502 E:31532 ||| .
Caspase  ||| S:31532 E:31540 ||| JJ
activity  ||| S:31540 E:31549 ||| NN
assays  ||| S:31549 E:31566 ||| VBD
Cells  ||| S:31566 E:31572 ||| NNP
( ||| S:31572 E:31573 ||| -LRB-
10  ||| S:31573 E:31576 ||| CD
6per  ||| S:31576 E:31581 ||| CD
60  ||| S:31581 E:31584 ||| CD
mm  ||| S:31584 E:31587 ||| CD
dish ||| S:31587 E:31591 ||| CD
)  ||| S:31591 E:31593 ||| -RRB-
were  ||| S:31593 E:31598 ||| VBD
grown  ||| S:31598 E:31604 ||| VBN
for  ||| S:31604 E:31608 ||| IN
16  ||| S:31608 E:31611 ||| CD
h ||| S:31611 E:31612 ||| NNS
.  ||| S:31612 E:31614 ||| .
After  ||| S:31614 E:31630 ||| IN
washing  ||| S:31630 E:31638 ||| VBG
with  ||| S:31638 E:31643 ||| IN
PBS ||| S:31643 E:31646 ||| NNP
,  ||| S:31646 E:31648 ||| ,
the  ||| S:31648 E:31652 ||| DT
cells  ||| S:31652 E:31658 ||| NNS
were  ||| S:31658 E:31663 ||| VBD
incubated  ||| S:31663 E:31673 ||| VBN
with  ||| S:31673 E:31678 ||| IN
50  ||| S:31678 E:31681 ||| CD
to  ||| S:31681 E:31684 ||| TO
100  ||| S:31684 E:31698 ||| CD
Î¼M  ||| S:31698 E:31701 ||| JJ
bile  ||| S:31701 E:31706 ||| JJ
acids  ||| S:31706 E:31712 ||| NNS
for  ||| S:31712 E:31716 ||| IN
1  ||| S:31716 E:31718 ||| CD
to  ||| S:31718 E:31721 ||| TO
2  ||| S:31721 E:31723 ||| CD
h ||| S:31723 E:31724 ||| NNS
.  ||| S:31724 E:31726 ||| .
After  ||| S:31726 E:31732 ||| IN
the  ||| S:31732 E:31736 ||| DT
incubation  ||| S:31736 E:31747 ||| JJ
period ||| S:31747 E:31753 ||| NN
,  ||| S:31753 E:31765 ||| ,
the  ||| S:31765 E:31769 ||| DT
medium  ||| S:31769 E:31776 ||| NN
was  ||| S:31776 E:31780 ||| VBD
discarded  ||| S:31780 E:31790 ||| VBN
and  ||| S:31790 E:31794 ||| CC
adherent  ||| S:31794 E:31803 ||| JJ
cells  ||| S:31803 E:31809 ||| NNS
were  ||| S:31809 E:31824 ||| VBD
harvested  ||| S:31824 E:31834 ||| VBN
in  ||| S:31834 E:31837 ||| IN
PBS  ||| S:31837 E:31841 ||| NNP
and  ||| S:31841 E:31845 ||| CC
sedimented  ||| S:31845 E:31856 ||| NN
by  ||| S:31856 E:31859 ||| IN
centrifugation  ||| S:31859 E:31874 ||| NNS
( ||| S:31874 E:31875 ||| -LRB-
500  ||| S:31875 E:31879 ||| CD
Ã  ||| S:31879 E:31891 ||| CD
g ||| S:31891 E:31892 ||| CD
) ||| S:31892 E:31893 ||| -RRB-
.  ||| S:31893 E:31895 ||| .
The  ||| S:31895 E:31899 ||| DT
cells  ||| S:31899 E:31905 ||| NNS
were  ||| S:31905 E:31910 ||| VBD
resuspended  ||| S:31910 E:31922 ||| VBN
in  ||| S:31922 E:31925 ||| IN
buffer  ||| S:31925 E:31932 ||| NN
containing  ||| S:31932 E:31943 ||| VBG
50  ||| S:31943 E:31946 ||| CD
mM  ||| S:31946 E:31959 ||| JJ
Tris-HCl  ||| S:31959 E:31968 ||| NN
( ||| S:31968 E:31969 ||| -LRB-
pH  ||| S:31969 E:31972 ||| NNP
7.5 ||| S:31972 E:31975 ||| CD
) ||| S:31975 E:31976 ||| -RRB-
,  ||| S:31976 E:31978 ||| ,
1 ||| S:31978 E:31979 ||| CD
%  ||| S:31979 E:31981 ||| NN
Nonidet  ||| S:31981 E:31989 ||| NNP
P-40 ||| S:31989 E:31993 ||| NNP
,  ||| S:31993 E:31995 ||| ,
and  ||| S:31995 E:31999 ||| CC
150  ||| S:31999 E:32003 ||| CD
mM  ||| S:32003 E:32006 ||| JJ
NaCl ||| S:32006 E:32010 ||| NN
.  ||| S:32010 E:32022 ||| .
Following  ||| S:32022 E:32032 ||| VBG
10  ||| S:32032 E:32035 ||| CD
min  ||| S:32035 E:32039 ||| JJ
incubation  ||| S:32039 E:32050 ||| NN
on  ||| S:32050 E:32053 ||| IN
ice ||| S:32053 E:32056 ||| NN
,  ||| S:32056 E:32058 ||| ,
lysed  ||| S:32058 E:32064 ||| JJ
cells  ||| S:32064 E:32070 ||| NNS
were  ||| S:32070 E:32085 ||| VBD
centrifuged  ||| S:32085 E:32097 ||| VBN
for  ||| S:32097 E:32101 ||| IN
10  ||| S:32101 E:32104 ||| CD
min ||| S:32104 E:32107 ||| NN
,  ||| S:32107 E:32109 ||| ,
10,000  ||| S:32109 E:32116 ||| CD
Ã  ||| S:32116 E:32118 ||| CD
g  ||| S:32118 E:32120 ||| NN
at  ||| S:32120 E:32123 ||| IN
4Â°C ||| S:32123 E:32126 ||| CD
.  ||| S:32126 E:32128 ||| .
The  ||| S:32128 E:32142 ||| DT
supernatant  ||| S:32142 E:32154 ||| NN
was  ||| S:32154 E:32158 ||| VBD
assayed  ||| S:32158 E:32166 ||| VBN
for  ||| S:32166 E:32170 ||| IN
caspase  ||| S:32170 E:32178 ||| JJ
activity  ||| S:32178 E:32187 ||| NN
in  ||| S:32187 E:32190 ||| IN
20  ||| S:32190 E:32193 ||| CD
mM  ||| S:32193 E:32206 ||| JJ
Piperazine-N ||| S:32206 E:32218 ||| NN
, ||| S:32218 E:32219 ||| ,
N ||| S:32219 E:32220 ||| NNP
' ||| S:32220 E:32221 ||| POS
-bis ||| S:32221 E:32225 ||| JJ
( ||| S:32225 E:32226 ||| -LRB-
2-ethanesulfonic  ||| S:32226 E:32243 ||| NNP
acid ||| S:32243 E:32247 ||| NN
)  ||| S:32247 E:32249 ||| -RRB-
( ||| S:32249 E:32250 ||| -LRB-
pH  ||| S:32250 E:32253 ||| NNP
6.8 ||| S:32253 E:32256 ||| CD
) ||| S:32256 E:32257 ||| -RRB-
,  ||| S:32257 E:32259 ||| ,
100  ||| S:32259 E:32273 ||| CD
mM  ||| S:32273 E:32276 ||| JJ
NaCl ||| S:32276 E:32280 ||| NN
,  ||| S:32280 E:32282 ||| ,
1  ||| S:32282 E:32284 ||| CD
mM  ||| S:32284 E:32287 ||| JJ
EDTA ||| S:32287 E:32291 ||| NNP
,  ||| S:32291 E:32293 ||| ,
1 ||| S:32293 E:32294 ||| CD
%  ||| S:32294 E:32296 ||| NN
CHAPS ||| S:32296 E:32301 ||| NNP
,  ||| S:32301 E:32303 ||| ,
and  ||| S:32303 E:32307 ||| CC
10 ||| S:32307 E:32309 ||| CD
%  ||| S:32309 E:32311 ||| NN
sucrose  ||| S:32311 E:32319 ||| NN
with  ||| S:32319 E:32334 ||| IN
Z-IETD-AFC  ||| S:32334 E:32345 ||| JJ
for  ||| S:32345 E:32349 ||| IN
caspase  ||| S:32349 E:32357 ||| CD
8  ||| S:32357 E:32359 ||| CD
[  ||| S:32359 E:32361 ||| -LRB-
42  ||| S:32361 E:32364 ||| CD
43  ||| S:32364 E:32367 ||| CD
]  ||| S:32367 E:32369 ||| -RRB-
.  ||| S:32369 E:32371 ||| .
The  ||| S:32371 E:32375 ||| DT
release  ||| S:32375 E:32383 ||| NN
of  ||| S:32383 E:32386 ||| IN
the  ||| S:32386 E:32400 ||| DT
fluorogenic-leaving  ||| S:32400 E:32420 ||| JJ
group  ||| S:32420 E:32426 ||| NN
was  ||| S:32426 E:32430 ||| VBD
detected  ||| S:32430 E:32439 ||| VBN
by  ||| S:32439 E:32442 ||| IN
excitation  ||| S:32442 E:32453 ||| NN
at  ||| S:32453 E:32466 ||| IN
400  ||| S:32466 E:32470 ||| CD
nm  ||| S:32470 E:32473 ||| NNS
and  ||| S:32473 E:32477 ||| CC
emission  ||| S:32477 E:32486 ||| NN
at  ||| S:32486 E:32489 ||| IN
505  ||| S:32489 E:32493 ||| CD
nm ||| S:32493 E:32495 ||| NNS
.  ||| S:32495 E:32497 ||| .
Free  ||| S:32497 E:32502 ||| NNP
AFC  ||| S:32502 E:32506 ||| NNP
was  ||| S:32506 E:32510 ||| VBD
used  ||| S:32510 E:32515 ||| VBN
to  ||| S:32515 E:32528 ||| TO
generate  ||| S:32528 E:32537 ||| VB
standard  ||| S:32537 E:32546 ||| JJ
curve ||| S:32546 E:32551 ||| NN
.  ||| S:32551 E:32581 ||| .
PI3K  ||| S:32581 E:32586 ||| NNP
activity  ||| S:32586 E:32595 ||| NN
assay  ||| S:32595 E:32611 ||| VBZ
Crude  ||| S:32611 E:32617 ||| JJ
membrane  ||| S:32617 E:32626 ||| JJ
fractions  ||| S:32626 E:32636 ||| NNS
were  ||| S:32636 E:32641 ||| VBD
isolated  ||| S:32641 E:32650 ||| VBN
from  ||| S:32650 E:32655 ||| IN
CHO.asbt  ||| S:32655 E:32674 ||| NNP
and  ||| S:32674 E:32678 ||| CC
McNtcp.24  ||| S:32678 E:32688 ||| CD
cells  ||| S:32688 E:32694 ||| NNS
as  ||| S:32694 E:32697 ||| RB
described  ||| S:32697 E:32707 ||| VBN
previously  ||| S:32707 E:32718 ||| RB
[  ||| S:32718 E:32720 ||| -LRB-
44  ||| S:32720 E:32723 ||| CD
]  ||| S:32723 E:32725 ||| -RRB-
.  ||| S:32725 E:32727 ||| .
To  ||| S:32727 E:32740 ||| TO
prepare  ||| S:32740 E:32748 ||| VB
lipid  ||| S:32748 E:32754 ||| JJ
suspension ||| S:32754 E:32764 ||| NN
,  ||| S:32764 E:32766 ||| ,
phosphatidylserine  ||| S:32766 E:32785 ||| NN
and  ||| S:32785 E:32799 ||| CC
phosphatidylinositol  ||| S:32799 E:32820 ||| NNS
( ||| S:32820 E:32821 ||| -LRB-
1 ||| S:32821 E:32822 ||| LS
: ||| S:32822 E:32823 ||| :
1 ||| S:32823 E:32824 ||| LS
)  ||| S:32824 E:32826 ||| -RRB-
were  ||| S:32826 E:32831 ||| VBD
sonicated  ||| S:32831 E:32841 ||| VBN
in  ||| S:32841 E:32844 ||| IN
25  ||| S:32844 E:32847 ||| CD
mM  ||| S:32847 E:32860 ||| JJ
3- ||| S:32860 E:32862 ||| NNP
( ||| S:32862 E:32863 ||| -LRB-
N-morpholino ||| S:32863 E:32875 ||| NNP
) ||| S:32875 E:32876 ||| -RRB-
propanesulfonic  ||| S:32876 E:32892 ||| JJ
acid  ||| S:32892 E:32897 ||| NN
( ||| S:32897 E:32898 ||| -LRB-
MOPS ||| S:32898 E:32902 ||| NNP
;  ||| S:32902 E:32904 ||| :
pH  ||| S:32904 E:32907 ||| JJ
7.0 ||| S:32907 E:32910 ||| CD
) ||| S:32910 E:32911 ||| -RRB-
,  ||| S:32911 E:32913 ||| ,
1  ||| S:32913 E:32915 ||| CD
mM  ||| S:32915 E:32928 ||| JJ
EGTA ||| S:32928 E:32932 ||| NNP
,  ||| S:32932 E:32934 ||| ,
1  ||| S:32934 E:32936 ||| CD
mM  ||| S:32936 E:32939 ||| JJ
Na  ||| S:32939 E:32953 ||| NNP
3  ||| S:32953 E:32955 ||| CD
VO  ||| S:32955 E:32969 ||| CD
4  ||| S:32969 E:32971 ||| CD
.  ||| S:32971 E:32973 ||| .
Cell  ||| S:32973 E:32978 ||| NN
extracts  ||| S:32978 E:32987 ||| NNS
were  ||| S:32987 E:32992 ||| VBD
assayed  ||| S:32992 E:33000 ||| VBN
in  ||| S:33000 E:33003 ||| IN
25  ||| S:33003 E:33016 ||| CD
mM  ||| S:33016 E:33019 ||| JJ
MOPS  ||| S:33019 E:33024 ||| NNP
( ||| S:33024 E:33025 ||| -LRB-
pH  ||| S:33025 E:33028 ||| NNP
7.5 ||| S:33028 E:33031 ||| CD
) ||| S:33031 E:33032 ||| -RRB-
,  ||| S:33032 E:33034 ||| ,
5  ||| S:33034 E:33036 ||| CD
mM  ||| S:33036 E:33039 ||| JJ
MgCl  ||| S:33039 E:33055 ||| JJ
2  ||| S:33055 E:33057 ||| CD
,  ||| S:33057 E:33059 ||| ,
1  ||| S:33059 E:33061 ||| CD
mM  ||| S:33061 E:33064 ||| JJ
EGTA ||| S:33064 E:33068 ||| NNP
,  ||| S:33068 E:33070 ||| ,
1  ||| S:33070 E:33072 ||| CD
mM  ||| S:33072 E:33075 ||| JJ
Na  ||| S:33075 E:33089 ||| NNP
3  ||| S:33089 E:33091 ||| CD
VO  ||| S:33091 E:33105 ||| CD
4  ||| S:33105 E:33107 ||| CD
,  ||| S:33107 E:33109 ||| ,
130  ||| S:33109 E:33113 ||| CD
Î¼M  ||| S:33113 E:33116 ||| JJ
ATP ||| S:33116 E:33119 ||| NNP
,  ||| S:33119 E:33121 ||| ,
20  ||| S:33121 E:33124 ||| CD
Î¼Ci  ||| S:33124 E:33128 ||| NNS
[  ||| S:33128 E:33130 ||| -LRB-
32P ||| S:33130 E:33133 ||| NNP
] ||| S:33133 E:33134 ||| -RRB-
-ATP  ||| S:33134 E:33149 ||| NNP
( ||| S:33149 E:33150 ||| -LRB-
3000  ||| S:33150 E:33155 ||| CD
Ci ||| S:33155 E:33157 ||| CD
/ ||| S:33157 E:33158 ||| CD
mmol ||| S:33158 E:33162 ||| CD
)  ||| S:33162 E:33164 ||| -RRB-
and  ||| S:33164 E:33168 ||| CC
0.2  ||| S:33168 E:33172 ||| CD
mg ||| S:33172 E:33174 ||| FW
/ ||| S:33174 E:33175 ||| FW
ml  ||| S:33175 E:33178 ||| FW
sonicated  ||| S:33178 E:33188 ||| FW
lipids ||| S:33188 E:33194 ||| FW
.  ||| S:33194 E:33196 ||| .
The  ||| S:33196 E:33210 ||| DT
reaction  ||| S:33210 E:33219 ||| NN
was  ||| S:33219 E:33223 ||| VBD
allowed  ||| S:33223 E:33231 ||| VBN
to  ||| S:33231 E:33234 ||| TO
proceed  ||| S:33234 E:33242 ||| VB
for  ||| S:33242 E:33246 ||| IN
10  ||| S:33246 E:33249 ||| CD
min  ||| S:33249 E:33253 ||| NN
at  ||| S:33253 E:33256 ||| IN
37Â°C  ||| S:33256 E:33261 ||| NNP
and  ||| S:33261 E:33275 ||| CC
stopped  ||| S:33275 E:33283 ||| VBD
by  ||| S:33283 E:33286 ||| IN
addition  ||| S:33286 E:33295 ||| NN
of  ||| S:33295 E:33298 ||| IN
300  ||| S:33298 E:33302 ||| CD
Î¼l  ||| S:33302 E:33305 ||| NN
of  ||| S:33305 E:33308 ||| IN
1N  ||| S:33308 E:33311 ||| NNP
HCl ||| S:33311 E:33314 ||| NNP
: ||| S:33314 E:33315 ||| :
methanol  ||| S:33315 E:33324 ||| CD
( ||| S:33324 E:33325 ||| -LRB-
1 ||| S:33325 E:33326 ||| LS
: ||| S:33326 E:33327 ||| :
1 ||| S:33327 E:33328 ||| LS
) ||| S:33328 E:33329 ||| -RRB-
.  ||| S:33329 E:33341 ||| .
Lipids  ||| S:33341 E:33348 ||| NNP
were  ||| S:33348 E:33353 ||| VBD
extracted  ||| S:33353 E:33363 ||| VBN
twice  ||| S:33363 E:33369 ||| RB
with  ||| S:33369 E:33374 ||| IN
350  ||| S:33374 E:33378 ||| CD
Î¼l  ||| S:33378 E:33381 ||| CD
chloroform  ||| S:33381 E:33392 ||| NNS
and  ||| S:33392 E:33406 ||| CC
the  ||| S:33406 E:33410 ||| DT
organic  ||| S:33410 E:33418 ||| JJ
phases  ||| S:33418 E:33425 ||| NNS
from  ||| S:33425 E:33430 ||| IN
both  ||| S:33430 E:33435 ||| DT
extractions  ||| S:33435 E:33447 ||| NN
were  ||| S:33447 E:33452 ||| VBD
combined  ||| S:33452 E:33471 ||| VBN
then  ||| S:33471 E:33476 ||| RB
washed  ||| S:33476 E:33483 ||| VBN
once  ||| S:33483 E:33488 ||| RB
with  ||| S:33488 E:33493 ||| IN
700  ||| S:33493 E:33497 ||| CD
Î¼l  ||| S:33497 E:33500 ||| CD
1  ||| S:33500 E:33502 ||| CD
N  ||| S:33502 E:33504 ||| NNP
HCl ||| S:33504 E:33507 ||| NNP
/ ||| S:33507 E:33508 ||| NNP
methanol  ||| S:33508 E:33517 ||| NN
( ||| S:33517 E:33518 ||| -LRB-
1 ||| S:33518 E:33519 ||| LS
: ||| S:33519 E:33520 ||| :
1 ||| S:33520 E:33521 ||| LS
) ||| S:33521 E:33522 ||| -RRB-
.  ||| S:33522 E:33534 ||| .
Lipids  ||| S:33534 E:33541 ||| NNP
were  ||| S:33541 E:33546 ||| VBD
dried ||| S:33546 E:33551 ||| VBN
,  ||| S:33551 E:33553 ||| ,
and  ||| S:33553 E:33557 ||| CC
then  ||| S:33557 E:33562 ||| RB
taken  ||| S:33562 E:33568 ||| VBN
up  ||| S:33568 E:33571 ||| RP
in  ||| S:33571 E:33584 ||| IN
chloroform ||| S:33584 E:33594 ||| NNS
: ||| S:33594 E:33595 ||| :
methanol  ||| S:33595 E:33604 ||| CD
( ||| S:33604 E:33605 ||| -LRB-
1 ||| S:33605 E:33606 ||| LS
: ||| S:33606 E:33607 ||| :
1 ||| S:33607 E:33608 ||| LS
) ||| S:33608 E:33609 ||| -RRB-
.  ||| S:33609 E:33611 ||| .
The  ||| S:33611 E:33615 ||| DT
samples  ||| S:33615 E:33623 ||| NNS
were  ||| S:33623 E:33628 ||| VBD
spotted  ||| S:33628 E:33636 ||| VBN
along  ||| S:33636 E:33652 ||| RP
with  ||| S:33652 E:33657 ||| IN
pure  ||| S:33657 E:33662 ||| JJ
phosphoinositol  ||| S:33662 E:33678 ||| JJ
phosphate  ||| S:33678 E:33688 ||| JJ
standards  ||| S:33688 E:33698 ||| NNS
( ||| S:33698 E:33699 ||| -LRB-
Avanti  ||| S:33699 E:33716 ||| NNP
Polar  ||| S:33716 E:33722 ||| NNP
Lipids ||| S:33722 E:33728 ||| NNP
,  ||| S:33728 E:33730 ||| ,
Alabaster ||| S:33730 E:33739 ||| NNP
,  ||| S:33739 E:33741 ||| ,
AL ||| S:33741 E:33743 ||| NNP
,  ||| S:33743 E:33745 ||| ,
USA ||| S:33745 E:33748 ||| NNP
)  ||| S:33748 E:33750 ||| -RRB-
onto  ||| S:33750 E:33755 ||| IN
1.2 ||| S:33755 E:33758 ||| CD
%  ||| S:33758 E:33760 ||| NN
potassium  ||| S:33760 E:33780 ||| FW
oxalate  ||| S:33780 E:33788 ||| FW
impregnated  ||| S:33788 E:33800 ||| FW
TLC  ||| S:33800 E:33804 ||| FW
plates  ||| S:33804 E:33811 ||| FW
[  ||| S:33811 E:33813 ||| -LRB-
45  ||| S:33813 E:33816 ||| CD
]  ||| S:33816 E:33818 ||| -RRB-
.  ||| S:33818 E:33820 ||| .
The  ||| S:33820 E:33824 ||| DT
chromatogram  ||| S:33824 E:33847 ||| NN
was  ||| S:33847 E:33851 ||| VBD
developed  ||| S:33851 E:33861 ||| VBN
in  ||| S:33861 E:33864 ||| IN
chloroform ||| S:33864 E:33874 ||| NNS
:  ||| S:33874 E:33876 ||| :
methanol ||| S:33876 E:33884 ||| NN
:  ||| S:33884 E:33886 ||| :
water ||| S:33886 E:33891 ||| NN
:  ||| S:33891 E:33893 ||| :
aqueous  ||| S:33893 E:33911 ||| FW
ammonia  ||| S:33911 E:33919 ||| FW
( ||| S:33919 E:33920 ||| -LRB-
90 ||| S:33920 E:33922 ||| CD
: ||| S:33922 E:33923 ||| :
70 ||| S:33923 E:33925 ||| CD
: ||| S:33925 E:33926 ||| :
17 ||| S:33926 E:33928 ||| CD
: ||| S:33928 E:33929 ||| :
3 ||| S:33929 E:33930 ||| LS
)  ||| S:33930 E:33932 ||| -RRB-
[  ||| S:33932 E:33934 ||| -LRB-
46  ||| S:33934 E:33937 ||| CD
]  ||| S:33937 E:33939 ||| -RRB-
.  ||| S:33939 E:33941 ||| .
The  ||| S:33941 E:33945 ||| DT
incorporation  ||| S:33945 E:33959 ||| NN
of  ||| S:33959 E:33962 ||| IN
[  ||| S:33962 E:33964 ||| -LRB-
32P ||| S:33964 E:33967 ||| NNP
]  ||| S:33967 E:33979 ||| -RRB-
into  ||| S:33979 E:33984 ||| IN
phosphatidylinositol  ||| S:33984 E:34005 ||| NN
was  ||| S:34005 E:34009 ||| VBD
quantitated  ||| S:34009 E:34021 ||| VBN
by  ||| S:34021 E:34034 ||| IN
phosphorimaging  ||| S:34034 E:34050 ||| NNS
using  ||| S:34050 E:34056 ||| VBG
a  ||| S:34056 E:34058 ||| DT
Fuji  ||| S:34058 E:34063 ||| NNP
BAS1000  ||| S:34063 E:34071 ||| NNP
phosphorimager ||| S:34071 E:34085 ||| NN
.  ||| S:34085 E:34097 ||| .
Visualization  ||| S:34097 E:34111 ||| NNP
of  ||| S:34111 E:34114 ||| IN
standards  ||| S:34114 E:34124 ||| NNS
was  ||| S:34124 E:34128 ||| VBD
done  ||| S:34128 E:34133 ||| VBN
by  ||| S:34133 E:34136 ||| IN
dippingTLC  ||| S:34136 E:34147 ||| JJ
plates  ||| S:34147 E:34164 ||| NN
in  ||| S:34164 E:34167 ||| IN
10 ||| S:34167 E:34169 ||| CD
%  ||| S:34169 E:34171 ||| NN
CuSO  ||| S:34171 E:34187 ||| JJ
4  ||| S:34187 E:34189 ||| CD
, ||| S:34189 E:34190 ||| ,
10 ||| S:34190 E:34192 ||| CD
%  ||| S:34192 E:34194 ||| NN
H  ||| S:34194 E:34207 ||| NNP
3  ||| S:34207 E:34209 ||| CD
PO  ||| S:34209 E:34223 ||| CD
4  ||| S:34223 E:34225 ||| CD
and  ||| S:34225 E:34229 ||| CC
heating  ||| S:34229 E:34237 ||| NN
at  ||| S:34237 E:34240 ||| IN
200Â°C  ||| S:34240 E:34246 ||| CD
for  ||| S:34246 E:34250 ||| IN
10  ||| S:34250 E:34253 ||| CD
min ||| S:34253 E:34256 ||| NNS
.  ||| S:34256 E:34286 ||| .
Statistical  ||| S:34286 E:34298 ||| JJ
analysis  ||| S:34298 E:34317 ||| NN
Each  ||| S:34317 E:34322 ||| DT
set  ||| S:34322 E:34326 ||| NN
of  ||| S:34326 E:34329 ||| IN
experiments  ||| S:34329 E:34341 ||| NNS
was  ||| S:34341 E:34345 ||| VBD
repeated  ||| S:34345 E:34354 ||| VBN
at  ||| S:34354 E:34357 ||| IN
least  ||| S:34357 E:34363 ||| JJS
twice ||| S:34363 E:34368 ||| RB
.  ||| S:34368 E:34380 ||| .
The  ||| S:34380 E:34384 ||| DT
data  ||| S:34384 E:34389 ||| NN
is  ||| S:34389 E:34392 ||| VBZ
represented  ||| S:34392 E:34404 ||| VBN
by  ||| S:34404 E:34407 ||| IN
means  ||| S:34407 E:34413 ||| VBZ
Â±  ||| S:34413 E:34415 ||| NNP
SD ||| S:34415 E:34417 ||| NNP
.  ||| S:34417 E:34419 ||| .
Differences  ||| S:34419 E:34441 ||| NNS
between  ||| S:34441 E:34449 ||| IN
control  ||| S:34449 E:34457 ||| NN
and  ||| S:34457 E:34461 ||| CC
test  ||| S:34461 E:34466 ||| NN
cells  ||| S:34466 E:34472 ||| NNS
were  ||| S:34472 E:34477 ||| VBD
evaluated  ||| S:34477 E:34487 ||| VBN
by  ||| S:34487 E:34490 ||| IN
a  ||| S:34490 E:34502 ||| DT
Student ||| S:34502 E:34509 ||| NNP
's  ||| S:34509 E:34523 ||| POS
t  ||| S:34523 E:34525 ||| JJ
test ||| S:34525 E:34529 ||| NN
.  ||| S:34529 E:34531 ||| .
Differences  ||| S:34531 E:34543 ||| NNS
in  ||| S:34543 E:34546 ||| IN
the  ||| S:34546 E:34550 ||| DT
slope  ||| S:34550 E:34556 ||| NN
of  ||| S:34556 E:34569 ||| IN
regression  ||| S:34569 E:34580 ||| JJ
lines  ||| S:34580 E:34586 ||| NNS
were  ||| S:34586 E:34591 ||| VBD
evaluated  ||| S:34591 E:34601 ||| VBN
by  ||| S:34601 E:34604 ||| IN
analysis  ||| S:34604 E:34613 ||| NN
of  ||| S:34613 E:34616 ||| IN
variance ||| S:34616 E:34624 ||| NN
.  ||| S:34624 E:34636 ||| .
P  ||| S:34636 E:34638 ||| NN
values  ||| S:34638 E:34645 ||| NNS
of  ||| S:34645 E:34648 ||| IN
< ||| S:34648 E:34649 ||| SYM
0.05  ||| S:34649 E:34654 ||| CD
were  ||| S:34654 E:34659 ||| VBD
considered  ||| S:34659 E:34670 ||| VBN
statistically  ||| S:34670 E:34694 ||| RB
significant ||| S:34694 E:34705 ||| JJ
.  ||| S:34705 E:34738 ||| .
List  ||| S:34738 E:34743 ||| NN
of  ||| S:34743 E:34746 ||| IN
abbreviations  ||| S:34746 E:34760 ||| VBG
used  ||| S:34760 E:34773 ||| VBN
asbt ||| S:34773 E:34777 ||| NN
,  ||| S:34777 E:34779 ||| ,
apical  ||| S:34779 E:34786 ||| FW
sodium ||| S:34786 E:34792 ||| FW
/ ||| S:34792 E:34793 ||| FW
bile  ||| S:34793 E:34798 ||| FW
acid  ||| S:34798 E:34803 ||| FW
cotransporter ||| S:34803 E:34816 ||| FW
;  ||| S:34816 E:34818 ||| :
GCA ||| S:34818 E:34821 ||| NNP
,  ||| S:34821 E:34831 ||| ,
glycocholic  ||| S:34831 E:34843 ||| JJ
acid ||| S:34843 E:34847 ||| NN
;  ||| S:34847 E:34849 ||| :
GCDCA ||| S:34849 E:34854 ||| NNP
,  ||| S:34854 E:34856 ||| ,
glycochenodeoxycholic  ||| S:34856 E:34878 ||| JJ
acid ||| S:34878 E:34882 ||| NN
;  ||| S:34882 E:34884 ||| :
HBAB ||| S:34884 E:34888 ||| NNP
,  ||| S:34888 E:34898 ||| ,
human  ||| S:34898 E:34904 ||| JJ
bile  ||| S:34904 E:34909 ||| JJ
acid  ||| S:34909 E:34914 ||| NN
binder ||| S:34914 E:34920 ||| NNS
;  ||| S:34920 E:34922 ||| :
LDH ||| S:34922 E:34925 ||| NNP
,  ||| S:34925 E:34927 ||| ,
lactate  ||| S:34927 E:34935 ||| JJ
dehydrogenase ||| S:34935 E:34948 ||| NN
;  ||| S:34948 E:34950 ||| :
PI3K ||| S:34950 E:34954 ||| CD
,  ||| S:34954 E:34964 ||| ,
phosphatidylinositol  ||| S:34964 E:34985 ||| CD
3-kinase ||| S:34985 E:34993 ||| CD
;  ||| S:34993 E:34995 ||| :
TCA ||| S:34995 E:34998 ||| NNP
,  ||| S:34998 E:35000 ||| ,
taurocholic  ||| S:35000 E:35012 ||| JJ
acid ||| S:35012 E:35016 ||| NN
,  ||| S:35016 E:35026 ||| ,
TCDCA ||| S:35026 E:35031 ||| NNP
,  ||| S:35031 E:35033 ||| ,
taurochenodeoxycholic  ||| S:35033 E:35055 ||| FW
acid  ||| S:35055 E:35075 ||| FW
